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Abstract 
Incidences of foodborne gastroenteritis cases are at least four million annually in 
Australia, costing the country about $1.2 billion per year. OzFoodNet reported 154 
separate outbreaks of foodborne and suspected foodborne illnesses in 2012, affecting 
2,146 people including 157 cases of hospitalisation and 15 deaths. The overall rate of 
foodborne disease outbreaks was reported to be 6.9 per million population in 2010. This 
demonstrates the economic and social significance of research into antimicrobial agents 
that can potentially contribute to food safety.   
 
Lactic acid bacteria (LAB) have a long history of application in fermented foods because of 
their beneficial influence on nutritional, organoleptic, and shelf-life characteristics. The 
use of functional starter cultures of LAB to confer functionalities beyond acidification is 
attracting increasing interest. LAB produce a variety of compounds with antimicrobial 
activities, these include bacteriocins which are small proteins having antimicrobial activity 
against bacterial species closely related to the producer strain and / or other bacteria. As 
the demand for natural additive free and microbiologically safe food products grows, 
bacteriocin producing-LAB have considerable potential in the food industry as natural 
food preservatives. 
 
Lactobacillus plantarum B21 was previously isolated from Vietnamese sausages (nem 
chua) by Tran in 2010. The bacteriocin produced by this strain demonstrated inhibition of 
Gram-positive bacterial growth with good pH stability (pH 3.0 - 10.0) and moderate 
thermo-stability (up to 20 min at 90 °C). The B21 bacteriocin was selected for further 
characterization due to these properties and its rather unique source. The aim of this 
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project was to study the genes responsible for bacteriocin production and to purify and 
characterise the bacteriocin produced by L. plantarum B21. The study was extended 
subsequently to other isolates from the same source. 
 
The first objective was to study the effect of various growth factors on L. plantarum B21 
growth and bacteriocin production. The antimicrobial activity of LAB strain B21 was 
evaluated against a range of indicator strains and the proteinaceous nature of the 
antimicrobial activity was confirmed. The antimicrobial activity of seven other LAB strains 
also isolated from nem chua (B14, B15, B20, B31, B33, A6 and A17) was also investigated. 
Two other strains (B31 and B33) demonstrated significant antimicrobial activity. The 
optimum culture conditions for bacteriocin production by LAB B21 were determined 
purification and characterisation.  
 
In the second part of this study, 16S rRNA sequencing was used to identify and classify the 
new LAB strains.  Two of the LAB isolates (B14 and B15) showed 100% identity to L. brevis 
species, while six other isolates (B20, B21, B31, B33, A6 and A17) were  
L. plantarum. The pln locus responsible for production of classical bacteriocin(s) in  
L. plantarum strains has been widely studied. An existing pln locus from recent genomic 
data was used to design specific primers to identify the bacteriocin related genes and to 
map their classical pln loci in detail. This enabled the development of a classification for 
the new L. plantarum strains based on their pln locus organisation and structure. The pln 
locus of L. plantarum B20, B21, B31 and B33 was highly similar to the pln locus 
organisation in L. plantarum WCFS1 and C11, while the pln locus of strain A6 showed 
more similarity to L. plantarum J23. The pln structural genes from strain B21 and a 
xxx 
 
number of associated but non-bacteriocin related genes from other LAB strains were 
sequenced and studied at the bioinformatics level.  
 
Commercial Illumina-based genome Next Generation Sequencing (NGS) was undertaken 
for LAB B21 to provide a new reference genome for the best bacteriocin producer, the full 
pln locus was also mapped and compared with published data.  The locus was shown to 
be impaired by a novel transposon insertion interrupting the bacteriocin production 
regulatory operon plnABCD. A PCR-based approach was used to identify the same 
transposon gene in some of the other new LAB strains. The transposon appeared to be 
unique, and had not been reported previously in L. plantarum strains. 
 
In order to identify the similarities and differences between the remaining strains B20, 
B21 and A6 pln loci and the new reference genome for B21, in-house genome sequencing 
using the Ion Proton system was carried out. Two non-bacteriocin producing strains  
L. brevis B15 and L. plantarum A17 were also sequenced for overall comparison with the 
genome data for the bacteriocin producing strains and B21 in particular.  
 
Since genome data showed that the function of the classical pln locus was impaired at the 
genetic level, the question of identifying the actual bacteriocin responsible for its 
antimicrobial activity still needed to be resolved. The bacteriocin protein from the B21 
culture supernatant was purified by a four-step process. This consisted of a cell free 
supernatant (CFS) concentration step, extraction into butanol, desalting/buffer-exchange 
on Sephadex G-25 and a final cation exchange chromatography (FPLC) step. The overall 
bacteriocin yield was approximately 19% and the overall purification factor was more 
xxxi 
 
than 8,000-fold. A simple back calculation suggested that LAB B21 produces 
approximately 1 µg/mL bacteriocin in its CFS.  
 
Further analysis was then performed on the purified bacteriocin from LAB B21. The 
bacteriocin protein showed great stability during eight weeks of storage at 4 °C.  
Tris-Tricine-SDS-PAGE suggested a molecular weight of approx. 5.5 kDa and  
MALDI-TOF MS measurements of 5668 Da. The purity of the protein sample was 
confirmed by a single major peak on a RP-HPLC C18 column and single peak on MALDI. The 
UV-Vis data and the peptide sequence were then used to calculate a molar extinction 
coefficient at 280 nm and showed a clear Trp signal. CD spectroscopy was used to 
investigate the secondary structure of the protein and showed that the protein structure 
consisted of 63% α-helix. Initial attempts to determine the N-terminal amino acid 
sequence of the B21 bacteriocin protein by Edman-degradation failed, suggesting that the 
peptide was potentially N-terminally blocked. A de novo sequencing approach was then 
taken to identify the peptide sequence of the purified bacteriocin protein using  
LC-MS/MS techniques. Two short sequences were manually obtained from the MS/MS 
data and were searched against a six frame translation of the entire B21 genome. A 
strong hit was found which correctly predicted the remaining B ions in the MS/MS data. 
Furthermore a mass discrepancy of 18 Da between the theoretical and experimental 
masses, strongly suggested that the bacteriocin was in fact cyclic. The new bacteriocin 
was named plantacyclin B21AG. The bacteriocin sequence was that of a new member of 
the cyclic bacteriocin family with 67% identity over the mature sequence to a known 
homolog. The bacteriocin locus responsible for its production was fully mapped to the 
genome data and its gene structure analysed. On the basis of extensive literature review 
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and to the best of our knowledge, plantacyclin B21AG presently appears to be the only 
cyclic bacteriocin produced from L. plantarum. 
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Chapter 1 
Introduction 
1.1 Lactic acid bacteria (LAB) and introduction to bacteriocins 
1.1.1 Introduction to LAB  
In 1873, ten years after Louis Pasteur studied lactic acid fermentation, the first pure 
culture of a lactic acid bacterium (“Bacterium lactis”) was obtained by Joseph Lister 
(1878).  LAB are characterized by the production of lactic acid as a major catabolic end 
product from glucose (König & Fröhlich 2009). LAB consists of a group of Gram-positive 
bacteria sharing similar morphological, metabolic and physiological characteristics (Lars 
2011). They are non-sporulating, catalase negative in the absence of porphorinoids, 
aerotolerant, acid tolerant, organotrophic, and strictly fermentative rod or cocci which 
produce lactic acid as the main fermentation end product of (König & Fröhlich 2009; Lars 
2011). 
  
LAB have been associated with food and feed (meat, vegetables, fruits, beverages, dairy 
products, and silage) fermentations and are generally considered beneficial organisms, 
some strains are seen as health-promoting bacteria (Lars 2011; Vandamme et al. 1996). 
LAB have a beneficial influence on nutritional, organoleptic, and shelf-life characteristics 
of fermented products as well as inhibiting the growth of food spoiling bacteria by the 
production of antimicrobial substances and the production of large amounts of lactic acid 
(Adetunji & Adegoke 2007; De Vuyst & Leroy 2007). LAB are also known to be involved in 
the spoilage of some food products including beer and wine and to occur in the 
respiratory, intestinal, and genital tracts of humans and animals, in sewage, and in plant 
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materials (Vandamme et al. 1996). Some genera of LAB (Streptococcus, Lactococcus, 
Enterococcus, and Carnobacterium) contain species that are recognised as human or 
animal pathogens (Lars 2011).  
 
LAB are widely used as starter cultures in fermented food products. Industrial food 
fermentation is currently performed by the addition of LAB as starter cultures, replacing 
the traditional back-sloping process, resulting in better product consistency and quality 
control (De Vuyst & Leroy 2007). In recent decades, the use of functional starter cultures 
that offer functionalities over and above acidification has received increasing attention  
(Cotter, Hill & Ross 2005; Cotter, Ross & Hill 2012; Hernández, Cardell & Zárate 2005; 
Müller et al. 2009; Papagianni & Anastasiadou 2009; Settanni & Corsetti 2008; Smaoui et 
al. 2010). LAB are capable of inhibiting the growth of various microorganisms in a food 
environment and display attractive antimicrobial properties with respect to food 
preservation and safety (Abee, Krockel & Hill 1995; Cleveland et al. 2001; Jeevaratnam, 
Jamuna & Bawa 2004; Stiles & Hastings 1991). 
 
1.1.2 Classification of LAB  
Some of the important criteria for classification of LAB are, morphology (rods, cocci, 
tetrads), mode of glucose fermentation, substrate spectrum, growth at different 
temperatures (15 to 45 °C), stereoisomer of lactic acid produced and ability to grow at 
high salt concentrations (up to 18% NaCl). Other attributes used in classification include 
acid, alkaline or ethanol tolerance, fatty acid cell wall composition, PCR-based 
fingerprinting techniques, DNA-DNA homology, soluble protein pattern, 16S rDNA and 
gene sequencing (Axelsson 2004; König & Fröhlich 2009).  
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The division of lactobacilli into three groups (Thermobacterium, Streptobacterium, and 
Betabacterium) on the basis of their fermentation patterns, as suggested by Orla-Jensen 
(1919), is still used for pragmatic reasons, however it does not reflect the current 
phylogeny of the genus (Lars, 2011). The LAB belong to the Gram-positive bacteria, 
phylum Firmicutes, with ‘low’ (≤55 mol%) GC in the DNA, class Bacilli, and order 
Lactobacillales, according to current taxonomic classification (Holzapfel & Wood 2014; 
Lars 2011). The three classes of the Firmicutes consist of Clostridia (Class I), Mollicutes 
(Class II) and Bacilli (Class III). Based on comparative sequence analysis of the 16S rRNA, 
lower GC content (≤55 mol%), is the main factor distinguishing the Firmicutes from the 
other Gram-positive phylum (Actinobacteria), which have ≥55 mol% GC content 
(Holzapfel & Wood 2014). The Lactobacillales consists of six families with more than 30 
genera and an increasing number of species, >200 by end of 2011 (Holzapfel & Wood 
2014). The current taxonomic outline of LAB is presented in Table 1.1. The six different 
families include Aerococcaceae, Carnobacteriacea, Enterococcaceae, Lactobacillaceae, 
Leuconostocaceae and Streptococcaceae with the common genera consist of 
Carnobacterium, Enterococcus, Lactobacillus, Lactococcus, Leuconostoc, Oenococcus, 
Pediococcus, Streptococcus, Tetragenococcus, Vagococcus, and Weissella (Vandamme et 
al. 1996).   
 
The food associated LAB tend to belong to the genera: Carnobacterium, Enterococcus, 
LactobacilIus, Lactococcus, Leuconostoc, Oenococcus, Pediococcus, Streptococcus, 
Tetragenococcus, Vagococcus and Weissella (Vandamme et al. 1996) and their main 
characteristics are presented in Table 1.2. 
 
CHAPTER 1 
4 
 
The classical phenotypic identification of LAB is rather tedious and not always reliable 
(Schleifer et al. 1995). The 16s or 23s rRNA-targeted sequencing may be an alternative, 
for a faster and more reliable classification of LAB. During the last couple of years, several 
Lactobacillus species were transferred to a different Lactobacillus species groups or to 
new or already existing genera on the basis of rRNA sequencing or DNA-based typing 
methods (Holzapfel & Wood 2014; Lars 2011; Vandamme et al. 1996). These taxonomic 
reassignments are demonstrating discrepancies between the results obtained by 
traditional phenotypic tests (classical taxonomy) and more recent phylogenetic 
approaches based on molecular taxonomy (Vandamme et al. 1996). 16S rRNA sequencing 
has been widely used for the classification of LAB in recent years (Elegado et al. 2004; 
Quere, Deschamps & Urdaci 1997; Smaoui et al. 2010; Tiwari & Srivastava 2008).   
 
L. plantarum and L. brevis are among the LAB species frequently associated with food 
products (Daeschel & Fleming 1984). L. plantarrum belongs to the facultative 
heterofermentative group which is phylogenetically a very homogeneous group 
(Wassenaar & Lukjancenko 2014) whose morphology consists of short to medium rods 
that are usually arranged singly.  Their optimum growth temperature is in the range of 30-
35 °C and they can tolerate 8% NaCl in the medium (Daeschel & Fleming 1984).  
L. plantarum predominates the fermented food microbial community, particularly in the 
later period of fermentation, because of its greater acid tolerance (Daeschel, & Fleming 
1984).  L. brevis strains are obligately heterofermentative LAB consisting of short rods 
that occur singly or in short chains. Their optimum growth temperature is 30 °C and they 
generally do not grow in a medium containing 8% NaCl (Daeschel & Fleming 1984).  
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Table 1.1 Current taxonomic of LAB (König & Fröhlich 2009; Holzapfel & Wood 2014; 
Vandamme et al. 1996).  
Phylum 
Class 
Order 
 
Family 
 
Genus 
 
Species known to be 
associated with food 
products  
“Firmicutes” 
“Bacilli” 
“Lactobacillales” 
I. Lactobacillaceae I. Lactobacillus brevis 
buchneri 
casei 
curvatus 
delbrueckii 
diolivorans 
fermentum 
fructivorans 
hilgardii 
jensenii 
kunkeei 
nagelii 
paracasei 
plantarum 
  II. Paralactobacillus  
  III. Pediococcus pentosaceus 
parvulus 
damnosus 
 II. Aerococcaceae I. Aerococcus 
II. Abiotrophia 
III. Dolosicoccus 
IV. Eremococcus 
V. Facklamia 
VI. Globicatella 
VII. Ignavigranum 
 
 III. Carnobacteriaceae I. Carnobacterium 
II. Agitococcus 
III. Alkalibacterium 
IV. Allofustis 
V. Alloiococcus 
VI. Desemzia 
VII. Dolosigranulum 
VIII. Granulicatella 
IX. Isobaculum 
X. Lactosphaera 
XI. Marinilactibacillus 
XII. Trichococcus 
 
 IV. Enterococcaceae I. Enterococcus 
II. Atopobacter 
III. Melissococcus 
IV. Tetragenococcus 
V. Vagococcus 
 
 V. Leuconostocaceae I. Leuconostoc 
II. Oenococcus 
III. Weissella 
mesenteroides 
oeni 
paramesenteroides 
 VI. Streptococcaceae I. Streptococcus 
II. Lactococcus 
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Table 1.2 Common genera of LAB associated with food products and their differential characteristics (Lars 2011).   
 
Family Genera Characteristics 
Shape CO2 
from 
glucose 
Growth  
at 10 °C 
Growth  
at 45 °C 
Growth  
in 6.5% NaCl 
Growth  
in 18% NaCl 
Growth  
at pH 4.4 
Growth 
 at pH 9.6 
Type of lactic 
acid 
Carnobacteriaceae Carnobacterium Rods - + - ND - ND - L 
Enterococcaceae Enterococcus Cocci - + + + - + + L 
 Tetrageonococcus Cocci (tetrads)  + - + + -Variable +  
 Vagococcus Cocci  + - - -  -  
Lactobacillaceae Lactobacillus Rods Variable Variable Variable Variable - Variable  D, L, DL 
 Pediococcus Cocci (tetrads)
 - Variable Variable Variable - + - L, DL 
Leuconostocaecae Leuconostoc Cocci
a + + - Variable - Variable - D 
 Oenococcus  + + - Variable - Variable - D 
 Weissella  + + - Variable - Variable - D, DL 
Streptococcaceae Lactococcus
b
 Cocci - + - - - Variable - L 
 Streptococcus  - - Variable - - - - L 
Note: ND, not determined; 
a 
Some Weissella strains are rod shape; 
b 
In older literature lactococci are referred to as Group N streptococci.  
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1.1.3 Bacteriocins of LAB  
The wide spread use of currently available antibiotics in medicine and agriculture in 
recent decades, has decreased the effectiveness of antibiotics due to the selection of an 
increasing number of resistant strains (Smaoui et al. 2010). There is a growing need to 
focus on new antimicrobial agents to overcome this problem. LAB produce a variety of 
compounds with antimicrobial activity including acids, hydrogen peroxide, carbon 
dioxide, diacetyl, acetaldehyde and bacteriocins (De Vuyst & Vandamme 1994). 
Bacteriocins are protein or protein complexes with antimicrobial activity against other 
bacterial species that are usually closely related to the producer organism (Klaenhammer 
1988); however some bacteriocins demonstrate a broader spectrum of activity against 
non-related species (Cleveland et al. 2001; Gong, Meng & Wang 2010; Smaoui et al. 2010; 
Todorov & Dicks 2005). The first bacteriocin, colicin V, was discovered by Gratia in 1925.  
 
Bacteriocins are found in many Gram-positive and Gram-negative bacteria (Riley & Wertz 
2002), they are diverse in molecular weight, biochemical properties, host sensitivity, 
mode of action (Klaenhammer 1988). Bacteriocins from LAB have received particular 
attention in recent years because of their potential application in the food industry as 
natural preservatives to inhibit food spoilage and pathogenic bacteria (Cleveland et al. 
2001; Cotter, Hill & Ross 2005; De Vuyst & Leroy 2007; O’sullivan, Ross & Hill 2002; 
Settanni & Corsetti 2008). In addition to the antimicrobial activity against undesirable 
bacteria, bacteriocins are believed to contribute to the competitiveness of the producer 
bacterium (Vogel et al. 1993). This gives the bacteriocin-producing LAB considerable 
advantage as starter cultures in food applications.  
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The interest in Lactobacillus plantarum has arisen because of its application as a starter 
culture for vegetable fermentation (Daeschel & Fleming 1984; McKay & Baldwin 1990), 
and in fermented sausage products (Bacus & Brown 1985; Hugas et al. 1993; Hugas, 
Marta & Monfort 1997). A wide range of bacteriocins from L. plantarum have been 
isolated and studied (Abo-Amer 2007; Fiorentini et al. 2001; Hata, Tanaka & Ohmomo 
2010; Hurtado et al. 2011; Maldonado, Ruiz-Barba & Jiménez-Díaz 2004; Müller et al. 
2009; Ogunbanwo, Sanni & Onilude 2004; Tiwari & Srivastava 2008; Todorov 2008). 
 
1.1.4 Classification of bacteriocins 
Several approaches have been taken to classify bacteriocins. The original classification of 
bacteriocins from LAB was suggested by Klaenhammer (1993) based on the biochemical 
and genetic properties, dividing them into four major classes.  
- Class I, lantibiotics, small membrane-active peptides (< 5 kDa) containing post-
translationally modified amino acids 
- Class II, small heat-stable membrane-active peptides ( < 10 kDa) 
- Class III, larger (> 30 kDa) heat-labile proteins 
- Class IV, complex bacteriocins, containing lipid or carbohydrate molecules 
required for activity 
 
Class II was then further classified into three sub-classes, Class IIa (anti-listeria 
pediocin like bacteriocins with N-terminal sequence of -Tyr-Gly-Asn-Gly-Val-Xaa-Cys-), 
Class IIb, (two-peptide bacteriocins) and Class IIc (Thiol-activated peptides requiring 
reduced cysteine residues for activity) (Klaenhammer 1993).  
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Ten years later, Kemperman et al.  (2003) suggested a new distinct class (Class V) for 
bacteriocins consisting of ribosomally synthesized, head-to-tail-ligated cyclic 
antibacterial peptides. These are post-translationally modified (head-to-tail-ligated), 
small bacteriocins, which has taken them out of bacteriocin Classes II and III. They do 
not contain post-translationally modified amino acids or any other chemical moiety 
(lipid or carbohydrate) and cannot be classified in Class I or IV (KempermanKuipers, et 
al. 2003).  
 
Cotter et al. (2005) have recommended a modification to the Klaenhammer 
classification for LAB bacteriocins, classifying bacteriocins into two main categories: 
lantibiotics (Class I) and non-lanthionine-containing bacteriocins (Class II). The 
Klaenhammer Class III bacteriocins were renamed bacteriolysins, and Class IV was 
removed. It was suggested that the Klaenhammer Class II, sub-class IIa and IIb be 
retained, and that the class V (cyclic peptides) proposed by Kemperman et al.  (2003) 
be reassigned as class IIc. Heng et al. (2007) agreed broadly with this classification 
scheme but recommended a further modification, suggesting that cyclic bacteriocins 
be moved to a new Class IV and also favoured the retention of Class III containing the 
much larger lysins. The bacteriocin classification scheme continues to evolve and is 
adapted by most investigators in the field as new examples are discovered (Cotter, 
Ross & Hill 2012; Rea et al. 2011).  
 
We agree with the classification proposed by Heng et al. (2007) in respect of cyclic 
bacteriocins classification (Class IV). Cyclic bacteriocins go through post-translational 
modification (head-to-tail-ligation) and have typical common characteristics including 
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stability, secondary structure and biochemical properties that distinguish them from 
other class II bacteriocins and it is better that they are classified separately. The 
classification scheme proposed by Heng et al. (2007) is presented in Figure 1.1.  The 
two-peptide (Class IIb) and cyclic bacteriocins (Class IV) are the focus of this work and 
are described in detail in Sections 1.2 and 1.3.  
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Figure 1.1 Classification of bacteriocins of LAB, adapted from Heng et al. (2007). 
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1.2 Two-peptide bacteriocins (Class IIb)  
1.2.1 General characteristics of Class IIb bacteriocins 
The Class II bacteriocin group are small peptides (<10 kDa) containing standard, non-
modified amino acid residues (Klaenhammer 1993). This group was subdivided into three 
classes by Klaenhammer (1993), IIa pediocin-like, IIb two-peptide and IIc  
thiol-activated. Alternative classification schemes were suggested, but all classifications 
agree on the two major classes, the Class IIa “pediocin-like” or anti-Listeria, and the Class 
IIb two-peptide bacteriocins (Rea et al. 2011).  
 
The two-peptide (class-IIb) bacteriocins are unique as they consist of two different 
peptides and maximum activity requires complimentary peptides in approximately equal 
amounts (Anderssen et al. 1998; Dutton et al. 2001; Nissen-Meyer et al. 1992). The first 
two-peptide bacteriocin, lactococcin G, was identified by Nissen-Meyer et al. (1992). 
Since then, at least 15 two-peptide bacteriocins have been isolated and characterized 
(Nissen-Meyer et al. 2009). 
 
The three-dimensional structure of two-peptide bacteriocins is not as well characterized 
as that of the pediocin-like bacteriocins. The circular dichroism (CD) and nuclear magnetic 
resonance (NMR) structural studies have been carried on three two peptide bacteriocins 
lactococcin G, plantaricin EF and JK (Fimland et al. 2008; Hauge et al. 1998; Nissen-Meyer 
et al. 2010; Rogne et al. 2009). CD studies show that the peptides of these bacteriocins 
are unstructured in aqueous solution (Nissen-Meyer et al. 2010). 
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1.2.2 Mode of action of Class IIb bacteriocins 
In general, the amphiphilic helical structure of the bacteriocins from class II allows them 
to insert into the membrane of the target cell, leading to depolarisation and cell death 
(Cotter, Hill & Ross 2005). The studies on the mode of action of two-peptide bacteriocins, 
lactococcin G (Moll et al. 1996), thermophilin 13 (Marciset et al. 1997), plantaricin EF and 
KJ (Moll et al. 1999) and lactacin F (Abee, T, Klaenhammer & Letellier 1994), suggest that 
they make the target-cell membranes permeable to a variety of small molecules. The 
small molecules that the different two-peptide bacteriocins allow ‘to leak’ across 
membranes are specific for each bacteriocin type. For instance, plantaricin EF and JK 
render the membrane permeable to monovalent cations, including H+ (in contrast to 
lactococcin G, (Moll et al. 1996)), but not for divalent cations (Mg++) or anions 
(phosphate) (Moll et al. 1999). The leakage of various ions caused as a result of 
bacteriocin activity, dissipates the transmembrane electrical potential and / or the 
transmembrane pH gradient and eventually leads to cell death (Nissen-Meyer et al. 
2009). The ability of these bacteriocins to differentiate between molecules they transfer 
across membranes suggests that they do not cause membrane leakage by a detergent-
like disruption of membranes, but form rather sophisticated pores that show specificity 
with respect to the transport of ions (Nissen-Meyer et al. 2011).  
 
1.2.3 Genetics of Class IIb bacteriocins 
The number of amino acid residues within the two-peptide bacteriocins varies from less 
than 40 amino acid (lactococcin G, Nissen-Meyer et al. (1992)) to more than 50 residues 
(brochocin C, McCormick et al. (1998)). The genes encoding the peptides of two-peptide 
bacteriocins are located next to each other in the same operon. In the same or a 
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neighbouring operon are also located the genes for (a), the self-immunity protein, next to 
and downstream of the bacteriocin structural gene, that makes the bacteriocin-producer 
immune to its own bacteriocin, (b), a dedicated ABC-transporter that cleaves off the N-
terminal bacteriocin leader peptide and is responsible for the extracellular secretion and 
(c), an accessory protein whose actual function is not as yet known (Diep, Håvarstein & 
Nes 1996; Kjos et al. 2011; Maldonado, Ruiz-Barba & Jiménez-Díaz 2003; Nissen-Meyer et 
al. 2011).  
 
A summary of different bacteriocin locus organisations in L. plantarum strains is 
presented in Figure 1.2. The production of some two-peptide bacteriocins (for instance, 
NC8 (Maldonado, Ruiz-Barba & Jiménez-Díaz 2003), plantaricin EF and plantaricin JK 
(Diep, Håvarstein & Nes 1996; Diep & Nes 1995) is regulated transcriptionally by means of 
a three-component regulatory system that consists of a peptide pheromone, a 
membrane-associated histidine protein kinase, and other response regulators (Anderssen 
et al. 1998; Diep, Håvarstein & Nes 1996; Kleerebezem & Quadri 2001). Upon export from 
the bacteria, the peptide pheromone interacts with the membrane-associated histidine 
kinase and stimulates the kinase to phosphorylate the intracellular response regulator, 
enabling the response regulator to activate the operons that are required for bacteriocin 
synthesis and secretion (Kleerebezem & Quadri 2001; Nissen-Meyer et al. 2011). 
 
Among L. plantarum strains, C11 isolated from cucumber fermentation, is one of the first 
two-peptide bacteriocin (plantaricin) producers that have been studied and characterized 
thoroughly at the genetic level in respect to bacteriocin biosynthesis and gene regulation 
(Anderssen et al. 1998; Daeschel, M. A., McKenney & McDonald 1990; Diep, Håvarstein & 
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Nes 1996; Diep & Nes 1995; Mathiesen et al. 2004). This strain produces the two two-
peptide bacteriocins, plantaricin EF and JK, as well as the peptide pheromone plantaricin 
A that prompts the production of the two bacteriocins (Anderssen et al. 1998; Diep, 
Håvarstein & Nes 1996). The plantaricin (pln) locus from four other L. plantarum strains, 
WCFS1 (Kleerebezem et al. 2003; Siezen et al. 2012; Sturme et al. 2007) , NC8 
(Maldonado, Ruiz-Barba & Jiménez-Díaz 2003) , J51 (Navarro et al. 2008) and J23 (Rojo-
Bezares et al. 2008) have been also studied and characterised in detail; however only the 
gapless genome of WCFS1 is available. The WCFS1 strain is from a human saliva source, 
while the other four strains have been isolated from fermented food sources. The 
genome of WCFS1 shows a very similar pln structure and sequence to that of C11 
(Kleerebezem et al. 2003). 
 
Classically L. plantarum produces mainly bacteriocins from Class II. Five different pln loci 
have been characterized from different strains of L. plantarum, C11, NC8, WCFS1, J23 and 
J51. The pln locus consists of approximately 25 genes of 18–19 kb that are organised into 
5-6 operons (Figure 1.2). The more conserved region of the all loci contains one 
bacteriocin operon (plnEFI) and one transport operon (plnGHSTUVW) while the less 
conserved region contains a regulatory operon, and two or three bacteriocin operons. 
Each locus also contains one or two operons with unknown function, in the less 
conserved region (Diep et al. 2009; Sáenz et al. 2009).  
 
In C11 and WCFS1 the pln loci have been shown to contain five operons (Diep, Håvarstein 
& Nes 1996; Kleerebezem et al. 2003; Sturme et al. 2007). The regulatory operon, 
plnABCD (Figure 1.2), encodes an inducing peptide (PlnA), a histidine protein kinase (PlnB) 
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and two response regulators (PlnC and PlnD). The plnEFI and plnJKLR operons encode 
two-peptide bacteriocins, plantaricin EF and plantaricin JK, and their immunity proteins. 
The plnMNOP codes for four putative proteins of which PlnN contains an N-terminal 
double-glycine leader consensus similar to two-peptide bacteriocins (PlnK, PlnJ, PlnE and 
PlnF); however, no bacteriocin activity was observed for a synthetic peptide version based 
on the mature PlnN sequence (Anderssen et al. 1998). The plnGHSTUVWXY operon 
encodes proteins necessary for the ABC transporter system that is responsible for 
maturation and secretion of the bacteriocin peptides (Sáenz et al. 2009). The PlnA 
peptide controls the transcription of these five operons (Diep et al. 2003).  
 
The gene content and genetic organization of the pln loci in strains NC8, J23 and J51 is 
different from that of C11 and WCFS1. Strain NC8 is a silage isolate (Aukrust & Blom 1992) 
and contains a different regulatory operon, plnNC8IF-plNC8HK-plnD (Figure 1.2), from 
that of C11 and WCFS1. This operon encodes the putative auto-induction factor 
(PLNC8IF), a histidine kinase (PLNC8HK) and a response regulator (PlnD) (Maldonado, 
Jiménez-Díaz & Ruiz-Barba 2004; Maldonado, Ruiz-Barba & Jiménez-Díaz 2004).  
 
In 2008, two new pln loci of L. plantarum from strains J23 and J51 were isolated from 
grape must and have been characterised by two research groups in Spain (Navarro et al. 
2008; Rojo-Bezares et al. 2008). These pln loci also share some similarities with those of 
C11 and NC8, but demonstrate a different organisation of the pln genes and the presence 
of some new operons (Figure 1.2). The J23 pln locus (~20 kb) consists of plnJLR, plnMNOP, 
plnEFI, plnGHSTUVWXY, and plnNC8IF-plNC8HK-plnD operons, as well as a new region 
that includes three new open reading frames (ORF) (Rojo-Bezares et al. 2008). As for NC8, 
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the J23 regulatory system has major differences relative to those of C11 and WCFS1, 
which contain the plnABCD operon which encodes a cell density dependent quorum-
sensing mechanism (Diep, Håvarstein & Nes 1996; Diep & Nes 1995). The regulation of 
bacteriocin production in NC8 and J23 is not induced by high inoculum size, but rather 
when the strains are co-cultured with very specific LAB strains (Maldonado, Jiménez-Díaz 
& Ruiz-Barba 2004; Rojo-Bezares et al. 2007).  
 
The pln locus of J51 (Navarro et al. 2008) (~20 kb) consists of five operons, plNC8βαc, 
plnLR-like, plnABCD, plnEFI, plnGHSTUVW and a new region that contains the orf3, orf4 
and orf5 of unidentified function (Figure 1.2). The structure of the pln locus of J51 
appears to be a combination of the previously described pln loci from strains C11 and 
NC8. As for C11, it contains the plnEFI and plnGHSTUVW operons, while in contrast to 
C11, the plnJK and plnMNOP operons are absent and three new ORFs (orf3, orf4 and orf5) 
are present (Navarro et al. 2008). Like NC8, J51 also contains the plNC8βαc operon; 
however its pln locus contains the plnABCD regulatory system instead of plnNC8IF-
plNC8HK-plnD. The regulatory mechanism in J51 is cell density-dependent quorum-
sensing, similar to C11. These similarities and differences at the genetic level are more 
easily appreciated and summarised in Figure 1.2. 
 
 
  
CHAPTER 1 
18 
 
 
Figure 1.2 Summary of the genetic maps of the pln locus for L. plantarum reference strains 
C11, WCFS1, J23, J51 and NC8, data obtained from previously publish works (Diep, 
Håvarstein & Nes 1996; Kleerebezem et al. 2003; Maldonado, Ruiz-Barba & Jiménez-Díaz 
2003; Navarro et al. 2008; Rojo-Bezares et al. 2008; Sáenz et al. 2009). The pln genes 
represented by arrows in different colours which correspond to the functionality of each 
operon. The incomplete arrows represents incomplete gene sequences based on available 
data in GenBank (accession numbers X94434, AF522077, AL935263, DQ323671 and 
DQ340868). Small black arrows represent the promoter sequences. Colours code for pln 
operons: yellow/black for the genes from the regulatory operon; red/green for two-
peptide bacteriocins, the operons plnEFI and plnJKLR; blue colour for plnMNOP operon; 
pink for plNC8βαc operon and purple for the ABC transporter system genes. Unique strain 
specific genes are presented as ‘orf’ and in different colours (Sáenz et al. 2009).    
L. plantarum  WCFS1 
                                                                                                                                                                                                      
 
 L. plantarum  C11 
                                                                                                                                                                                           
 
 L. plantarum  J23 
                                                                                                                                                                                                      
 
 L. plantarum  J51 
                                                                                                                                                                                                      
 
 L. plantarum  NC8 
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1.3 Cyclic bacteriocins (Class IV) 
1.3.1 General characteristics of cyclic bacteriocins  
There is no complete agreement in respect of the cyclic bacteriocin classification. This 
class of bacteriocins are reported as Class IIc, Class IV and Class V by different 
investigators (Cotter, Hill & Ross 2005; Heng et al. 2007; KempermanKuipers, et al. 2003; 
Rea et al. 2011). It is important to note that cyclic bacteriocins are ribosomally 
synthesised and therefore are recognisable from enzymatically synthesised cyclic 
antimicrobial peptides such as gramicidin S (Maqueda et al. 2008; Mogi & Kita 2009). The 
post-translational modifications of the precursor proteins for this class of bacteriocins 
results in the covalent linkage of their N- and C-terminals to construct a circular backbone 
(Rea et al. 2011). These peptides are generally heat stabile and demonstrate resistance to 
digestion by proteolytic enzymes (Rea et al. 2011). Enterocin AS-48 was the first 
bacteriocin identified with a head-to-tail cyclic backbone structure (Gálvez et al. 1989; 
Maqueda et al. 2004; Martínez-Bueno et al. 1994).  
 
Subtilosin A is a circular lantibiotic-like bacteriocin produced by Bacillus subtilis (Kawulka 
et al. 2003; Kawulka et al. 2004; Maqueda et al. 2008; Marx et al. 2001). Subtilosin A has 
some unique structural features that are different to other circular bacteriocins. It has 
three thioether bridges linking the sulphur atoms of three cysteine residues with the  
α-carbon of one threonine and two phenylalanine residues. It is also much smaller than 
other circular bacteriocins (Kawulka et al. 2003).  
 
To date, 11 cyclic bacteriocins have been described excluding subtilosin A (Table 1.3).  
Nine are LAB associated (enterocin AS-48, lactocyclicin Q, garvicin ML, uberolysin, 
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carnocyclin A, acidocin B, gassericin A, reutericin 6 and pentocin KCA1) and two are non-
LAB bacteriocins (cirularin A and butyrivibriocin AR10 produced by Clostridium beijerinckii  
and Butyrivibrio fibrisolvens, respectively). Based on the amino acid sequence identity, 
they have been subdivided into two sub-classes, Group I and Group II (Cotter, Hill & Ross 
2005; Martin-Visscher et al. 2009) (Table 1.3).  
 
NMR and X-ray diffraction approaches have been used to investigate the three-
dimensional structure of two cyclic bacteriocins, carnocyclin A (Martin-Visscher et al. 
2009) and AS-48 (Maqueda et al. 2004) and have revealed the presence of regularly 
repeated α-helical motifs. Martin-Visscher et al. (2009), showed that the circular 
bacteriocins are likely to share a common structural motif. This consists of four or five 
conserved α helices surrounding a compact hydrophobic core, with the common 
architecture of the saposin fold which imparts unique stability to these peptides. The 
structures of carnocyclin A and AS-48 and the homology models of lactocyclicin Q (Sawa 
et al. 2009) and circularin A (KempermanKuipers, et al. 2003), show a group of basic 
residues which provides a localized positive charge on the surface of the peptide which is 
responsible for attracting the peptides to the surface of the anionic target membrane 
(Martin-Visscher et al. 2009).  
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Table 1.3# Characteristics of cyclic bacteriocins from Gram-positive bacteria.  
Bacteriocin Producer strain Leader peptide Bacteriocin peptide Molecular weight (Da) Reference 
Subtilosin A Bacillus subtilis 168 8 35 3398 (Babasaki et al. 1985; 
Kawulka et al. 2003) 
Group I      
Enterocin AS-48 Enterococcus faecalis S-48 35 70 7150 (Gálvez et al. 1986) 
Lactocyclicin Q Lactococcus sp. strain 
QU12 
2 61 6062 (Sawa et al. 2009) 
Garvicin ML Lactococcus garvieae 
DCC43 
3 60 6004 (Borrero et al. 2011) 
Circularin A Clostridium beijerinckii 
ATCC 25752 
3 69 6771 (KempermanKuipers, et 
al. 2003) 
Uberolysin Streptococcus uberis 42 6 70 7048 (Wirawan et al. 2007) 
Carnocyclin A Carnobacterium 
maltaromaticum UAL307 
4 60 5862 (Martin-Visscher et al. 
2008) 
#This table continues on the next page.  
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Table 1.3 (continued) Characteristics of cyclic bacteriocins from Gram-positive bacteria.  
Bacteriocin Producer strain Leader peptide Bacteriocin peptide Molecular weight (Da) Reference 
Group II      
Acidocin B  Lactobacillus acidophilus 
M46 
33 58 5620* (Leer et al. 1995; van 
der Vossen et al. 1994) 
Gassericin A Lactobacillus gasseri LA39 33 58 5652 (Kawai et al. 1998) 
Reutericin 6 Lactobacillus reuteri LA6 33 58 5652 (Toba et al. 1991) 
Butyrivibriocin AR10  Butyrivibrio fibrisolvens 
AR10 
22 58 5981 (Kalmokoff & Teather 
1997) 
Pentocin KCA1 Lactobacillus pentosus 
KCA1 
33 58 5672* (Anukam et al. 2013) 
*Theoretically calculated molecular weight 
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1.3.2 Mode of action of cyclic bacteriocins 
The cyclic bacteriocins make the membrane of the susceptible bacteria permeable to 
specific molecules resulting in disruption of the membrane, leakage and the cell death, in 
a manner similar to other bacteriocins from Gram-positive bacteria. Kawai et al. (2004) 
indicated that gassericin A and reutericin 6 target the cytoplasmic membrane of the 
target cell and cause cell death through efﬂux of potassium ions. Similarly, it has been 
shown that cyclic bacteriocin AS-48 acts by formation of pores in bacterial membranes 
making them permeable to ions and non-specific low molecular weight compounds which 
eventually result in the collapse of the membrane potential and cell death (Gálvez et al. 
1991). Gálvez, Antonio et al. (1991) demonstrated that higher concentration of the 
bacteriocin peptide induced greater membrane disorganisation, an alternative 
mechanism for the permeation of the outer membrane of Gram-negative bacteria. 
Thennarasu et al. (2005) showed that subtilosin A interacts with the lipid head group 
region of membrane bilayers in a concentration dependent manner. Similarly, Gong et al. 
(2009) demonstrated that the bactericidal activity of carnocyclin A is through formation of 
channels in lipid bilayers which have specific selectivity for anions. Their work reports that 
a receptor may not be required for the interaction between the cyclic bacteriocin and the 
cytoplasmic membrane because carnocyclin A interacts directly with the lipid bilayer.  
 
1.3.3 Genetics of cyclic bacteriocins  
Production of bacteriocin is a complex process involving structural genes that encode the 
bacteriocin precursor as well as set of additional genes responsible for the maturation, 
secretion and immunity of the antimicrobial peptide (Cho et al. 2010; Maqueda et al. 
2008; Sáenz et al. 2009; Wada et al. 2009).  The maturation process is more complex for 
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cyclic bacteriocins including the peptide bond formation between the N- and C-terminal 
of the pre-peptide to create a cyclic structure with antimicrobial activity (Maqueda et al. 
2004).  
 
The genes involved in the production of cyclic bacteriocins are either located on the 
chromosome or on plasmids, and the gene clusters for several cyclic bacteriocins have 
been characterised (Anukam et al. 2013; Ito et al. 2009; Kalmokoff et al. 2003; Kawai et al. 
1998; KempermanKuipers, et al. 2003; Martin-Visscher et al. 2008; Martínez-Bueno et al. 
1994; Wirawan et al. 2007). In general, sequence homology of the putative proteins 
(Anukam et al. 2013; Wirawan et al. 2007) and genetics (Diaz et al. 2003; 
KempermanJonker, et al. 2003) have been used to propose a functional role for the genes 
in terms of cyclic bacteriocin production. The genes from the cyclic bacteriocin gene 
cluster share some common characteristics despite the differences in the number of 
genes and the limited sequence homology (van Belkum, Martin-Visscher & Vederas 
2011). Common features among these gene clusters include, the multiple putative 
membrane associated proteins, including a membrane protein from the conserved DUF95 
family domain, one or more ATP-binding proteins and a member of small hydrophobic 
peptides, possibly involved in the bacteriocin immunity (Figure 1.3).   
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Figure 1.3 A summary of the genetic maps for the gene clusters involved in the production 
of cyclic bacteriocins, adapted from van Belkum, Martin-Visscher & Vederas (2011). The 
data for cyclic bacteriocins, AS-48, circularin A, uberolysin, carnocyclinin A, butyrivibriocin 
AR10, gassericin A and pentocin KCA1 was obtained from the previously publish works 
(Anukam et al. 2013; Ito et al. 2009; Kalmokoff et al. 2003; Kawai et al. 1998; 
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KempermanKuipers, et al. 2003; Martin-Visscher et al. 2008; Martínez-Bueno et al. 1994; 
Wirawan et al. 2007). The genes represented by arrows in different colours corresponding 
to the gene functionality. Colours code for gene: red for bacteriocin precursor; orange for 
immunity protein; grey for putative membrane; green for ATP-binding protein; hatched for 
multicomponent ABC-transporter; dotted for member of the DUF95 family of proteins.   
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1.4 Genomics of LAB 
LAB are ‘generally recognised as safe’ (GRAS) microorganisms (Adams 1999; O’sullivan, 
Ross & Hill 2002; Salminen et al. 1998) and some have demonstrated health promoting 
features (Taverniti & Guglielmetti 2012). The genomes of many LAB have been sequenced 
due to their significant contribution to various industries. The availability of LAB genome 
sequences provides the basis for a better understanding of their evolution and reveals a 
trend of progressive reduction in genome size (Makarova & Koonin 2007; Van de Guchte 
et al. 2006). Genome analysis suggests the adaption of the organism to rich food 
environments as a main cause for genes loss and overall reduction in genome size 
(Schroeter & Klaenhammer 2009). The genomes of LAB contain single circular 
chromosomes with a length between 1.3 and 3.35 Mb (Zhang & Zhang 2014) with the 
number of genes ranging from ~1,600 to ~3,000 (Makarova & Koonin 2007). The first 
genome of LAB, for Lactococcus lactis IL1403, was sequenced and published in 2001 
(Bolotin et al. 2001). Bolotin et al. (2001) used two strategies consisting of diagnostic 
sequencing of the whole genome and a shotgun improvement step. The first step 
consisted of random sequencing of clones containing relatively short fragments (1-20 kb) 
of the genome and multiple long PCR reactions to connect the resulting contigs to fill in 
the gaps (Bolotin et al. 2001). The second step, so-called “shotgun polishing”, consisted of 
random sequencing of additional clones and primer walking from PCR generated 
templates to achieve a 4X coverage (Bolotin et al. 2001).   
 
The number of rRNA operons is quite variable in LAB, ranging from two in Oenococcus 
oeni to nine in Lactobacillus delbrueckii. This corresponds to the number of tRNA genes, 
which may reflect complex ecological drivers as bacteria compete in the microbial 
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community (Klappenbach, Dunbar & Schmidt 2000).  LAB genomes often contain 
transposons occupying 0.2% to 5% of the genome (Makarova, K et al. 2006). Many LAB 
also contain plasmids which carry genes involved in bacterial growth, adaption, metabolic 
processes, membrane transport and production of bacteriocins (McKay & Baldwin 1990). 
The genes encoded by plasmids range from 0% to 4.8% of the total gene content 
(Makarova, K et al. 2006).  
 
1.4.1 Next generation sequencing (NGS)  
Since the first introduction of DNA sequencing by Sanger et al. in 1977, whole genome 
sequencing has been transformed dramatically. The increasing demand for high 
throughput data has forced increasing automation and the parallel use of sequencing 
instruments resulting in the completion of the first human genome in 2004 (Consortium 
2004). A huge amount of time and resources was required for the first Human Genome 
Project which raised the need for faster, higher throughput and less expensive 
technologies. Current NGS methods have three major common features as improvements 
from the original Sanger sequencing technology, (I) the cloning of DNA fragments have 
been replaced by the preparation of cell-free system NGS libraries (II) the number of 
parallel sequencing reactions has increased from hundreds to millions, (III) the 
sequencing output is directly translated to base calling without the need for 
electrophoresis (van Dijk et al. 2014).  
  
A technological revolution occurred in 2005 with the development and introduction of 
the ‘sequencing by synthesis’ technology, initially by 454 Life Sciences in corporation with 
several universities and research institutes in the USA (Margulies et al. 2005). A strategy 
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was developed that increased the sequencing throughput dramatically in comparison to 
older-style Sanger sequencing technology.  An emulsion-based method for DNA 
amplification and a pyro-sequencing protocol required a very low volume of sample. The 
‘sequencing by synthesis’ technology initially started with a read length of 100 bp which 
then increased to more than 500 bp in a few years (Loman et al. 2012). The 
Solexa/Illumina and SOLID were the second and third sequencing technologies introduced 
to the market in 2006 and 2007, respectively. The number of reads generated by the 
Illumina® and SOLiD™ sequencers was much higher than the previous 454 system (Liu et 
al. 2012). Ion Torrent introduced the Personal Genome Machine (PGM) in 2010 which was 
subsequently developed by the founder of the 454 sequencer, Jonathan Rothberg, using 
non-optical DNA sequencing technology (Rothberg et al. 2011). This resulted in even 
faster and more cost effective sequencing.  
 
A third type of sequencing technology, markedly different from previous technologies 
does not perform DNA amplification prior to sequencing. This method is a so-called third-
generation sequencing technology which is based on the sequencing of a single molecule 
of DNA without amplification (Schadt, Turner & Kasarskis 2010). Pacific Biosciences is the 
current leader in this field and is the first sequencing technology to generate very long 
read lengths (average read lengths are 2-3 kb) without GC-bias or systematic errors, this 
enables sequencing gap closure and makes it ideal for de novo genome assembly (English 
et al. 2012). The disadvantage of this technology is lower throughput and accuracy in 
comparison to other NGS platforms (English et al. 2012). An overview of few popular NGS 
platforms is presented in Table 1.4.  
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Table 1.4 Overview of NGS platforms (Buermans & den Dunnen 2014; Chen et al. 2014; Jünemann et al. 2013; Liu et al. 2012; Quail et al. 2012; 
Reis-Filho 2009; Shokralla et al. 2012; Stranneheim & Lundeberg 2012).   
NGS Platform Sequencing 
reaction 
Amplification Run type Sequencing 
output (Gb) 
Run time Read length 
(bp) 
Disadvantage Major error 
454 GS FLX Pyrosequencing Emulsion PCR Single end  0.5-0.7 10 - 24 h 400-700  High cost, error rate, 
low throughput   
Indel 
Illumina Hiseq 
2000 
Reversible 
terminator 
Bridge PCR Single & 
paired end 
600 3 - 10 days 100-200 High capital cost Substitution 
Illumina Miseq Reversible 
terminator 
Bridge PCR Single & 
paired end 
Up to 15 19 - 27 h Up to 150 Relatively low 
throughput   
Substitution 
Ion PGM 
 
Proton release Emulsion PCR Single & 
paired end 
 ≥1 2 - 5.5 h  Up to 400 High error rate Indel 
Ion Proton Proton release Emulsion PCR Single end 8-10 3 - 4 h 150-200 High error rate, short 
reads 
Indel 
PacBio Single molecule 
real-time DNA 
sequencing 
None Single end 0.1 0.5 - 2 h ≥ 1500 High error rate, low 
throughput, high cost 
Indel 
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1.4.1.1 Illumina sequencing technology  
Illumina sequencing represents one of the most widely used platforms for NGS due to its 
high capacity (Shokralla et al. 2012). Its sequencers include Genome Analyzers I/II/IIe/IIx, 
Miseq, HiSeq and the new Nextseq (introduced in 2014). This technology was first 
introduced by Solexa in 2006, and was subsequently purchased by Illumina in 2007 (Mitra 
et al. 2014).  This technology uses a bridge amplification approach to amplify the 
template DNA. Briefly, the forward and reverse oligos that are complementary to adapter 
sequences are introduced during the library preparation steps (Mardis 2008). These are 
attached to the internal surface of the flow cell lanes. Denaturation of the double 
stranded DNA into individual single stranded DNA molecules is the first step in loading the 
library onto the flow cell. In the flow cell these hybridise to oligonucleotides on the 
surface which serves as primers to form the initial copy of each sequencing template 
molecule (Buermans & den Dunnen 2014). The initial library molecules are then removed 
and the newly synthesised copies that are attached to the flow cell are used to create a 
cluster of identical template molecules by means of isothermal amplification. During 
these steps the 3’ end of the copied library molecules hybridise to the complementary 
oligos on the flow cell and form a bridge structure. The removal of one strand of double 
stranded DNA fragments using the cleavage site in the surface oligos and the blocking all 
3’ ends with ddNTP are the final steps (Buermans & den Dunnen 2014; Liu et al. 2012).   
 
Illumina uses the “sequencing by synthesis” strategy. In summary a double stranded DNA 
is made from a single stranded DNA as a cluster of molecules. A DNA polymerase starts at 
one end of the DNA molecule and sequentially adds a single nucleotide which is a match 
to the nucleotide on the single strand (Mitra et al. 2014). The synthesis then starts by 
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addition of a single fluorescently labelled deoxyribonucleotide triphosphate (dNTP) to the 
nucleic acid chain and the nucleotide label acts as a terminator for DNA polymerisation. 
After incorporation of each dNTP, a base is called as a result of the fluorescent dye image. 
The dye is then cleaved to allow incorporation of the next nucleotide.  All four reversible 
terminator-bound dNTPs (A, T, C and G) are present in separate molecules and naturally 
compete for the incorporation into the DNA strand. Base calls are made directly from 
signal intensity measurements during each cycle (Liu et al. 2012; Mitra et al. 2014). A 
schematic diagram of the Illumina sequencing is presented in Figure 1.4.  
 
The sequencing output of the HiSeq 2000, HiSeq 1000 and Genome Analyzer IIx are 600, 
300 and 95 Gb, respectively (Shokralla et al. 2012). The Miseq platform was able to 
generate up to 2 Gb of data, this has now been increased up to 15 Gb in 2014 
(http://www.illumina.com/systems/miseq.ilmn). In 2012, Illumina introduced the Hiseq 
2500 platform as an upgrade to the Hiseq 2000 which could generate up to 120 Gb data 
(Shokralla et al. 2012).  In 2014, Illumina introduced two new sequencers, the NextSeq 
500 and the HiSeq X Ten. The NextSeq 500 is a smaller version of the Hiseq 2500 with 
higher flexibility enabling both medium (40 Gb) and high (120 Gb) output (Buermans & 
den Dunnen 2014).  The main purpose of the HiSeq X Ten design was to sequence human 
genomes for a $1000 run cost. This was achieved through the introduction of patterned 
flow cells. Other improvements of this sequencer include the optimisation of the cluster 
density, faster scanning protocols and tailored software. The data output of the X ten is as 
high as 1.8 Tb which is enough for 15 whole human genome sequences to be obtained 
(Buermans & den Dunnen 2014).   
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Figure 1.4 Schematic diagram of the Illumina sequencing platform (sequence by synthesis) 
(Ross & Cronin 2011).   
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1.4.1.2 Ion Torrent sequencing technology  
The Ion Torrent technology, Personal Genome Machine (PGM) was first introduced at the 
end of 2010 (Liu et al. 2012). Ion Torrent sequencing technology depends on emulsion-
PCR on a bead or sphere. An oil-water emulsion is created to separate the small reaction 
vesicles that individually contain only one sphere, containing in principle one library 
molecule and amplification reagents (Buermans & den Dunnen 2014).  There are two 
primers complementary to the sequence of the library adaptors, one in the solution and 
one attached to the sphere. This results in the selective loading of library molecules onto 
the beads each having both an A and a B adaptors. Molecules with an AA or BB adaptor 
are excluded. This also ensures a uniform orientation of the library molecules on the 
sphere. Each library molecule is amplified during emulsion PCR, to produce millions of 
identical copies attached to the beads which allows for better signal detection (Buermans 
& den Dunnen 2014).  
 
The technology introduced by Ion Torrent uses a complementary metal-oxide 
semiconductor (CMOS) sensor array chip which enables the collection of necessary data 
for a simple, on-chip sequencing chemistry (Merriman et al. 2012). The ion semiconductor 
chips containing arrays of micro-wells. These micro-wells have an ion sensitive layer 
underneath each well and will host one single stranded DNA molecule and one DNA 
polymerase during the sequencing process (Mitra et al. 2014). During sequencing, the 
micro-wells are flooded with a single deoxyribonucleotide triphosphate (dNTPs). The 
complementary dNTPs get incorporated onto the strand complementary to the template 
and the DNA polymerisation results in the releases a hydrogen ion. A sensor capable of 
detecting either pyrophosphate or H+ directly detects the nucleotide incorporation 
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(Merriman et al. 2012) and results in the base calling (Figure 1.5). The final steps of signal 
processing and DNA assembly are performed in embedded software. The Ion Torrent 
approach is faster and less expensive than other technologies as it has completely 
removed the need for the modified nucleotides or optical instruments (Mitra et al. 2014). 
Life technologies introduced its new bench top semiconductor sequencer ‘Ion proton’ in 
2012 which was designed to deliver a human genome in just a few hours (Shokralla et al. 
2012). 
 
 
Figure 1.5 Schematic cross-section of a single well of an Ion Torrent sequencing chip (Ion 
Torrent Amplicon sequencing note, Life Technologies). Each well accommodates the Ion 
Sphere™ particles containing DNA template. The incorporation of a nucleotide results in a 
proton release and change of the pH of the well. A sensing layer detects and translates the 
change in pH to a digital signal. 
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The Ion Torrent technology has two major limitations. First, it cannot handle the repeats 
of the same nucleotide in a homopolymer region. The repeat of the same nucleotide 
results in the release of more hydrogen ions per cycle and greater change in the pH. The 
instrument cannot effectively differentiate between high repeat number that varies by 
plus or minus one nucleotide; the pH difference simply is too small. The second major 
disadvantage is the short read length which makes assembly more problematic for de 
novo genome sequencing (Mitra et al. 2014).  
 
Liu et al. (2012) investigated the sequencing quality of Ion Torrent data  in comparison 
with Hiseq 2000, by sequencing the 4.2 Mb high GC content (66%) genome of 
Rhodobacter sample. The summary of their findings are presented in Table 1.5. The rates 
of insertions and deletions are approximately 70 and 300 times higher, respectively in Ion 
Torrent data compared to Illumina data gathered on a Hiseq 2000, even though the 
mismatch rate was three times lower in the Ion Torrent data. In another study, Quail et al. 
(2012) investigated whether or not the higher error rate in the Ion PGM affected its ability 
to call Single-nucleotide polymorphisms (SNPs). This was done by aligning the reads from 
a Staphylococcus aureus genome against a reference genome. Their study revealed that 
while the data obtained from Ion Torrent PGM had a higher error rate (~1.8%) than 
Illumina (<0.4%), the coverage in PGM resulted in an SNP calling ability being closely 
matched to that obtained by Illumina with a higher true positive called from the Ion 
Torrent data, but far less false positives being called from the Illumina data. 
 
The sequencing technologies have advanced dramatically in recent years with many 
improvements and novel technologies continuing to emerge. Cost reduction, method 
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improvement and more efficient assembly and mapping algorithms will further expand 
the capabilities of NGS, continuing to transform genomic research. 
 
 
Table 1.5 Comparison of NGS outcomes between Ion Torrent and HiSeq 2000 (Liu et al. 
2012). 
 Ion Torrenta Hiseq 2000b 
Total reads number  165,518 205,683 
Total bases number  18,574,086 18,511,470 
Max read length (bp) 201 90 
Min read length (bp) 15 90 
Total mismatch base  53,475 142,425 
Total insertion base  109,550 1,397 
Total insertion number  95,740 1,332 
Total deletion base  152,495 431 
Total deletion number 139,264 238 
Average mismatch rate (%) 0.338 1.004 
Average insertion rate (%)  0.693 0.009 
Average deletion rate (%) 0.965 0.003 
            Alignment software: aTMAP 2, bSOAP2. 
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1.4.2 Comparative genomics of LAB 
At the moment (August 2014) more than 4000 genome sequences from bacteria are 
available on NCBI database (http://www.ncbi.nlm.nih.gov/genome/browse/). These 
include 511 orders of Bacilli, 225 families of Lactobacillales and 79 species of 
Lactobacillus; among these are 23 strains of L. plantarum and 6 strains of L. brevis. The  
L. plantarum genome assembly and annotation report summary (August 2014) is 
presented in Tables 1.6 and 1.7.  
 
The L. plantarum genomes have been sequenced and assembled at three different levels 
of completion, (a), gapless chromosome (6), (b), scaffold (2) and (c), contig (15) (Table 
1.6). Currently, only six gapless chromosome sequences of L. plantarum strains are 
available from the NCBI database including strains JDM1, 16, WCFS1, ZJ316, P-8 and ST-III. 
These provide very valuable information for reference sequencing and comparative 
genome analysis of new L. plantarum strains. The sequencing platforms used for the 
genome sequencing of L. plantarum strains include Sanger, 454, Illumina, Ion Torrent with 
the gapless chromosomes being generated by Sanger, 454 and Illumina technology (Table 
1.6). Interestingly, 18 out of 23 genomes for L. plantarum strains have been released in 
the last 18 months, corresponding to the massive advancement and cost reduction in the 
NGS technology. According to the available information from NCBI database, currently 
the genomes of six L. brevis strains have been sequenced including two gapless 
chromosomes (strains ATCC 367 and KB290), with another four scaffold and contig 
assemblies (Table 1.7). Based on a limited number of available genomes for L. plantarum 
and L. brevis strains, sequencing of new genomes for novel strains of commercial 
significance can still contribute to the field.  
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Table 1.6* L. plantarum genome assembly and annotation report (August 2014) (http://www.ncbi.nlm.nih.gov/genome/genomes/1108).  
Strain Assembly Sequencing 
technology 
Levela Size 
(Mb) 
GC% WGSC Scaffolds Gene Protein Release  
dateb 
Modify  
dateb 
AG30 GCA_000687495.1 Illumina  c 3.44 44.30 JHWA01 48 3184 3001 08/04/14 11/07/14 
Lp90 GCA_000731855.1 Illumina  c 3.32 44.30 JIBX01 33 3273 3155 21/07/14 21/07/14 
16 GCA_000412205.1 Roche 454 a 3.36 44.31 - 11 3171 3088 18/06/13 31/01/14 
19L3 GCA_000604365.1 Roche 454 c 3.28 44.40 AWTS01 241 3164 2795 28/03/14 11/07/14 
2025 GCA_000466905.1 Ion Torrent c 3.06 44.70 AVFJ01 595 3776 3533 13/09/13 17/07/14 
2165 GCA_000466845.1 Ion Torrent c 3.17 44.50 AVFI01 192 3327 3108 13/09/13 17/07/14 
4_3 GCA_000507045.1 Illumina c 3.32 44.30 AYTU01 105 3205 3150 12/12/13 30/12/13 
AY01 GCA_000469115.1 Roche 454 c 3.31 43.70 AVAI01 169 3241 3174 20/09/13 24/10/13 
EGD-AQ4 GCA_000463075.1 Illumina  c 3.42 46.40 AVAQ01 52 3135 3035 23/08/13 17/07/14 
IPLA88 GCA_000410795.1 Illumina  c 3.25 44.40 ASJE01 208 3165 3116 13/06/13 08/01/14 
JDM1 GCA_000023085.1 Roche 454 a 3.19 44.70 - 1 3028 2947 17/07/09 31/01/14 
    
 *Table continues on the next page. 
  a Level: (a) Gapless chromosome, (b) Scaffold, (c) Contig; b Date format: DD/MM/YY; C WGS: whole genome sequencing.   
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Table 1.6 (continued) L. plantarum genome assembly and annotation report (August 2014). 
Strain Assembly Sequencing 
technology 
Levela Size 
(Mb) 
GC% WGSC Scaffolds Gene Protein Release  
dateb 
Modify  
dateb 
LP91 GCA_000473935.1 Illumina c 2.92 45.10 AXDQ01 145 2724 2618 17/10/13 11/07/14 
UCMA 3037 GCA_000347515.1 Illumina  b 3.10 44.50 APHP01 68 2997 2932 19/03/13 08/01/14 
WCFS1 GCA_000203855.3 Sanger and Solexa a 3.34 44.45 - 4 3174 3063 07/02/03 16/05/14 
WHE 92 GCA_000604145.1 Ion Torrent c 2.92 44.70 AWOY01 186 2868 1964 28/03/14 26/06/14 
WJL GCA_000474695.1 Illumina  c 3.47 44.20 AUTE01 102 3484 3409 18/10/13 08/01/14 
ZJ316 GCA_000338115.2 Illumina a 3.29 44.45 - 4 3352 3276 06/02/13 31/01/14 
wikim18 GCA_000648755.1 Ion Torrent c 3.35 44.30 JMEL01 323 3138 2927 29/04/14 11/07/14 
ATCC 14917 GCA_000143745.1 Roche 454 b 3.21 44.50 ACGZ02 9 3223 3154 20/02/09 17/09/13 
JCM 1149 GCA_000615325.1 Ion PGM c 3.20 44.50 BALV01 39 2996 2493 01/04/14 11/07/14 
NC8 GCA_000247735.2 Roche 454 c 3.20 44.60 AGRI01 10 3007 2868 16/02/12 08/01/14 
P-8 GCA_000392485.1 Unpublished a 3.22 44.56 - 7 3206 3090 14/05/13 31/01/14 
ST-III GCA_000148815.2 Roche 454 and Solexa a 3.30 44.50 - 2 3182 3038 01/10/10 31/01/14 
a Level: (a) Gapless chromosome, (b) Scaffold, (c) Contig; b Date format: DD/MM/YY; C WGS: whole genome sequencing.  
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Table 1.7 L. brevis genome assembly and annotation report (August 2014) http://www.ncbi.nlm.nih.gov/genome/genomes/1110. 
Strain Assembly Sequencing 
technology 
Levela Size 
(Mb) 
GC% WGSC Scaffolds Gene Protein Release  
dateb 
Modify  
dateb 
AG48 GCA_000526755.1 Illumina c 2.59 45.60 JAGR01 9 2604 2436 14/01/14 11/07/14 
ATCC 14869 GCA_000469365.1 Illumina b 2.47 45.90 AWVK01 86 2687 2630 18/09/13 09/01/14 
ATCC 367 GCA_000014465.1 Shotgun sequencing a 2.34 46.04 - 3 2351 2218 13/10/06 28/01/14 
EW GCA_000474675.1 Illumina and Roche 
454 
c 2.88 45.20 AUTD01 38 2892 2766 18/10/13 11/07/14 
KB290 GCA_000359625.1 Applied Biosystems a 2.58 45.57 - 10 2582 2582 29/03/13 11/06/13 
ATCC 27305 GCA_000159175.1 Roche 454 and 
Illumina 
b 3.14 40.00 ACGG01
  
106 3106 3041 12/02/09 17/09/13 
a Level: (a) Gapless chromosome, (b) Scaffold, (c) Contig; b Date format: DD/MM/YY; C WGS: whole genome sequencing. 
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1.4.3 Horizontal gene transfer in LAB  
Mobile genetic elements, including transposons, integrons, genomic islands, 
bacteriophages and plasmids, can be exchanged randomly between a broad range of 
bacteria and contribute to the plasticity of the bacterial genome (Sørensen et al. 2005). 
The fast evolution of bacteria is not only the result of mutation and rapid multiplication 
but is also due to DNA transfer which may result in strains with beneficial mutations from 
more than one parent (Thomas & Nielsen 2005). The conjugative transfer of DNA occurs 
by means of cell-to-cell contact, mate-pair formation and DNA transfer through pores, 
and is unidirectional and conservative (Sørensen et al. 2005; Thomas & Nielsen 2005). The 
insertion sequence (IS) elements are the simplest transposable elements a minimum 
length of 600 to 700 bp encoding a simple transposase (Thomas & Nielsen 2005).  
 
Since mobile genetic elements are widespread in LAB, they are able to exchange genetic 
information between the same species, different species or different genera (Morelli, 
Vogensen & Von Wright 2004).  Strong indications of horizontal gene transfer amongst 
different LAB, and between LAB and enterobacteria has been reported (Bolotin et al. 
2004). Bolotin et al. (2004) revealed that ycdB gene was exchanged in three examples 
between Lactococcus lactis and enteric bacteria with L. lactis being the donor. Similar 
gene transfer by conjugation has been observed between two subspecies of  
L. lactis.  The new gene acquired by horizontal transfer from other species may be 
detrimental, neutral or beneficial to the recipient (Bolotin et al. 2004). Deleterious genes 
should be removed by selection while beneficial ones should be selected for and retained. 
Neutral genes may also be retained.    
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Several mobile elements have been described from lactobacilli. This includes ISL2 in 
Lactobacillus helveticus (Zwahlen & Mollet 1994), ISL3 in Lactobacillus delbrueckii 
(Germond et al. 1995), IS1223 in Lactobacillus johnsonii (Walker & Klaenhammer 1994), 
IS1163 and IS1520 in Lactobacillus sakei (Skaugen & Nes 1994; Skaugen & Nes 2000) and 
ISLpl1 in Lactobacillus plantarum (Nicoloff & Bringel 2003). It has been reported that 
insertion elements were horizontally transferred by conjugation between the LAB during 
the co-culturing used for cheese manufacture (Guédon, Bourgoin & Decaris 1998). 
Widespread conjugative transposons in LAB result in resistance to kanamycin, 
tetracycline, chloramphenicol and erythromycin and also code for sucrose fermentation 
and immunity to the bacteriocin nisin (Mathur & Singh 2005; Rauch & De Vos 1992). 
  
1.5 Bacteriocin amino acid sequencing and proteomics approaches  
The de novo peptide sequencing goes back to Barber et al. (1965) who determined the 
structure and amino acid sequence of fortuitine, a natural peptidolipid from 
Mycobacterium fortuitum  using mass spectrometry (MS). Primary amino acid sequences 
were also determined by a combination of gas chromatography, reduction-based 
fragmentation and mass spectrometric ionisation (GC-MS) (Biemann & Vetter 1960). This 
technique was used when the Edman degradation approach was unsuccessful, due for 
example to N-terminal blocking (Burgus et al. 1970), or in combination with Edman 
degradation for the sequencing of very hydrophobic proteins (Khorana et al. 1979). 
Meanwhile, computer-based techniques were developed for determination of 
oligopeptides from high resolution mass spectral data (Biemann et al. 1966).  
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In the last decade, improved methods have been introduced which have enabled the 
ionisation of molecules with much higher molecular weight without the need for prior 
derivatization (Ma & Johnson 2012).  This includes the so called ‘tandem MS (MS/MS)’ 
methods which employs a combination of MS analysers to carry out mass selection of 
precursor ions followed by fragmentation of a selected ion and mass analysis of the 
resulting fragment ions (Ma & Johnson 2012).  
 
Data-base search programs have been widely used for amino acid sequencing of proteins 
in the recent years; however there is still an essential need to use traditional de novo 
sequencing (Ma & Johnson 2012). Firstly, there are many un-sequenced genomes and 
secondly, because most high throughput LC-MS/MS tandem mass spectra are not 
matched to a database search (Ma & Johnson 2012). 
 
Proteomics approaches have been used to characterise bacteriocin proteins (Borrero et 
al. 2011; Gray et al. 2006; Martin-Visscher et al. 2008).  De novo MS/MS peptide mapping 
was used to determine the amino acid sequence of a cyclic bacteriocin produced by 
Lactococcus garvieae DCC43, garvicin ML, when the N-terminal amino acid sequencing by 
Edman degradation failed to do so (Borrero et al. 2011).  Similarly, a de novo MS/MS 
approach revealed the sequence of carnocyclin A, produced by Carnobacterium 
maltaromaticum UAL307, by the means of sequencing various fragments and reverse 
genetics (Martin-Visscher et al. 2008).   
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1.6 Commercial applications of LAB bacteriocins and a rational for this 
study  
Bacteriocins produced by LAB have potential to be used in a wide range of applications in 
the food industry and medical sector (De Vuyst & Leroy 2007). Currently, there are two 
bacteriocins, nisin (Class I) and pediocin PA1/AcH (Class IIa) that are used widely in the 
food industry. A milk powder based preparation of nisin, Nisaplin® (Danisco), has been 
used in food applications for years. Nisin was recognised as GRAS by Food and Drug 
Administration (US FDA) in 1988 (Nisin preparation: affirmation of GTAS status as a direct 
human food ingredient 1988). It is used as a natural preservative in 57 countries 
worldwide (Jin et al. 2009). A commercial Nisaplin® preparation contains 2.5% nisin with 
NaCl (77.5%) and skim milk powder (12% protein and 6% carbohydrate) (Cotter, Hill & 
Ross 2005). A second commercial bacteriocin, pediocin PA1 (ALTA 2431,Quest) is 
produced by Pediococcus acidilactici 119 (Cotter, Hill & Ross 2005; Rodríguez, Martínez & 
Kok 2002; Szabo & Cahill 1998). Despite the apparent advantages, Nisin also has some 
limitations as a natural food preservative. While the solubility of nisin is increased under 
acidic conditions, it becomes less soluble at higher pH ranges (Delves-Broughton 2005). 
Nisin solutions demonstrate good activity (around 90%) in the pH range 3.0-3.5, but it 
loses most of its activity at pH values below and above this range (>90% loss at pH 1 or 7) 
(Delves-Broughton 2005). As demand for new antimicrobial substances grows in the food 
industry, the identification and characterisation of new antimicrobial compounds from 
LAB becomes an increasing timely direction for future research.  
 
Reports indicate that foodborne gastroenteritis cases are at least four million annually in 
Australia, costing the country about $1.2 billion per year (OzFoodNet Working Group 
CHAPTER 1 
46 
 
2012; Hall et al. 2005). This means that on average, every 3 to 4 years one might 
reasonably expect a foodborne illness (Hall et al. 2005). The OzFoodNet (OzFoodNet 
Working Group 2012) reported 154 separate outbreaks of foodborne and suspected 
foodborne illnesses in 2010. In total, 2,146 people were affected including 157 cases of 
hospitalisation and 15 deaths. The overall rate of foodborne disease outbreaks was 
reported to be 6.9 per million population in 2010 (OzFoodNet Working Group 2012). This 
demonstrates the potential economic and social significance of research into 
antimicrobial agents that can potentially contribute to food safety.   
 
Bacteriocins are required to possess specific properties to be considered for food 
preservation applications. These include, having GRAS status, a broad spectrum of 
inhibition against spoilage and pathogenic organisms, heat and pH stability, with no 
adverse effect on flavour and colour (Cotter, Hill & Ross 2005). The application of 
bacteriocins in meat, dairy, seafood and packaging industries as well as their 
enhancement of food safety in combination with high hydrostatic pressure (HPP) or 
pulsed electric field (PEF) processing methods have been reported (Chen & Hoover 2003; 
Gálvez et al. 2007). The incorporation of bacteriocin into food products can be performed 
in different ways. This includes the use of bacteriocin producing strains as starter cultures 
in fermented products, direct addition of purified or semi-purified bacteriocins to food or 
the use of an ingredient based on a fermentate of a bacteriocin-producing strain (Cotter, 
Hill & Ross 2005; Gálvez et al. 2007). 
 
It is reported that the bacteriocins with narrow inhibitory activities and no effectiveness 
against pathogens, still have considerable potential to improve the quality and flavour of 
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cheese products by accelerating the release of intracellular proteinases and peptidases 
from the starter culture, resulting in flavour enhancement (Deegan et al. 2006). Another 
application of bacteriocins, besides prevention of food spoilage or pathogenic bacteria, is 
to control unexpected non-starter flora such as non-starter LAB in cheese and wine 
(Daeschel, Jung & Watson 1991; O’sullivan, Ross & Hill 2002; Oumer et al. 2001; Radler 
1990; Ryan et al. 1996).  
 
Considering the medical applications of bacteriocins, the probiotic bacteria which have 
bacteriocin-producing properties have several potential applications for various health 
benefits to humans (Gaggia et al. 2011; Soomro, Masud & Anwaar 2002). The spread of 
antibiotic resistance pathogens in clinical microbiology has attracted a lot of attention in 
recent years (Hansen 2002). The World Health Organization already warned that 
infectious diseases might become untreatable due to the high levels of multiple antibiotic 
resistant pathogens (Balciunas et al. 2013). The non-toxicity of LAB bacteriocins and their 
inhibitory activity against Gram-positive human and animal pathogens has stimulated 
interest in their potential use in clinical applications (Cotter, Hill & Ross 2005). 
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1.7 Objectives of the project 
In a previous project by Tran (Tran 2010), 30 samples of Vietnamese fermented sausage, 
nem chua, were collected from different parts of Vietnam (north, middle and south) and 
105 strong acidifying LAB isolates and 39 antimicrobial producers were isolated from the 
samples (Tran et al. 2011). Lactobacillus plantarum and Pediococcus pentosaceous were 
reported as the predominant species in the nem chua samples. L. plantarum B21 
demonstrated the strongest antimicrobial activity against a range of bacterial strains due 
to the production of acid and bacteriocin. Some initial characteristics of the bacteriocin 
protein including pH and thermo-stability and the apparent molecular weight (SDS-PAGE) 
were determined; however the genetics of the bacteriocin production, identity of the 
bacteriocin protein and the amino acid composition were not investigated.   
 
The bacteriocin produced by LAB B21 demonstrated good pH stability (pH 3.0 – 10.0) and 
moderate thermo-stability (up to 20 min at 90 °C). The B21 bacteriocin was selected for 
further characterization due to these properties and its rather unique source. The aim of 
this project was to survey the genes responsible for bacteriocin production in this 
organism relative to those of related organisms and to purify and characterise the 
bacteriocin produced by L. plantarum B21. The study was then extended to other isolates 
from the same source. The main objectives of this study were: 
 
 Evaluation of antimicrobial activity of LAB isolates from nem chua (Chapter 3)  
 Determination of optimum culture conditions required for optimising bacteriocin 
production from L. plantarum B21 for purification and characterisation purposes 
(Chapter 3).  
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 Classification of the LAB isolates using a 16S rRNA sequencing approach  
(Chapter 4).  
 Identification of the bacteriocin genes and mapping the pln locus potentially 
responsible for production of Class II bacteriocin(s) in L. plantarum strains 
(Chapter 4). 
 Whole genome sequencing of nem chua LAB isolates using NGS platforms 
(Chapter 5).  
 Genomic analysis of the pln locus from a wider range of new LAB isolates from 
nem chua (Chapter 5). 
 Purification and characterisation of an unidentified (and later novel) bacteriocin 
protein from L. plantarum B21 (Chapter 6).  
 Peptide sequencing of the L. plantarum B21 bacteriocin, plantacyclin B21AG, using 
proteomics approaches (Chapter 6). 
 Identification and mapping of the genes responsible for production of plantacyclin 
B21AG (Chapter 6).  
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Chapter 2 
Materials and Methods  
2.1 Introduction 
This chapter describes the materials and methods used in this work. Firstly, the general 
material and methods including materials, chemicals and equipment used in this project 
are described in Section 2.2 and the specific methods for each results chapter are 
described in Section 2.3, Section 2.4, Section 2.5 and Section 2.6 for Chapter 3, Chapter 4, 
Chapter 5, and Chapter 6, respectively.  
 
2.2 General Materials and Methods  
2.2.1 General equipment 
The general equipment used in this project is listed in Table 2.1.   
Table 2.1 General equipment used in this project.  
Equipment Remarks 
Micropipette Finnpipette F1 (0.2-2 µL, 1-10 µL, 10-1000 µL, 1-10 mL),   
Thermo Scientific, Finland 
Balance  AND, EK-300i, Korea 
Analytical balance XS, Mettler Toledo, Switzerland 
Vortex/Platform mixer  Ratek Instruments, Australia 
Hot plate/stirrer  Industrial Equipment & Control Pty Ltd, Australia 
Temperature controlled incubator Thermoline Scientific, Australia 
Water bath Ratek Instruments, Australia 
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2.2.2 General procedures 
The deionised water from Millipore Milli-Q® Reference A+ water purification system 
(Millipore, Australia) was used for the preparation of all media and solutions used in this 
project. The Pyroneg detergent (JohnsonDiversey, Pty. Ltd., Australia) was used for 
washing the glassware followed by rinsing with deionised water. Chemical reagents used 
were of an analytical laboratory grade. Unless otherwise stated, glassware, solutions and 
media were sterilised by autoclaving at 121 °C for 20 min. All media were prepared using 
aseptic techniques and were stored at 4 °C until used.  
 
2.2.3 General media and solutions  
Agarose gel: 1.5% (w/v) DNA grade agarose (Promega, Spain) in 1X TAE buffer. The 
agarose powder was heated to dissolve in a microwave. 
CTAB-NaCl (CTAB 10% w/v, NaCl 0.7 M):  The sodium chloride 4.1 g (AMResco, USA) was 
dissolved in 80 mL water; during heating to 65 °C, 10 g CTAB (Hexadecyltrimethyl 
ammonium bromide, Sigma-Aldrich, USA) was added. The final volume was adjusted to 
100 mL with water and filtered through 0.2 µm microfilter (Sarstedt, Germany). The 
solution was stored at room temperature.  
Disodium phosphate buffer stock (Na2HPO4) 1 M: The solution was prepared by 
dissolving 28.4 g of sodium phosphate dibasic (BDH Chemicals, Australia) in 180 mL of 
water and adjusting the final volume to 200 mL with water.  
DNA sample loading buffer (6X): 0.25% (w/v) xylene cyanol FF (Sigma-Aldrich, USA), 
0.25% (w/v) bromophenol blue (BDH Chemicals, USA), 40% (w/v) sucrose (Sigma-Aldrich, 
USA) and 10 mM Tris-HCl (pH 7.6). 
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Ethanol 70% v/v: The solution was prepared by diluting 70 mL of absolute ethanol, 
analytical grade (Sigma-Aldrich, USA) in water to obtain a total volume of 100 mL. This 
solution was always prepared fresh (same day) for the NGS experiments.  
Hydrochloric acid (HCl) 5N: The solution was prepared by diluting 409.75 mL of 
concentrated HCl (~37.5%, Sigma-Aldrich, USA) in water to obtain the total volume of 1 L.    
Luria-Bertani (LB) broth: 1% (w/v) tryptone (Oxoid, England), 0.5% (w/v) yeast extract 
(Sigma, France) and 0.5% sodium chloride (AMResco, USA). 
Luria Bertani agar (LB agar): 1% (w/v) tryptone (Oxoid, England), 0.5% (w/v) yeast extract 
(Sigma, France), 0.5% sodium chloride (AMResco, USA) and 1.5% bacteriological agar 
(Oxoid, England). 
Monosodium phosphate buffer stock (NaH2PO4) 1 M: The solution was prepared by 
dissolving 27.6 g of sodium phosphate monobasic (BDH Chemicals, Australia) in 180 mL of 
water and adjusting the final volume to 200 mL with water.  
Semi-solid LB agar: Semi-solid LB agar was prepared by addition of 0.8% bacteriological 
agar (Oxoid, England) to LB broth. 
Sodium acetate 3M, pH 5.2: Sodium acetate 24.6 g (BDH Chemicals, Australia), was 
dissolved in 70 mL of water and the pH was adjusted to 5.2 using ~ 5.5 to 6 mL of glacial 
acetic acid (BDH Chemicals, Australia) and the final volume was then adjusted to 100 mL 
with water.  
Sodium Chloride (NaCl) 5M:  The solution was prepared by dissolving 29.22 g of NaCl 
(AMResco, USA) in 80 mL water and adjusting the final volume to 100 mL. The solution 
was filtered through 0.2 µm microfilter (Sarstedt, Germany) and stored at room 
temperature.   
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Sodium dodecyl sulphate (SDS) stock solution 10% (w/v):  The solution was prepared by 
addition of 10 g of SDS (BDH Chemicals, Australia) to 80 mL water in the fume hood. The 
stirring solution was heated to 68 °C to dissolve the powder completely. The final volume 
was adjusted to 100 mL with water. The solution was filtered through 0.2 µm microfilter 
(Sarstedt, Germany) and stored at room temperature.   
Sodium hydroxide (NaOH) 10N: The solution was prepared by gradually dissolving 80 g of 
NaOH dry pellets (Sigma-Aldrich, USA) in 200 mL water. The solution was cooled before 
use.  
Sodium hydroxide (NaOH) 1N: The solution was prepared by gradually dissolving 40 g of 
NaOH dry pellets (Sigma-Aldrich, USA) in 1 L water. This solution was prepared fresh 
(same day) for NGS experiments.  
Sodium phosphate buffer 0.1 M, pH 8.0: The monosodium phosphate buffer (1 M) and 
disodium phosphate buffer solutions at concentration of 0.1 M were prepared by diluting 
100 mL of the individual 1 M stock solution in 900 mL water. The pH of disodium 
phosphate buffer solution (0.1 M) was adjusted to 8.0 by gradually addition of the sodium 
phosphate monobasic solution (0.1 M). The solution was filtered through 0.2 µm 
microfilter (Sarstedt, Germany) and stored at room temperature.    
Tris-acetate-EDTA (TAE) buffer (50X): 2 M Tris base (Promega, USA), 1 M acetic acid, 
glacial (BDH Chemicals, Australia), 0.05 M EDTA (BDH Chemicals, USA) in water. The 
concentrated solution was diluted to 1X before use.  
Tris-EDTA (TE) buffer: 10 mM Tris base (Promega, USA), 1 mM EDTA (BDH Chemicals, 
USA), the pH adjusted to 8.0 with diluted HCl.  
Water-saturated butanol: The solution was prepared by mixing equal volume of water 
and 1-Butanol (Sigma-Aldrich, USA) and shaking vigorously. The two phases were allowed 
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to separate and the upper phase (butanol) was used. The solution was stored at room 
temperature.  
 
2.2.4 Media and solutions for growth of LAB isolates and antimicrobial activity assays 
de Man, Rogosa and Sharpe (MRS) broth: MRS broth (Oxoid, England) was prepared as 
recommended by the manufacturer by dissolving 52 g of the media into 1 L of distilled 
water at approximately 60 °C.  
de Man, Rogosa and Sharpe (MRS) agar: MRS agar (Oxoid, England) was prepared as 
recommended by the manufacturer by suspending 62 g of the media into 1 L of distilled 
water. The media was boiled to dissolve the medium completely.  
Hydrochloric acid (HCl) 0.02N: The solution was prepared by diluting 1 mL of HCl 5N in 
water to obtain the total volume of 250 mL.    
Nisaplin®: Nisaplin® (Danisco, Australia) is a commercial preparation of nisin (2.5%) and 
was used as a positive control in bacteriocin activity assays. The Nisaplin® standard 
solution, containing 5 × 104 IU/mL of nisin, was prepared as described by Cheigh et al. 
(2002). The solution was prepared by dissolving 0.5 g of the Nisaplin® powder in 9 mL of 
HCl (0.02 N). The final volume was adjusted to 10 mL using the same acid. The 
supernatant was prepared by centrifugation at 5000 × g for 10 min (3K10, Sigma, UK) and 
filtration through 0.2 µm microfilter (Sarstedt, Germany). The solution was stored at 4 °C.  
Saline water: 0.85% (w/v) sodium chloride (AMResco, USA) in water.  
Semi-solid MRS agar: Semi-solid MRS agar was prepared by addition of 0.8% 
bacteriological agar (Oxoid, England) to MRS broth (Oxoid, England) before sterilisation.   
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2.2.5 Media and solutions used for the investigation of the effect of culture conditions 
on bacteriocin production  
Lactose solution 10% (w/v): The solution was prepared by dissolving 10 g lactose (Sigma-
Aldrich, Netherlands) in 100 mL of water and filtered through 0.2 µm microfilter 
(Sarstedt, Germany) after sterilisation.   
M17 broth supplemented with lactose: M17 broth (Oxoid, England) was prepared as 
recommended by the manufacturer by suspending 37.25 g of the media in 950 mL of 
water and was boiled to dissolve the medium completely. The media was cooled after 
sterilisation to 50 °C and 50 mL of filtered lactose solution 10% (w/v) was added 
aseptically. 
Minced pork media: Minced pork (Home brand, Woolworths, Australia) was purchased 
from a local supermarket. The product (10 g) was transferred into tubes before 
sterilisation.   
MRS broth with adjusted initial pH: The MRS Broth (Oxoid, England) was prepared by 
dissolving 52 g of the media in 1 L of distilled water at approximately 60 °C. The media 
was then cooled down to room temperature before adjusting the pH to 4.0, 5.0, 6.0, 8.0 
and 9.0 using NaOH (10N) and HCl (5N), accordingly.  
MRS broth containing different carbon sources: The composition of MRS broth based on 
the formulation of the commercial product (Oxoid, England) is presented in Table 2.2. The 
MRS broth (based on the Oxoid MRS broth formulation) without added carbon sources 
was used as a basal medium and different carbon sources (glucose, fructose, lactose and 
sucrose) were added at the level of 2% (w/v).  
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 MRS broth containing different nitrogen sources: The MRS broth (based on the Oxoid 
MRS broth formulation, Table 2.2) without added nitrogen sources was used as a basal 
medium and different nitrogen sources (yeast extract, meat extract and tryptone) were 
added at the level of 2% (w/v). 
 
 
Table 2.2 The composition of MRS broth based on the formulation of the commercial 
media (Oxoid, England).  
Ingredient Quantity 
(g/L) 
Bacteriological peptone (Oxoid, England) 10.0 
Meat extract, Lab-Lemco (Oxoid, England) 8.0 
Yeast extract (Sigma-Aldrich, France) 4.0 
Glucose (Merck, Australia) 20.0 
Dipotassium hydrogen orthophosphate (BDH 
Chemicals, Australia) 
2.0 
Sodium acetate trihydrate (BDH Chemicals, Australia) 5.0 
Triammuniom citrate (BDH Chemicals, Australia) 2.0 
Magnesium sulphate heptahydrate (Merck, Germany) 0.2 
Manganese sulphate tetrahydrate (BHD Chemicals, 
England) 
0.05 
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2.2.6 Solutions for purification and analysis of the bacteriocin protein 
MALDI-TOF-MS matrix: The solution was prepared by dissolving the content of 10 mg 
tube of α-cyano-4-hydroxycinnamic acid matrix (Sigma-Aldrich, USA) in 1 mL of the 70% 
acetonitrile (ACN) (Sigma-Aldrich, USA) in 0.1% trifluoroacetic acid (TFA) solution (Sigma-
Aldrich, USA). The solution was stored in dark place and used within a week.  
SDS-PAGE fixing solution: The solution was prepared by addition of 20% (v/v) isopropanol 
(Sigma-Aldrich, USA) and 10% acetic acid, glacial (v/v) (BDH Chemicals, Australia) in water.  
Sodium phosphate buffer 20 mM, pH 6.0 (buffer A): The solution was prepared by 
addition of 17.54 mL of monosodium phosphate buffer (1 M) and 2.46 mL of disodium 
phosphate buffer (1 M) to 950 mL of water. The pH was adjusted to 6.0 using NaOH (10 
N) and the final volume was adjusted to 1 L with water. The solution was filtered through 
0.2 µm microfilter (Sarstedt, Germany) and stored at room temperature.   
Sodium phosphate buffer 20 mM, NaCl 1 M, pH 6.0 (buffer B): The solution was 
prepared by addition of 17.54 mL of monosodium phosphate buffer (1 M) and 2.46 mL of 
disodium phosphate buffer (1 M) to 950 mL of water and 58.44 g of NaCl (AMResco, USA) 
was dissolved in the solution and. The final volume was adjusted to 1 L with water and 
the pH was adjusted to 6.0 using NaOH (10 N). The solution was filtered through 0.2 µm 
microfilter (Sarstedt, Germany) and stored at room temperature.   
 
2.2.7 Microbiological materials and procedures 
2.2.7.1 Bacterial strains and culture conditions  
The list of the bacterial strains used in this project and their culture conditions are listed 
in Table 2.3. The LAB strains studied in this project, B14, B15, B20, B21, B31, B33, A17 and 
A6 had previously been isolated from nem chua by Tran (Tran 2010). The remaining 
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strains were used as indicator strains in bacteriocin activity assays and were purchased 
from the American Type Culture Collection (ATCC) or obtained from the RMIT University 
culture collection.  All LAB strains were grown in MRS broth (Oxoid, England) at 30 °C for 
24 h without shaking. For growth of the LAB strains on solid media MRS agar (Oxoid, 
England) was used and the plates were incubated at 30 °C for 48 h. The S. aureus and E. 
coli strains were grown in LB broth at 37 °C for 16 h in shaker incubator (BL8500, Bioline, 
Australia) set at 200 rpm.  These strains were grown on LB agar plates at 37 °C for 24 h 
when required.  
 
Stock cultures of bacterial strains were stored at -80 °C in MRS/LB broth supplemented 
with 30% (v/v) glycerol (Sigma, Germany). Working cultures of the bacterial strains were 
prepared on agar plates (MRS agar for LAB strains and LB agar for S. aureus and E. coli 
strains) and stored at 4 °C for up to four weeks.   
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Table 2.3 List of bacterial strains used in this project. 
Bacterial strain Source/Reference Medium/Culture 
conditions 
LAB strain B14 Tran (2010); Tran et al. (2011) MRS, 30 °C, no shaking  
LAB strain B15 Tran (2010); Tran et al. (2011) MRS, 30 °C, no shaking 
LAB strain B20 Tran (2010); Tran et al. (2011) MRS, 30 °C, no shaking 
LAB strain B21 Tran (2010); Tran et al. (2011) MRS, 30 °C, no shaking 
LAB strain B31 Tran (2010); Tran et al. (2011) MRS, 30 °C, no shaking 
LAB strain B33 Tran (2010); Tran et al. (2011) MRS, 30 °C, no shaking 
LAB strain A17 Tran (2010); Tran et al. (2011) MRS, 30 °C, no shaking 
LAB strain A6 Tran (2010); Tran et al. (2011) MRS, 30 °C, no shaking 
Lactobacillus plantarum ATCC 
8014 
Purchased from American Type 
Culture Collection (ATCC) 
MRS, 30 °C, no shaking 
Lactobacillus arabinosus 17-5 RMIT University culture collection* MRS, 30 °C, no shaking 
Lactococcus lactis 345-18 RMIT University culture collection* MRS, 30 °C, no shaking 
Lactobacillus brevis 19012 RMIT University culture collection* MRS, 30 °C, no shaking 
Lactobacillus casei ATCC 7469 RMIT University culture collection* MRS, 30 °C, no shaking 
Staphylococcus aureus ATCC 
25923 
RMIT University culture collection* LB, 37 °C, aerobically 
Escherichia coli ATCC 25922 RMIT University culture collection* LB, 37 °C, aerobically 
Escherichia coli ATCC 35218 RMIT University culture collection* LB, 37 °C, aerobically 
Escherichia coli NCTC 9001 RMIT University culture collection* LB, 37 °C, aerobically 
*School of Applied Sciences, Biosciences Department   
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2.2.7.2 Evaluation of antimicrobial activity by the well diffusion agar (WDA) assay 
2.2.7.2.1 Preparation of the culture supernatant from LAB 
The preparation method of culture supernatant was according to Schillinger & Lücke 
(1989). LAB strains from -80 °C stock preparation were resuscitated in 5 mL of MRS broth 
at 30 °C for 24 h. A 2% (v/v) 24 h culture was used to inoculate 10 mL MRS broth and 
incubated at 30 °C for 24 h. The cell free supernatant (CFS) was harvested by 
centrifugation at 5000 × g for 20 min at 4 °C (3K10, Sigma, UK). The effect of acid was 
eliminated by adjusting the pH of the CFS to 6.0 - 6.5 using sodium hydroxide (10 N). To 
rule out any possible inhibitory activity from hydrogen peroxide, catalase (Sigma-Aldrich, 
USA) was added at level of 5 mg/mL to the LAB CFS, followed by filtration through 0.2 µm 
microfilter (Sarstedt, Germany). 
 
2.2.7.2.2 The WDA assay methodology and calculation of the antimicrobial activity 
(AU/mL)  
The well diffusion agar (WDA) assay was modified from Tagg & McGiven (1971) for the 
evaluation of bacteriocin activity from LAB strains. Sterilised semi-solid MRS agar (20 mL) 
was mixed with approximately 106 CFU/mL of the overnight culture of the indicator strain 
at 47 °C and poured into petri dishes (Techno Plus, Australia). After agar solidification, 
wells of 8 mm in diameter and 100 µL in capacity were perforated using sterilised blue 
tips (Greiner Bio-one International, USA) and the bottom of the wells were sealed with 
one drop of melted MRS agar. Then 100 µL of the prepared CFS was placed into each well. 
The agar plates were held at 4 °C for 2 h to allow for the diffusion of the culture 
supernatant into the semi-solid agar and then incubated at 30 °C for 18-24 h before being 
examined for a clear zone of inhibition. The diameters of the inhibition zones were 
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measured and the diameter of the well (8 mm) was subtracted from the total zone 
diameter. To confirm the presence of antimicrobial activity or when limited amount of 
bacteriocin protein was available, the inhibitory activity was directly related to the zone 
of inhibition diameter in millimetre. Inhibition was recorded as negative if no zone was 
observed around the agar well.  The CFS from a non-bacteriocin producing strain was 
used as a negative control. Nisaplin® standard solution (Section 2.2.4) was used as a 
positive control.  
 
For quantitative bacteriocin activity assay, two-fold serial dilutions of the CFS were 
prepared using saline water solution. The antimicrobial activity was expressed as arbitrary 
units (AU/mL) as described by Todorov (2008), calculated as ab × 100, which “a” is the 
dilution factor and “b” the last dilution demonstrating an inhibition zone of at least 2 mm 
in diameter. The bacteriocin activity is expressed per mL by multiplication with 100. One 
AU is described as the reciprocal of the highest dilution producing a clear zone of growth 
inhibition (Todorov 2008).  As an example, if the 5th dilution is the last dilution showing 
the inhibition zone of at least 2mm, then the calculation of the antimicrobial activity will 
be as followed; “a” (dilution factor) = 2; “b” (last dilution showing inhibition) = 5, 
antimicrobial activity = 25 x 100 = 3200 (AU/mL). The response was shown to be 
proportional to strength of the bacteriocin solution using a range of Nisaplin® standards 
as the test sample.  
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2.2.7.3 Methods of DNA extraction and analysis 
2.2.7.3.1 Preparation of genomic DNA from LAB strains 
The method for extraction of good quality DNA from LAB strains was adapted from 
Ausubel (1987). The 24 h culture of the LAB strains was used as a 2% (v/v) inoculum for 5 
mL MRS broth (Oxoid, England) and grown overnight at 30 °C. The bacterial cells from 1.5 
mL of culture were collected by centrifugation at 10,000 × g for 5 min in a microcentrifuge 
(MiniSpin® plus, Eppendorf, Germany) and the supernatant was discarded. The pellet was 
resuspended in 576 µL TE buffer (Section 2.2.3). The cell suspension was transferred to a 
clean tube (Axygen, USA) and 20 µL of lysozyme (AMResco, USA) was added from a 100 
mg/mL stock solution and was incubated at 37 °C for 30 min. Lysis was completed by the 
addition of 30 µL of 10% SDS solution (Section 2.2.3) and 3 µL of 20 mg/mL proteinase K 
(Sigma-Aldrich, USA). This resulted in a final concentration of 100 µg/mL proteinase K in 
0.5% SDS and was mixed thoroughly before incubation at 37 °C for 1 h. This was followed 
by addition with mixing of 100 µL of 5 M NaCl (Section 2.2.3), followed by the addition of 
80 µL of pre-warmed (65 °C) CTAB/NaCl solution (Section 2.2.3) and incubation at 65 °C 
for 10 min. The protein and polysaccharide complexes bound to CTAB were removed by 
addition of equal volume of chloroform/isoamyl alcohol (24:1) (Sigma-Aldrich, USA) and 
spinning in microcentrifuge (MiniSpin® plus, Eppendorf, Germany) at 11,000 × g for 5 min. 
The aqueous phase was discarded and the viscous supernatant was transferred to a clean 
tube (Axygen, USA). An equal volume of phenol/chloroform/isoamyl alcohol (25:24:1) 
(Sigma-Aldrich, USA) was added before spinning in microcentrifuge (MiniSpin® plus, 
Eppendorf, Germany) for 5 min. The DNA was then precipitated with 0.6 volumes of 
isopropanol (Sigma-Aldrich, USA). The precipitate was collected by spinning at 11,000 × g 
for 10 min at room temperature.  The DNA pellet was washed using 70% (v/v) ethanol 
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(Section 2.2.3) and briefly dried at room temperature. It was redissolved in 100 µL of TE 
buffer pH 8.0 and stored at -20 °C.  The quality and quantity of the DNA sample was 
evaluated by measuring the 260/280 ratio on spectrophotometer (NanoDrop Lite 
Spectrophotometer, Thermo Scientific, USA). The ratio of 1.8-2.0 indicated high purity 
DNA (Kim et al. 1997). The DNA sample extracted using this methodology were used only 
for PCR amplification and sequencing experiments. The method for the DNA extraction 
for genome sequencing purposes is described in Sections 2.5.      
 
2.2.7.3.2 Polymerase Chain Reaction (PCR) 
2.2.7.3.2.1 Primer design 
Many of the primers used for the identification of the pln genes from LAB strains (Chapter 
4, Section 4.3.1) were described in previously published work (Maldonado, Ruiz-Barba & 
Jiménez-Díaz 2003; Remiger, Ehrmann & Vogel 1996; Sáenz et al. 2009). All other primers 
used in this project were designed using NCBI Primer-BLAST online design tool 
(http://www.ncbi.nlm.nih.gov/tools/primer-blast/) (Ye et al. 2012).  The initial criteria for 
the primer design were a GC content of 40-60%, 18-25 bp length, and melting 
temperature (Tm) between 50-65 °C. The primer sequences used for DNA amplification 
reactions are described in the corresponding chapter. The lyophilised primer samples 
were obtained from GeneWorks Pty. Ltd., Australia.  
 
2.2.7.3.2.2 General PCR procedure 
All PCR amplification reactions were performed in thermal cycler (GeneAmp®  PCR System 
2400, Applied Biosystems, Singapore) unless otherwise stated. The general reaction 
components and conditions are listed in Tables 2.4 and 2.5, respectively and specific 
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annealing conditions are described in the corresponding results chapters. The PCR master 
mix (Bio-Rad, USA) was used in all general PCR reactions contained  0.075 units/µL Taq 
DNA polymerase, reaction buffer, 4 mM of MgCl2, and 0.4 mM of each dNTP (dATP, dCTP, 
dGTP, dTTP). 
 
2.2.7.3.3 Agarose gel electrophoresis 
A PCR (10 µL) or an extracted DNA sample (5 µL) was mixed with the required amount of 
DNA loading buffer 6X (1-2 µL) (Section 2.2.3). The agarose gel electrophoresis was 
performed at 90 V for 80 min on Bio-Rad electrophoresis equipment (Bio-Rad, USA) using 
1.5% gel prepared in TAE buffer (Section 2.2.3). Fresh TAE buffer was used as the running 
buffer.  The gels were then stained using GelRed™ safe fluorescent nucleic acid gel stain 
(10,000X in water, Biotium, USA) using the manufacturer’s precast staining protocol, by 
mixing 10 µL of the stain with 100 mL of melted agarose gel during gel preparation. The 
nucleic acid gels were visualized and imaged using the Gel Doc™ Molecular Imager® (Bio-
Rad, USA). The DNA markers, 100 bp DNA ladder (Promega, USA), HyperLadder™ 50 bp 
(Bioline, USA), HyperLadder™ 1kb (Bioline, USA), HyperLadder™ 1kb Plus (Bioline, USA) 
and 1 kb Molecular Ruler (Bio-Rad) were used to estimate the size of the DNA fragments 
as specified in the gel image figure legends in the results chapters.   
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Table 2.4 Standard PCR reaction components for DNA amplification.  
PCR reagent Final concentration 50 µL reaction 
   
Master mix for PCR 2X (Bio-Rad, USA) 1X 25 µL 
Forward primer (10 µM) 0.4 µM 2 µL  
Reverse primer (10 µM) 0.4 µM 2 µL 
DNA template   1 µL 
Water    Made up to a 50 µL total. 
 
 
 
Table 2.5 Standard conditions of PCR procedure for DNA amplification. 
PCR step Temperature (°C) Time Number of cycle 
Initial denaturation 95  2 min 1 
Denaturation 95 30 s  
Annealing Specific annealing temperature  30 s 30 
Extension 72 1 min/kb  
    
Final extension 72 7 min 1 
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2.2.7.3.4 Extraction and purification of DNA from PCR products and agarose gel 
electrophoresis for sequencing  
The DNA fragments from PCR amplification reactions or excised from the agarose gels 
(using UV transilluminator, Novex Australia Pty. Ltd.) were extracted and purified using 
the Isolate II PCR and Gel Kit (Bioline, USA) following the manufacturer’s instructions, 
except that the DNAse free water (Ultrapure distilled water, Invitrogen by Life 
Technologies, USA) was used instead of the elution buffer. The DNA was eluted from the 
column with total of 20 µL of DNAse free water added in two steps. Firstly, 10 µL of water 
was added directly onto the column, incubated at room temperature for 1 min and 
centrifuged at 11,000 × g (MiniSpin® plus, Eppendorf, Germany) for 1 min. This was 
followed by the addition of another 10 µL to the column and incubation at room 
temperature for 5 min before centrifugation.  
 
2.2.7.3.5 PCR DNA sequencing and analysis  
The quality of the DNA purified from a PCR sample or from an agarose gel was evaluated 
using a 260/280 measurement (NanoDrop Lite Spectrophotometer, Thermo Scientific, 
USA) and the quantity of the purified DNA was estimated similarly and also by 
comparison of the intensity of the DNA bands againts standardised DNA ladder bands in 
the agarose gel.  The purified DNA samples (Section 2.2.7.3.4) were sent to Australian 
Genome Research Facility (AGRF) for sequencing of both strands as instructed by AGRF. 
The specific amount of DNA was mixed with nuclease free water (Ultrapure distilled 
water, Invitrogen by Life Technologies, USA) and forward or reverse primers as described 
in Table 2.6. The forward and reverse primers were added to the DNA templates at the 
level of 9.6 pmol/reaction and the total volume was adjusted to 12 µL with nuclease free 
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water (Ultrapure distilled water, Invitrogen by Life Technologies, USA). The PCR reaction 
mix was sent to AGRF under ambient temperature condition.  
 
The DNA sequences returned from AGRF were analysed using Sci-Ed Central Clone 
Manager Professional Suite software. The sequences from the forward and reverse 
strands were aligned and the regions with 100% match were used for analysis. Further 
bioinformatics analysis, alignments and homology searches, at the nucleotide and amino 
acid levels were performed using NCBI Basic Local Alignment Search Tool (BLAST) 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) (Altschul et al. 1990).  
 
 
Table 2.6 The quantity of DNA templates used for sequencing of purified PCR products, 
recommended by AGRF.  
DNA template Template quantity (ng) in 
total volume of 12 µL 
Primer (pmol) 
PCR product 100 - 200 bp 3 - 8 9.6 
PCR product 200 - 400 bp 6 - 12 9.6 
PCR product 400 - 600 bp 12 - 18 9.6 
PCR product 600 - 800 bp 18 - 30 9.6 
PCR product > 800 bp 30 - 75 9.6 
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2.3 Experimental procedures for Chapter 3  
2.3.1 Acid production of LAB isolates  
A 24 h LAB culture was used to provide a 2% (v/v) inoculum in 10 mL MRS broth (Oxoid, 
England) with the initial pH adjusted to 6.0. The cultures were incubated at 30 °C for 24 h. 
The CFS of the LAB strains was collected by centrifugation at 5000 × g for 20 min at 4 °C 
(3K10, Sigma, UK). The pH of the cultures supernatants was measured using a Metrohm 
pH meter (827 pH Lab, Metrohm, Switzerland) in triplicate.   
 
2.3.2 Evaluation of antimicrobial activity from LAB strains by the Spot-agar method  
The antimicrobial activity from LAB strains was evaluated using the Spot-agar method 
modified from Schillinger & Lücke (1989). This was performed by placing 10 μL of the 24 h 
culture of the LAB strains on the surface of a semi-solid MRS agar plate (Section 2.2.4) 
inoculated with approximately 106 CFU/mL of an overnight culture of the indicator strain. 
The plates were then incubated at 30 °C for 24 h to allow colonies growth. Plates were 
examined for an inhibition zone surrounding the colonies of the producer strain. The 
diameters of the inhibition zones were measured and the antimicrobial activity was 
recorded as positive if the clear zones around the colonies were larger than 2 mm.  
 
2.3.3 Investigation of the proteinaceous nature of the B21 antimicrobial activity  
The proteinaceous nature of the B21 antimicrobial activity was confirmed using a 
modified method from Omar et al. (2006). Proteolytic enzymes, proteinase K (Sigma-
Aldrich, USA), trypsin (Sigma-Aldrich, USA), pepsin (Sigma-Aldrich, USA) and catalase 
(Sigma-Aldrich, USA), as control, were prepared in sterilised Milli-Q® water at 
concentration of 10 mg/mL on the day of experiment. Each enzyme solution (10 µL) was 
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mixed with 100 µL of the LAB CFS (Section 2.2.7.2.1) and incubated at 37 °C for 3 h, to 
allow for digestion. This was followed by WDA assay (Section 2.2.7.2.2) to examine the 
loss of antimicrobial activity using L. plantarum A6 as an indicator strain. The clear zone of 
inhibition was compared with that produced by an untreated CFS or catalase treated. The 
loss or reduction in the size of the inhibition zone was taken as indication of the 
sensitivity of the antimicrobial activity to proteolytic digestion. The culture supernatant 
treated with catalase was used as a negative control.  
 
2.3.4 Evaluation of the effect of culture conditions on B21 bacteriocin acticity 
2.3.4.1 Incubation time 
The incubation time at which LAB strain B21 demonstrated the maximum bacteriocin 
activity was determined as follows; a 24 h culture of B21 was used to inoculate (2% (v/v)) 
10 mL MRS broth (Oxoid, England) and incubated at 30 °C. Samples were retrieved after 
0, 2, 4, 8, 12, 16, 24 and 36 h and were examined for pH (827 pH Lab, Metrohm, 
Switzerland), LAB count and bacteriocin activity. LAB count was performed on MRS agar 
(Oxoid, England) using a simple spread plate technique and dilution. The agar plates were 
incubated at 30 °C for 48 h and plates containing between 10 to 150 colonies (based on 
Australian standard, AS 5013.14.3–2012) were examined for the LAB colony count 
expressed as CFU/mL. The bacterial cell density was estimated by measuring the optical 
density (OD) at 600 nm on a UV spectrophotometer (BioPhotometer™, Eppendorf, 
Germany). A standard growth curve was generated by using viable counts (log CFU/mL) 
and absorbance measurements at OD600 and was used as a reference to estimate the LAB 
counts in all experiments. The bacteriocin activity was measured using WDA assay and 
expressed as AU/mL (Section 2.2.7.2.2) with L. plantarum A6 as the indicator strain.  
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2.3.4.2 Incubation temperature  
To study the effect of incubation temperature on B21 bacteriocin production, a the 24 h 
culture was used to inoculate (2% (v/v)) into 10 mL MRS broth (Oxoid, England) without 
pH adjustment and incubated at 25 °C, 30 °C and 37 °C (Thermoline Scientific, Australia), 
without agitation, for 24 h. The samples were then examined for antimicrobial activity 
(Section 2.2.7.2.2) and LAB count (2.3.4.1). 
 
2.3.4.3 Initial pH 
The effect of initial medium pH on the B21 bacteriocin production was investigated in 
MRS broth. The initial pH of the media was adjusted to pH 4.0, 5.0, 6.0, 8.0 and 9.0 
(Section 2.2.5) and a 24 h culture of L. plantarum B21 was again used to inoculate (2% 
(v/v)) into 10 mL of the pH adjusted media. The samples were incubated at 30°C for 24 h, 
without agitation before being examined for final pH and bacteriocin activity by WDA 
(Section 2.2.7.2.2).   
 
2.3.4.4 Media type and aeration 
To study the effect of medium type and aeration on the B21 bacteriocin production, three 
types of media, MRS broth (Section 2.2.4), M17 broth supplemented with lactose (Section 
2.2.5) and minced pork (Section 2.2.5), were used. A 24 h culture of B21 from an 
inoculum of 2% (v/v) was grown in the described media. The samples grown in each 
media type were incubated both aerobically (shaking using the shaker incubator, BL8500, 
Bioline, Australia set at 120 rpm) and anaerobically (in a 2.5 L anaerobic jar with one 
GasPak™ EZ Anaerobe Container System Sachet, BD, USA) at 30 °C. The samples were 
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examined for LAB cell count (2.3.4.1), pH (827 pH Lab, Metrohm, Switzerland) and 
bacteriocin activity (Section 2.2.7.2.2) after 24 h.  
 
2.3.4.5 Media composition, carbon and nitrogen sources 
The effect of different carbon and nitrogen sources on B21 bacteriocin production were 
investigated using the method of Todorov (2008). The MRS broth (based on the Oxoid 
MRS broth formulation) without added carbon and nitrogen sources was used as a basal 
medium (Section 2.2.5). The medium was then supplemented with individual carbon 
sources (glucose, fructose, lactose and sucrose) or nitrogen sources (yeast extract, meat 
extract, tryptone and the complex nitrogen source) at level of 2% (w/v) as described in 
Section 2.2.5. A 24 h culture of B21 from a 2% (v/v) inoculum was grown in each specific 
media at 30 °C for 24 h. The samples were then examined for the LAB count (2.3.4.1) and 
bacteriocin activity (Section 2.2.7.2.2).  
 
2.3.5 Statistical analysis  
All experiments described in Chapter 3 were conducted in triplicate and the mean values 
± standard deviations (SD) were reported. The statistical analyses were performed using 
the Minitab software (Version 14, Minitab Inc., USA). A one-way analysis of variance 
(ANOVA) was used to determine the significance at 95% confidence level and the 
correlation coefficient.  
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2.4 Experimental procedures for Chapter 4 
2.4.1 16S rRNA phylogenetic analysis 
Genomic DNA of LAB strains was prepared using the method described in Section 
2.2.7.3.1. The optimised primer set P1 (Section 4.2.2), forward 
ATTAATTTGAGAGTTTGATCCTGG and reverse AGAAAGGAGGTGATCCAGC, was used to 
amplify a 16r RNA region of ~1.6 kb. The PCR reactions were as described in Section 
2.2.7.3.2.2. The amplifications results were visualised using agarose gel electrophoresis as 
described in Section 2.2.7.3.3. The amplified fragments were extracted and purified from 
PCR reactions (Section 2.2.7.3.4) and were sequenced from both strands. The 16S rRNA 
from both strands was sequenced twice (from the same DNA sample) for each LAB strains 
and the sequences obtained were used to construct longer contigs (~1.1-1.5 kb) using  
Sci-Ed Central Clone Manager Professional Suite software to assist with the phylogenetic 
analysis. The final 16S rRNA sequence contigs from LAB strains were searched for 
homology against the NCBI database using the BLAST online tool 
(http://www.ncbi.nlm.nih.gov) (Altschul et al. 1990). The sequences were also used to 
construct a phylogenetic tree using the Phylogeny.fr online tool (Dereeper et al. 2008). 
The 16S rRNA sequences from the L. plantarum and L. brevis reference genomes, which 
showed homology to nem chua LAB isolates in the BLAST analysis, were also included in 
the phylogenetic analysis.     
 
2.4.2 Identification and analysis of the bacteriocin-encoding genes  
Genomic DNA for the LAB strains was prepared using the method described in Section 
2.2.7.3.1.  The primers used for identification of the bacteriocin genes and the PCR 
annealing temperatures were as described in the corresponding results chapter. The PCR 
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reaction components and procedures, DNA extraction and purification, gene sequencing 
and bioinformatics analysis were as described in Section 2.2.7.3.  
 
2.4.3 Long range PCR amplification  
Genomic DNA of bacteriocin producing strains, B21, B31 and B33 and non-bacteriocin 
producing strain B15 was prepared using the method described in Section 2.2.7.3.1. The 
specific primers used to amplify the ~16 kb region from the pln locus are described in the 
corresponding chapter. The LAB genomic DNA was amplified using GoTaq® Long PCR 
Master Mix (Promega, USA) being specifically design for long PCR targets (up to 30 kb). 
This master mix contains a blend of hot-start, recombinant Taq DNA polymerase and a 
recombinant proofreading DNA polymerase to ensure long amplification. The 
amplification reaction components and conditions were those recommended by the 
manufacturer as presented in Tables 2.7a and 2.7b. The amplifications results were 
visualised using agarose gel electrophoresis as described in Section 2.2.7.3.3. 
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Table 2.7a PCR reaction components for amplification of long range DNA.  
PCR reagent Final 
concentration 
50 µL reaction 
GoTaq® Long PCR Master Mix (Promega, 
USA) 
1X 25 µL 
Forward primer (10 µM) 0.4 µM 2 µL  
Reverse primer (10 µM) 0.4 µM 2 µL 
DNA template  0.1-0.5 µg 5 µL 
Water    Make up to total 50 
µL 
 
 
Table 2.7b PCR conditions for amplification of long range DNA*. 
PCR step Temperature (°C) Time Number of cycle 
Initial denaturation 95  2 min 1 
Denaturation 94 30 s  
Annealing 50  30 s 30 
Extension 72 15 min  
    
Final extension 72  10 min 1 
                *See Section 2.4.3 for further details. 
 
 
CHAPTER 2 
 
75 
 
2.5 Experimental procedures for Chapter 5 
2.5.1 Whole genome sequencing (WGS) of LAB B21 on the Illumina platform 
2.5.1.1 Large-scale CsCl preparation of B21 genomic DNA and restriction enzyme 
digestions  
The CsCl DNA extraction method was modified from Ausubel (1987). A fresh culture of 
B21 was grown from a 2% (v/v) inoculum in 100 mL of MRS broth at 30 °C for 24 h. The 
pellet was collected by centrifugation (Heraeus Multifuge 1S-R, Thermo Electron 
Corporation, Germany) at 4000 × g for 10 min and were gently resuspended in 9.5 mL of 
TE buffer at pH 8.0. Lysozyme (350 µL) (AMResco, USA) of 100 mg/mL concentration was 
mixed well into the cell suspension before addition of 9.5 µL of RNAse A (10mg/mL conc., 
Sigma-Aldrich, USA) to obtain a final concentration of 10 µL/mL and incubated at 37 °C for 
30 min. This was followed by addition of 0.5 ml of 10% SDS and 50 µL of proteinase K (20 
mg/mL conc., Sigma-Aldrich, USA), with incubation at 37 °C for 1 h.  
 
The precipitation and purification of the DNA from the solution was carried out as 
follows, 1.8 mL of NaCl (5 M) was added and the mixed thoroughly before addition of 1.5 
mL of pre-warmed CTAB-NaCl solution (10% CTAB (w/v), NaCl 0.7 M) with incubation at 
65 °C for 20 min. Equal volumes of chloroform/isoamyl alcohol (24:1) (Sigma-Aldrich, 
USA) were added and the mix was centrifuged at 6000 × g (Avanti® J-25I, JA-25.5 rotor, 
Beckman Coulter, Inc. USA) at room temperature for 10 min to separate the phases. The 
aqueous supernatant was transferred to a clean tube (Falcon polypropylene Round-
bottom tube, BD, USA) using a wide-bored pipette tip, leaving the interface behind. This 
step was repeated using an equal volume of phenol/chloroform/isoamyl alcohol (25:24:1) 
(Sigma-Aldrich, USA).  Ice-cold isopropanol (0.6 of volume) was added to precipitate the 
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DNA. The final spin was performed (Avanti® J-25I, JA-25.5 rotor, Beckman Coulter, Inc. 
USA) at 10,000 × g at 4 °C for 20 min and the supernatant was discarded. The DNA was 
washed with 1 mL of 70% (v/v) ice-cold ethanol and centrifuged at 10,000 × g for 10 min. 
the DNA obtained was redissolved overnight in 4 mL TE buffer (pH 8.0) at 4 °C.   
 
The DNA concentration was estimated using a NanoDrop Lite spectrophotometer 
(Thermo Scientific, USA) and was adjusted to 50 to 100 µg/mL. This resulted in 200 to  
400 μg chromosomal DNA per 4 mL gradient. Cesium chloride 4.3 g (CsCl, Sigma-Aldrich, 
USA) was dissolved per 4 mL TE buffer and followed by addition of 200 µL of ethidium 
bromide (EtBr) (10 mg/mL conc., Boehringer Mannheim Biochemicals, Germany). The mix 
was transferred to sealable centrifuge tubes (Quick-Seal®, Beckman Coulter, Inc. USA) and 
the volume of the tubes were balanced using CsCl in TE buffer (1.05 g/mL). The tubes 
were sealed and centrifuged overnight at 20°C using Beckman Coulter Optima™ L-80 XP 
ultracentrifuge (VTi90 rotor, Beckman Coulter, Inc. USA) at 55,000 rpm (~220,000 × g). 
The resulting gradient was visualised using an UV transilluminator (Novex Australia Pty. 
Ltd.). A single band was observed and removed from the tube using an 18-gauge needle 
(Terumo, Japan) and a 5-mL plastic syringe (Terumo, Philippines) (Figure 2.1). No evidence 
of plasmid contamination (as a separate band) was observed.   
 
EtBr was removed by sequential extractions with water-saturated butanol based on the 
method from Sambrook, Fritsch & Maniatis (1989).  An equal volume of water-saturated 
butanol was added to the DNA solution, mixed well and centrifuged at 1500 × g (3K10, 
Sigma, UK) at room temperature for 3 min. The lower aqueous phase was then 
transferred to a clean tube and the top organic phase was discarded. The butanol 
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extraction step was repeated four to six times till the pink colour had disappeared from 
both the aqueous and organic phase. The sample was then dialysed overnight against 2 L 
of TE buffer (pH 8.0) using a Slide-A-Lyzer dialysis cassette (10K MWCO, Thermo Scientific, 
USA) to remove the CsCl. The Slide-A-Lyzer dialysis cassette was used according to 
manufacturer’s instruction. The cassette was hydrated in sterilized Milli-Q® water for 15 
min before use. The dialysis buffer was initially changed after 2 h and then regularly every 
couple of hours.  
 
The solution was transferred into a clean tube and the genomic DNA was precipitated by 
addition of 3 M sodium acetate, pH 5.2 (1/10 of volume) and isopropanol (0.6 of volume, 
Sigma-Aldrich, USA). The DNA was collected by high speed centrifugation (Avanti® J-25I, 
JA-25.5 rotor, Beckman Coulter, Inc. USA) at 10,000 × g at 4 °C for 20 min, washed using 
70% (v/v) ice-cold ethanol and redissolved in 500 µL of TE buffer and stored at 4 °C 
overnight. The DNA sample was visualised using agarose gel electrophoresis (Section 
2.2.7.3.3) loading 1 µL of the sample on the gel. The quality and quantity of the DNA 
sample was evaluated on NanoDrop Lite spectrophotometer (Thermo Scientific, USA). 
This sample (stored on dry ice) was sent to Beijing Genomics Institute (BGI, Hong Kong) 
using express post and was used for WGS on the Illumina platform (HiSeq™ 2000, USA).  
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Figure 2.1 Collection of CsCl prepared genomic DNA. The yellow arrow indicates one single 
band of genomic DNA observed.    
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The CsCl prepared genomic DNA from LAB B21 was digested using restriction enzymes, 
EcoRI and BamHI (New England Biolabs, USA) following the manufacturer’s instructions. 
The details of the digestion reaction are presented in Table 2.8. The samples were 
incubated at 37 °C for 1 h. The enzyme reaction was then terminated using a stop-
solution, 10 µL per 50 µL sample (New England Biolabs, USA). The digested DNA was 
visualised using agarose gel electrophoresis (Section 2.2.7.3.3).   
 
 
  Table 2.8 Digestion of the B21 genomic DNA with restriction enzymes EcoRI and BamHI.   
Component Quantity 
Restriction enzyme 
EcoRI or BamHI (New England Biolabs, USA) 
2 µL 
DNA 1 µL 
CutSmart™ buffer 10X (New England Biolabs, USA) 5 µL 
Nuclease free water  
(Ultrapure distilled water, Invitrogen by Life 
Technologies, USA) 
42 µL 
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2.5.1.2 De novo genome sequencing    
The B21 genome was sequenced using the Illumina HiSeq 2000 sequencing platform (BGI, 
China). The library preparations contained fragment insertions with the length of 500 bp 
and 6 kb. A paired-end sequencing technology was used with 90 bp read length.   
 
2.5.1.3 Quality control and de novo genome assembly   
The quality control of the raw sequencing data and the genome assembly were 
performed by BGI. In summary, the raw data was subjected to quality control trimming in 
order to obtain accurate and reliable sequencing. The low quality reads, adaptors and 
short insert read contaminations were removed. For de novo assembly, the reads were 
assembled into genome sequence using SOAPdenovo (Version 2.04) software. The K-mer 
parameter setting was determined for the optimal assembly result. This assembly result 
was then locally re-assembled and optimised according to paired-end and overlap 
relationships which enabled the mapping of the reads into contig. 
 
2.5.2 WGS of new LAB strains on Ion Proton platform 
Five LAB strains (B21, B20, B15, A7 and A6) were subjected to WGS using the Ion Proton 
sequencing facility at RMIT University.  
 
2.5.2.1 Preparation of the genomic DNA from LAB  
The method used for DNA extraction of LAB strains was modified from Stephen et al.  
(1996). A 24 h culture of LAB strains from a 2% (v/v) inoculum was grown in MRS broth. 
The bacterial cells from 5 mL culture were harvested by centrifugation (Heraeus 
Multifuge 1S-R, Thermo Electron Corporation, Germany) at 4000 × g for 10 min. The pellet 
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obtained were resuspended in 0.5 mL of 0.1 M sodium phosphate buffer, pH 8.0 and 
mixed with the equal volume of phenol/chloroform/isoamyl alcohol (25:24:1) (Sigma-
Aldrich, USA). The mix then was transferred into 2 mL screw-cap tubes (Thermo Scientific, 
USA) containing 0.5 g of glass beads (212-300 μm, acid washed, Sigma-Aldrich, USA). The 
tubes were beat for 25 s using a bead-beater (Mini-BeadBeater, BioSpec Products, USA) 
and incubated on ice for 30 s, the bead beating was then repeated. The samples were 
centrifuged (Heraeus™ Fresco 17, Thermo Scientific, Germany) at 10,000 × g for 10 min at 
room temperature. The top phase was collected, 5 µL of RNAse A (10 mg/mL conc., 
Sigma-Aldrich, USA) was added and the sample was incubated at 37 °C for 15 min. This 
was followed by another two phenol/chloroform/isoamyl alcohol (25:24:1) (Sigma-
Aldrich, USA) extraction steps using an equal volume of the mix and the centrifugation as 
previously described. The aqueous phase collected was subjected to final cleaning using 
the GENECLEAN Turbo™ kit (MP Biomedicals, USA) according to the manufacturer’s 
instructions with modification. The DNA was eluted again in nuclease free water 
(Ultrapure distilled water, Invitrogen by Life Technologies, USA) instead of the 
GENECLEAN Turbo™ elution solution. The DNA sample was visualised using agarose gel 
electrophoresis (Section 2.2.7.3.3). The quality and quantity of the DNA sample was 
evaluated on the NanoDrop Lite spectrophotometer (Thermo Scientific, USA). Except LAB 
B21 which genomic DNA was prepared using CsCl method, the genomic DNA of four other 
LAB strains (B15, B20, A6 and A17) were prepared by this method and were used for 
genome sequencing, on the in-house Ion Proton platform. 
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2.5.2.2 Library preparation for Ion Proton sequencing  
2.5.2.2.1 Library preparation of new LAB strains  
The genomic library preparations from Lab strains were performed using Ion Xpress™ Plus 
gDNA Fragment Library Preparation kit (Life Technologies, USA) according the 
manufacturer’s instructions. The workflow diagram of the library preparation procedures 
is presented in Figure 2.2. In summary, the concentration of the DNA was measured using 
Qubit (Invitrogen by Life Technologies, Singapore) according to the manufacturer’s 
instructions. Based on the Qubit reading, 50-100 ng of genomic DNA (gDNA) was used for 
the library preparation.  The gDNA was then fragmented using Ion Shear™ Plus Reagents 
(Life Technologies, USA). The fragmentation reaction time was optimised for the gDNA of 
LAB strains in order to produce fragments with a median size of 100-200 bp. Every library 
preparation step was followed by purification and cleaning of the DNA using Agencourt® 
AMPure® XP Reagent (Beckman Coulter, Inc., USA) according to the manufacturer’s 
instructions. The DNA fragments were then ligated to Ion-compatible adapters (Figure 
2.2). This was followed by nick-repair to complete the linkage between the adapters and 
DNA inserts. In the case of barcoded libraries, adapters from the Ion Xpress™ Barcode 
Adapter kits (Life Technologies, USA) were used. The adapter-ligated and nick-translated 
DNA was the purified and cleaned before being size selected. The adapter-ligated library 
was size selected to have the optimum length according to the targeted read length of 
~220 bp. The size selection was performed using E-gel® agarose gel (size select 2%, 
Invitrogen, Israel), E-gel® safe imager and real-time transilluminator (Invitrogen by Life 
Technologies, Israel). The final step was library amplification followed by purification and 
final cleaning of the library preparations.  
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2.5.2.2.2 Library preparation analysis using Bioanalyzer  
The library preparations were then evaluated for the quality and quantity using a 
Bioanalyzer (Agilent® 2100, Germany) before use in template preparation steps. The High 
Sensitivity DNA Analysis Kit (Agilent Technologies, Germany) was used for the sample and 
chip preparations according to the manufacturer’s instructions. The Bioanalyzer (Agilent® 
2100, Agilent Technologies, Germany) uses a chip-based nucleic acid separation system 
performing capillary electrophoresis on micro-fabricated channels. It performs detection 
and online data evaluation in an automated manner. The data obtained from the 
Bioanalyzer was used to determine the molar concentration of the DNA samples and to 
evaluate the size distribution of the libraries.  The DNA molar concentrations were then 
used to calculate the appropriate dilution of the library required for template 
preparation. 
 
CHAPTER 2 
 
84 
 
 
Figure 2.2 Overview of the genomic DNA library preparation using the Ion Xpress™ Plus gDNA 
Fragment Library Preparation kit (Ion Xpress™ Plus Fragment Library Preparation User Guide. ‘A’ 
and ‘P1’, Ion-compatible adaptors; ‘BC’, barcode.   
 
 
 
 
 
 
 
 
Genomic DNA 
Fragment Ion ShearTM Plus 
reagents  
Ligate barcode adapters  Barcode adapters  A-X  
P1  
Size select  
Unamplified 
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2.5.2.3 Template preparation 
The sequencing template preparation for LAB strains was performed using the Ion 
OneTouch™ 2 system and Ion PI™ Template OT2 200 Kit v3 (Life Technologies, USA) 
according to the manufacturer’s instructions. The Ion OneTouch™ 2 System included the 
Ion OneTouch™ 2 instrument (Life Technologies, USA) the Ion OneTouch™ ES instrument 
(Life Technologies, USA). The final library preparation with concentration of 8 pM was 
used for template preparation of new LAB strains. In summary, the template-positive 
ISPs, containing clonally amplified DNA, were prepared by emulsion-PCR using the Ion PI™ 
Template OT2 200 Kit v3 (Life Technologies, USA) with the Ion OneTouch™ 2 Instrument 
(Life Technologies, USA). Then the template-positive ISPs were enriched using the Ion 
OneTouch™ ES (Life Technologies, USA). The enriched ISPs were then collected and 
washed before being used in the sequencing reaction.  
 
2.5.2.4 Sequencing run 
The sequencing reaction was carried out using the Ion PI™ Sequencing 200 Kit v3 (Life 
Technologies, USA) on the Ion Proton™ Semiconductor sequencer (Life Technologies, 
USA) according to the manufacturer’s instructions. In summary, a planned run was 
created using Torrent Suite™ software connected to the Ion Proton™ Sequencer. This 
specified the number of runs, kit types, barcode used, the run type (gDNA sequencing) 
and the reference sequences. The Ion Proton™ sequencer (Life Technologies, USA) was 
cleaned using chlorite cleaning and water cleaning according to the instructions followed 
by the sequencer initialisation. In a separate experiment, the Ion PI™ Chip (v2) (Life 
Technologies, USA) was prepared for loading by repetitive washing with nuclease-free 
water (Invitrogen by Life Technologies, USA), isopropanol (Sigma-Aldrich, USA), Ion PI™ 
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Chip preparation solution (Life Technologies, USA) and NaOH (0.1 M, freshly prepared). 
This was followed by the Ion PI™ Chip calibration according to the manufacturer’s 
instruction.  
 
The template-positive Ion PI™ ISPs was prepared for sequencing by addition of the Ion 
PI™ Control Ion Sphere™ particles (Life Technologies, USA) to the enriched ISPs. This was 
followed by annealing the Ion PI™ Sequencing Primer (Life Technologies, USA) to the 
enriched ISPs. Then the chip was loaded with 55 µL of the template-positive ISPs with 10 
min centrifugation using Ion Chip™ Minifuge (Ion Torrent, Life Technologies, Korea). The 
chip containing the sample was then flooded with annealing buffer (Life Technologies, 
USA) and the prepared foaming Solution (10% Triton® X‑100, Life Technologies, USA). 
Lastly, the chip was flushed with the flushing solution (Life Technologies, USA) and the Ion 
PI™ Sequencing Polymerase (Life Technologies, USA) was loaded on the chip. The 
sequencing run was then started.  
  
2.5.2.5 Sequencing data analysis and quality control – technical definitions 
The raw sequencing data was downloaded on the Torrent Browser (Life Technologies). 
The initial quality control and analysis was performed using Torrent Suite™ software. A 
Torrent Browser run report was created for the LAB sequencing run. The report contained 
information in regards to the quantity of the data obtained, key signal and ISP summary 
(loading, enrichment, clonal and final library). The descriptions of some of the sequencing 
metrics (before alignment), according to Torrent Browser analysis report guide, are as 
follows.  
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Total reads: The total number of filtered and quality (Q20) trimmed reads independent of 
the read length.   
Usable Sequence: The percentage of the library ISPs that pass the quality control through 
polyclonal, low quality and primer dimer filters. This value is calculated by dividing the 
final library ISPs by the total library ISPs. 
Chip loading (%): The chip loading percentage is the percentage of the chip wells that 
contain live ISP. This is calculated by dividing the total number of loaded ISPs by the 
number of potentially addressable well.  
Empty wells (%): The percentage of the chip wells which do not contain an ISP.  
Enrichment (%): The ISP enrichment percentage is based on the predicted number of live 
ISPs that contain a key signal identical to the library key signal. The value of the 
enrichment percentage is the number of loaded ISPs which are library ISPs after removing 
the Test Fragment ISPs.  
Clonal (%): The clonal ISP defines as all DNA fragments that are cloned from a single 
original template. This includes all library and Test Fragment ISPs that are not polyclonal 
and is calculated by dividing the number of ISPs with single beads by the number of the 
live wells.    
Polyclonal (%): The percentage of the ISPs that carry clones from two or more templates. 
The percentage value is calculated by dividing the polyclonal ISPs by the live ISPs.  
 
2.5.2.5.1 Coverage analysis (CA)  
The CA plugin from the Torrent Suite™ software was used to describe the level of the 
sequence coverage produced for targeted genomic regions by means of statistical 
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analysis and graphs. Some of the CA metrics that are used in Chapter 5 are described in 
the Torrent Browser analysis report guide (Torrent 2014c), as follows. 
Bases in targeted reference: The total number of bases in all targeted regions from the 
reference sequence.  
Average base coverage depth: The average number of the reads from the bases of 
targeted reference that were read at least once.  
Uniformity of base coverage: The percentage of bases in the whole genome which is 
covered by at least 0.2X the average base coverage depth. 
Genome base coverage at NX: The percentage of the bases from the reference genome 
that is covered by at least N reads. 
Genome bases with no strand bias: The percentage of the whole genome that did not 
show any indication of a bias towards forward or reverse strand read alignments. An 
individual target has a read bias if it has at least 10 reads and the fraction of forward or 
reverse reads to total reads is greater than 70%. 
 
2.5.2.5.2 Variant Caller analysis 
The Torrent Variant Caller (TVC) analysis plugin from the Torrent Suite™ software was 
used to call single-nucleotide polymorphisms (SNPs), multi-nucleotide polymorphisms 
(MNPs), insertion, and deletion (Indels) variants against specific targeted references. The 
plugin parameters were customised for the LAB sequence analysis to balance the 
specificity and sensitivity required. High stringency settings, optimised to minimise false 
positives, were used for most analysis (B15, B20, A6 and A17). The low stringency 
settings, optimised to minimise false negative results, were used for comparison between 
the B21 Illumina and Ion Proton genome sequencing data.   
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2.5.2.5.3 De novo genome assembly  
The sequencing data for LAB strains (A6, A17, B20, B15 and B21) having ‘Fastq’ file format 
was sent to AGRF for de novo assembly. The Ion proton sequencing data was screened 
using Fastqc tools (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/) 
(Andrews et al. 2014). As a part of quality control step the Ion Torrent  
barcodes and adaptors were removed using ea-utils fastq-mcf 
(http://hannonlab.cshl.edu/fastx_toolkit/) (Aronesty 2011).  The reads were also quality 
trimmed at the ends using fastq_quality_trimmer at with Q20 quality cut-off.  The de 
novo assembly of LAB genomes was performed using Mira 4 (Chevreux et al. 2004).  
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2.6 Experimental procedures for Chapter 6 
2.6.1 Purification of B21 bacteriocin protein 
The B21 bacteriocin protein was purified from the culture supernatant by a four-step 
protocol consisting of a cell free supernatant (CFS) harvesting and concentration step, 
extraction into butanol, a size exclusion/desalting/buffer-exchange step and a final cation 
exchange chromatography by Fast Protein Liquid Chromatography (FPLC). All the 
purification steps were carried out at room temperature.  
 
2.6.1.1 Concentration of B21 CFS 
LAB strain B21 was used as an inoculum 2% (v/v) into 1.6 L of MRS broth with an initial pH 
of 6.0 and was incubated at 30 °C for 24 h without shaking. The neutralised culture 
supernatant was prepared as described in Section 2.2.7.2.1. Two initial trials were carried 
out to evaluate the efficiency of the bacteriocin protein concentration using a 10 and 30 
kDa membrane cut off. In the first attempt the B21 CFS was concentrated using an 
ultrafiltration (UF) cell (Amicon Model 8200, Millipore, USA) with a 10 kDa cut off 
membrane (polyethersulphone, PES - 10 kDa ultrafiltration membrane discs, Generon, 
UK). In the second trial, a 30 kDa cartridge (Prep/Scale Spiral Wound TFF-2 Module PLTK, 
Merck Millipore, Germany) was used for the concentration. The filtrate and concentrate 
from both trials were collected and WDA assays were performed to evaluate the 
efficiency of recovery. Based on the results presented in Chapter 6 (Section 6.2.1), 1.6 L of 
B21 CFS was concentrated using the 10 kDa cut off membrane (polyethersulphone, PES-
10 kDa ultrafiltration membrane discs, Generon, UK). The concentration was carried out 
at room temperature. The UF cell set up consisted of Amicon Model 8200 (Millipore, USA) 
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equipped with a 200 mL filtration cell. A nitrogen gas cylinder (Coregas, Australia) was 
used to maintain the required pressure gradient (3 bar) to force the CFS solution through 
the membrane. A magnetic stirrer was used to impart necessary shear force to reduce the 
solid protein built up on the membrane surface to reduce membrane polarisation. The 
final volume of the B21 CFS concentrate was reduced to 70 mL for use in the next 
purification step.  
 
2.6.1.2 Ammonium sulphate (AS) precipitation trials 
The method for precipitation of bacteriocin protein using ammonium sulphate was 
adapted from Scopes (1982). The amount (in grams) of ammonium sulphate (Fisher 
Scientific, UK) added to 1 L of the B21 culture supernatant at 20 °C was calculated using 
the formula as follows;  
 
At S1% saturation, to take it to S2% saturation:  
  
           
          
 
 
The ammonium sulphate fractionation consisted of three trials. All experiments were 
performed at room temperature on 70 mL of CFS concentrate from above. In the first 
trial, AS saturation level was increased from 0% to 80% at three intervals (0% to 20%, 20% 
to 55% and 55% to 80%). The second trial also consisted of three AS fractionations, 
increasing the saturation level from 0% to 80% at intervals of 0% to 35%, 35% to 60% and 
60% to 80%. In the third trial the AS level was increased from 0% to 55% before achieving 
the final saturation level of 80%. The calculated amount of solid AS (Fisher Scientific, UK) 
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was added to the B21 CFS concentrate and the sample was stirred for 10 min before 
centrifugation (Heraeus Fresco 17, Thermo Scientific, Germany) at 10,000 × g for 10 min. 
A pellet was only observed at 80% saturation level and was redissolved in 500 µL of 20 
mM sodium phosphate buffer (pH 6.0). The resuspended pellets and supernatants were 
collected and examined for antimicrobial activity.  
 
2.6.1.3 Butanol extraction 
The method for extraction of bacteriocin protein from 70 mL of concentrated B21 culture 
supernatant using n-butanol was modified from Abo-Amer (2007). The concentrated B21 
CFS was mixed with ½ volume of water saturated butanol for 20 s. The mix was incubated 
at room temperature for 10 min before being centrifuged (Heraeus Fresco 17, Thermo 
Scientific, Germany) at 10,000 × g for 10 min. The butanol phase from the top was 
transferred to a clean tube. The bottom aqueous phase was again subjected to the 
protein extraction using a ½ volume of water saturated butanol, the aqueous and organic 
phases were retained and the butanol fractions containing the bacteriocin protein were 
combined and freeze dried (FDU-8612, Operon Co. Ltd, Korea) to remove the solvent. A 
small part of the dried sample (3-5 mg) was redissolved in 20 mM sodium phosphate 
buffer (pH 6.0) and the antimicrobial activity in the butanol and aqueous fractions using 
WDA assay. The butanol dried fraction was stored at -80 °C for later use in further 
purification steps. It retained more than 95% of the bacteriocin related activity.  
 
2.6.1.4 Gel filtration/desalting trials  
A portion of the B21 dried butanol extraction (equivalent to 165 mL of CFS) was thawed 
from the sample stored at -80 °C and was resuspended in 1 mL of 20 mM sodium 
CHAPTER 2 
 
93 
 
phosphate buffer (pH 6.0). The redissolved protein sample was desalted using a NAP10 
desalting column pre-packed with Sephadex G-25 resin (NAP™-10 Columns, Sephadex™ 
G25, GE Healthcare Life Sciences, UK) according to manufacturer’s instructions. The 
column was firstly washed with 15 mL of 20 mM sodium phosphate buffer (pH 6.0) 
(buffer A). The bacteriocin sample (1 mL) was added to the column and a total of 2.5 mL 
of buffer A (500 µL + 2 mL) was used to elute the sample from the NAP-10 column 
resulting in 3.5 mL of eluted fractions. The collected ‘pools’ (early, F1 and F2, middle F3-
F8, and late F9 and F10) were examined for antimicrobial activity by WDA assay. Only the 
middle ‘pool’, F3-F8 (0.5 mL), contained active bacteriocin.  
 
2.6.1.5 FPLC cation exchange chromatography 
Purification of the desalted bacteriocin protein was performed using fast protein liquid 
chromatography (FPLC) system (BioLogic DuoFlow System, Bio-Rad, USA) equipped with 
QuadTec™ UV detector and Econo™ Gradient Pump according to manufacturer’s 
instructions. BioLogic software connected to the FPLC system was used for the raw data 
analysis. The chromatography was carried out using a 12 × 55 mm Uno S-6 prepacked 
monolith cation exchange column (Bio-Rad, USA) according to the manufacturer’s 
instructions. The protocol used for the cation exchange chromatography is presented in 
Table 2.9. The 20 mM sodium phosphate buffer (buffer A) and 1 M NaCl in buffer A 
(buffer B) were prepared as described in Section 2.2.6. A flow rate of 2 mL/min was used 
in and the UV absorbance was monitored at 214 and 280 nm simultaneously using the 
BioLogic QuadTec™ UV detector (Bio-Rad, USA). The Uno S-6 column (Bio-Rad, USA) was 
equilibrated with 5 mL of buffer A and the QuadTec™ UV detector (280 nm) baseline was 
returned to zero. Approximately 1 mL of the desalted bacteriocin extract was adsorbed to 
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a 6 mL column of Uno S-6 (Bio-Rad, USA). The column was then washed with 20 mL of 
buffer A.  The bacteriocin was eluted from the column with a linear NaCl gradient  
(0-1 M) in buffer A in 66 mL at 2 mL/min (Table 2.9). The column was washed with 7.8 mL 
of 100% buffer B followed with 13 mL of buffer A. A total of 33 fractions of 3 mL were 
collected and assayed for the antimicrobial activity.  
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Table 2.9 The FPLC cation exchange chromatography protocol using BioLogic DuoFlow System (Bio-Rad, USA). 
 Volume Description Parameters 
1 0.0 Isocratic flow Buffer A 100% Volume: 5 mL 
Buffer B 0% Flow: 2 mL/min 
2 5.0 Zero baseline UV detector - 214 nm    
3 5.0 Zero baseline UV detector - 280 nm   
4 5.0 Load/inject sample Sample  Volume: 3 mL 
Static loop Auto inject valve Flow: 2 mL/min 
5 8.0 Isocratic flow Buffer A 100% Volume: 20 mL 
Buffer B 0% Flow: 2 mL/min 
6 28.0 Linear gradient Buffer A       100%                 0%  Volume: 66 mL 
Buffer B 0%                 100% Flow: 2 mL/min 
7 94.0 Isocratic flow Buffer A 0% Volume: 7.8 mL 
Buffer B 100% Flow: 2 mL/min 
8 101.80 Isocratic flow Buffer A 100% Volume: 13 mL 
Buffer B 0% Flow: 2 mL/min 
 114.80 End of protocol    
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2.6.1.6 Concentration of bacteriocin protein 
The two FPLC-fractions showing the strongest bacteriocin activity (F14 and F15) were 
pooled together (6 mL) and concentrated using an Amicon® Ultra-4 Centrifugal Filter 
Units (3 kDa, Millipore, Ireland) according to the manufacturer’s instructions. In summary, 
the bacteriocin sample of 6 mL was transferred into the centrifugal filter units and was 
centrifuged (Heraeus Multifuge 1S-R, Thermo Electron Corporation, Germany) for 4000 × 
g at 4 °C. In order to remove salt from the solution, the buffer exchange was performed 
using 20 mM sodium phosphate buffer (pH 6.0). The final volume of the purified 
bacteriocin protein fraction was reduced to 200 µL. This sample was referred to as B21 
purified bacteriocin protein and was used for further protein analysis.  
 
2.6.1.7 BCA protein assay 
The concentration of the bacteriocin protein was measure after each step of protein 
purification using Pierce™ BCA Protein Assay Kit (Thermo Fisher Scientific, USA) according 
to manufacturer’s instruction. The Thermo Scientific™Pierce™BCA Protein Assay performs 
the colorimetric detection and quantitation of total protein using a detergent-compatible 
formulation based on bicinchoninic acid (BCA). The method uses highly sensitive and 
selective colorimetric detection of the cuprous cation (Cu+1) by means of a unique reagent 
containing bicinchoninic acid (Smith et al. 1985). The detection is based on the biuret 
reaction which explains the reduction of Cu+2 to Cu+1 by protein in an alkaline medium.  
 
The working reagent was prepared according to the manufacturer’s instructions. The 
microplate procedure was used with the detection range of 20-2000 μg/mL. In summary, 
25 μL of each standard or B21 bacteriocin sample was transferred into a microplate well 
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(96 well microplate, Nunc™, Denmark) and mixed for 30 s with 200 μL of the working 
solution. The plate was covered and incubated at 37 °C for 30 min before being examined 
for the absorbance at 562 nm on a plate reader (POLARstar Omega, BGM Labtech, 
Germany). The protein concentrations were determined with reference to a standard 
curve with bovine serum albumin (BSA). 
 
2.6.2 Protein analysis of the B21 purified bacteriocin 
2.6.2.1 Stability of the bacteriocin antimicrobial activity 
Two bacteriocin FPLC-purified fractions, F14 and F15, were stored at 4 °C for a period of 
eight weeks. At specific time intervals, 1, 2, 4 and 8 weeks, samples were examined for 
bacteriocin activity by WDA assay using L. plantarum A6 as an indicator.  
 
2.6.2.2 Polyacrylamide gel electrophoresis (Tris-Tricine-SDS-PAGE) 
The molecular weight and purity of bacteriocin preparations was determined using  
tris-tricine-sodium doedecyl suflate-polyacrylamide gel electrophoresis (Tris-Tricine-SDS-
PAGE) according to Schägger & Von Jagow (1987). A lower molecular weight marker 
ranging from 2-250 kDa was used (Precision Plus Protein™ Dual Xtra Standards, Bio-Rad, 
USA). The Mini-Protean® Tris-Tricine Precast gel was used (stacking gel, 4% T, 2.6% C, 
separating gel, 16.5%, Bio-Rad, USA) according to the manufacturer’s instructions. 
Bacteriocin protein sample was mixed with equal volume of tricine sample buffer (Bio-
Rad, USA) and was boiled for 3 min using a heat block (Ratek Instruments, Australia) 
before being loaded on the gel. The electrophoresis was carried out at 60 V for 30 min 
and then at 100 V for 1.5 h in an electrophoresis unit (Mini-PROTEAN Tetra Cell, Bio-Rad, 
China) using Tris/Tricine/SDS running buffer (Bio-Rad, USA). The gel was then cut into two 
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halves. One half was stained using a coomassie based staining solution (Expedeon, UK) for 
30 min and was used for the determination of the apparent bacteriocin molecular weight. 
The protein band on the second half (non-stained) was fixed using the fixing solution 
(20% isopropanol, 10% acetic acid in Milli Q® water) for two hours followed by a two 
hours wash in water. The gel was then used to examine the antimicrobial activity of the 
protein band (Van Reenen, Dicks & Chikindas 1998). The semi-solid MRS agar containing 
106 of the indicator strain (10 mL) was poured into a petri dish. After solidification the 
electrophoresis gel was placed on the agar and was overlaid with another 10 mL of 
seeded semi-solid MRS agar. The plates were stored at 4 °C for 2 h and were then 
incubated at 30 °C for 18-24 h before being examined for a zone of inhibition around the 
protein band of interest.    
 
2.6.2.3 Matrix-assisted laser desorption/ionization time-of-flight mass spectrometer 
(MALDI-TOF MS)  
The average molecular mass of FPLC-purified fractions which demonstrated bacteriocin 
activity (F3, F4, F14, F15 and E15) was investigated by matrix-assisted laser 
desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) (Vater et al. 
2002). The MALDI-TOF mass spectra were recorded using an Autoflex Speed MALDI-TOF 
instrument (Bruker, Germany) containing a 355-nm Smartbeam II laser for desorption and 
ionization. The matrix solution (α-cyano-4-hydroxycinnamic acid in 70% ACN containing 
0.1% (v/v) TFA) was a prepared as described in Section 2.2.6. A molecular mass gate of 
450 Da improved the measurement by ﬁltering out most matrix ions. Bacteriocin samples 
of 5 µl were mixed with the same volume of matrix solution and 1 µL of the mix was 
spotted onto the target, air dried and measured.  
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2.6.2.4 Protein purity check using analytical RP-HPLC  
The purity of the purified bacteriocin protein was also evaluated using analytical reverse-
phase high-performance liquid chromatography (RP-HPLC) (Elegado, Kim & Kwon 1997). 
An Agilent analytical HPLC system (1100, Agilent Technologies, Germany) fitted with 
automated gradient controller, UV detector (220 and 280 nm) and a ZORBAX Eclipse XDB 
analytical C18 column (4.6 × 150 mm, 5 µm particle size, Agilent Technologies, USA) was 
used. The Agilent HPLC ChemStation software was used for the chromatography analysis. 
The solvents used were solvent A (0.1% TFA in water) and solvent B (0.1% TFA in ACN) 
and the flow rate was 1.0 mL/min. The bacteriocin sample was diluted 10-fold in solvent A 
and 50 µL of the diluted sample was loaded on the column. The column temperature was 
set at 30 °C and the protein peaks were monitored at 220 and 280 nm. Initially the ACN 
concentration gradient was increased to 60% using a 40-min linear water-ACN gradient. 
The conditions for the solvent B gradient against solvent A was as follows; 0-2 min, 5% 
solvent B, 2-40 min, solvent B gradient 5% to 60%. As no protein was eluted using an 
ACN-water gradient up to 60% (ACN), the bacteriocin protein was eluted from the column 
by increasing the gradient to 95% using the conditions as follows; 0-15 min, 3% solvent B, 
15-30 min, solvent B gradient 3% to 95%, 30-40 min, 95% solvent B. This protocol was 
repeated four times and the peaks from all runs overlapped and showed good 
reproducibility.  
 
2.6.2.5 UV/Vis spectroscopy 
The optical absorbance spectrum of purified B21 bacteriocin protein was recorded using a 
UV/Vis spectrophotometer (1800, Shimadzu, China) controlled with UVProve software 
version 2.34 according to the manufacturer’s instructions. A matched pair of far UV 
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quartz cuvettes (CXA-150-180J, Hellma Analytics, Germany) with 10 mm lighpath were 
used. The UV absorbance wavelength ranged from 500 to 190 nm. The bacteriocin sample 
was diluted 3 folds in the 20 mM sodium phosphate buffer (pH 6.0). The spectra were 
recorded versus the 20 mM sodium phosphate buffer (pH 6.0) blank. The protein 
concentration was correlated with the A280 values recorded.  
 
The bacteriocin polypeptide sequence (Chapter 6, Section 6.4) was used in an online tool 
to determine a theoretical molar extinction coefficient for the protein 
(http://web.expasy.org/protparam/) (Artimo et al. 2012) by taking into account 
coefficients for the known amino acid composition. The absorbance at 280 nm and the 
molar extinction coefficient value were used to calculate the protein concentration using 
the following formula (Stoscheck 1990). 
A = ε c l 
A: Absorbance at 280 nm 
ε: Molar extinction coefficient (M-1cm-1)  
c: Protein concentration (µM) 
l: Cuvette length (cm) 
 
Protein concentrations were converted to mg/mL using the known polypeptide mass.   
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2.6.2.6 Circular dichroism (CD) spectroscopy  
The circular dichroism spectra of purified bacteriocin protein were recorded from 280 to 
200 nm using a Jasco J-815 CD Spectropolarimeter (Jasco International Co., Ltd., Japan) 
purged with N2 gas. The purified bacteriocin was diluted 6 fold in 20 mM sodium 
phosphate buffer (pH 6.0) resulting in the final concentration of ~25 µg/mL in the 
solution. The cell and sample buffer were run as a blank and did not contribute to the 
spectrum. The spectral measurements were repeated three times at 25 °C using a sample 
cell with a path length of 1 cm (UV quartz cuvettes, CXA-150-180J, Hellma Analytics, 
Germany) and the average spectrum was reported. The instrument parameters were as 
follows; scanning speed 50 nm/min, data pitch 0.1 nm, response time one second and 
bandwith 1.00 nm. The spectra were recorded in standard CD mdeg units and were 
converted to standard unit of molar ellipticity using the theoretical protein concentration.  
The CD data was used to predict the overall secondary structure of the bacteriocin by the 
K2D3 online tool (Louis-Jeune, Andrade-Navarro & Perez-Iratxeta 2012). 
 
2.6.3 De novo LC-MS/MS peptide sequencing  
A de novo sequencing approach was used to identify the peptide sequence of the purified 
bacteriocin peptide using an ESI-LC-MS/MS technique. Hands-on access to proteomics 
equipment and expertise was provided through The Bio21 institute proteomics facility 
(University of Melbourne, Australia) over a three month period. B21 purified bacteriocin 
was analysed using an LTQ™ Orbitrap Elite ETD (Thermo Scientific, USA) coupled to an 
UltiMate 3000 RSLCnano System (Dionex, Thermo Scientific, USA). The nanoLC system 
was equipped with an Acclaim™ Pepmap™ 100 C18 nano-trap column (1 × 2 cm, 5 µm 
particle size, Thermo Scientific, USA) and an Acclaim™ Pepmap™ 100 C18 analytical 
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column (length 15 cm, 5 µm particle size, Thermo Scientific, USA). Two microlitre of the 
bacteriocin sample was loaded onto the trap column at 3% (v/v) ACN (Merck, USA) 
containing 0.1% (v/v) formic acid (Sigma-Aldrich, USA) for 5 min before the enrichment 
column was switched in-line with the analytical column. An initial run on the LTQ™ 
Orbitrap Elite ETD mass spectrometer (Thermo Scientific, USA) was set to operate in data-
dependent mode, where subsequent MS/MS spectra were acquired for the top five peaks 
by collision induced dissociation (CID) activation, followed by higher-energy collision 
dissociation (HCD), and finally electron transfer dissociation (ETD). This experiment 
identified a strong precursor ion at m/z 1417.0630 (monoisotopic peak) corresponding to 
an intact mass of 5664.252. This was consistent with the average molecular mass of the 
bacteriocin protein obtained from MALDI-TOF MS and also the band size observed on 
SDS-PAGE gel.  Examination of the fragmentation spectra for this precursor indicated that 
both CID and HCD provided some fragment information however ETD failed to provide 
any useful data.  To improve the MS/MS information a targeted run was setup where the 
1417 precursor (with an isolation width of 4 Da) was subject to both CID and HCD at three 
different energy levels (CID: 26, 32, 36, and HCD: 24, 26, 30) and activation Q of 0.25 (CID) 
or activation time of 0.1 ms (HCD).  The resulting fragment ion spectra were recorded in 
the Orbitrap at a resolution of 240,000.  The spectrum produced from HCD at 26 eV was 
submitted to MASCOT, however the search failed to identify any candidate sequence in 
the database.  Given the spectrum appeared to contain significant sequence information, 
sequence tags were extracted by hand and BLAST used to search a six frame translation of 
the total L. plantarum B21 Illumina genome data (Chapter 5, Section 5.2). The six frame 
translation of the B21 Illumina genome data was produced using the getorf program 
(EMBOSS). The program identified the ORFs, defined as a specified minimum size 
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sequence (10 amino acids) between two STOP codons with the output being the 
corresponding protein sequence.  
 
2.6.4 Genetic analysis of plantacyclin B21AG gene cluster   
The DNA sequence of plantacyclin B21AG deduced from Illumina genome sequence data 
(Chapter 5, Section 5.2) was located on Scaffold 5. In order to identify the gene cluster 
involved in the production of the cyclic bacteriocin, the open reading frames of scaffold 5 
of ~20 kb were determined using online tool Rapid Annotation using Subsystem 
Technology (RAST) (http://rast.nmpdr.org/) (Aziz et al. 2008). All ORFs identified were 
then searched for identification of the possible conserved domains and homology 
searched against NCBI database using BLAST online tool (http://www.ncbi.nlm.nih.gov) 
(Altschul et al. 1990).  The ORFs (genes) which showed evidence of involvement in 
production of cyclic bacteriocins were analysed against the reference genes on the NCBI 
database.   
 
2.6.5 Phylogenetic analysis of plantacyclin B21AG protein and sequence alignment  
The plantacyclin B21AG amino acid sequence was identified using de novo LC-MS/MS 
sequencing techniques and a genome based ORF translation search. The amino acid 
sequences of previously studied cyclic bacteriocins (Chapter 1, Table 1.3) were obtained 
from NCBI database (http://www.ncbi.nlm.nih.gov) (Altschul et al. 1990) as follows; AS-
48, gassericin A, acidocin B, butyrivibriocinAR10, uberolysin, circularin A, garvicin ML, 
pentocin KCA1, lactocyclicin Q, carnocyclin A (accession numbers CAA72917.1, 
BAH08712.1, CAA84399.1, AAC69560.1, A5H1G9.1, AAN86036.1, ACZ98827.1, 
EIW14922.1, BAH29711.1, ACC93994.1, respectively). The protein sequences were used 
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for phylogenetic analysis and sequence alignment of the cyclic bacteriocins using the 
Phylogeny.fr online tool (Dereeper et al. 2008).  
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Chapter 3 
Growth of Lactobacillus plantarum B21 and bacteriocin-like 
substances production 
3.1 Introduction  
LAB produce different types of antimicrobial compounds including acids, hydrogen 
peroxide, carbon dioxide, diacetyl, acetaldehyde and bacteriocins (De Vuyst & Vandamme 
1994). Bacteriocins are protein or protein complexes capable of inhibiting the growth of 
other bacteria, often closely related to the producer organism (Klaenhammer 1988); 
Bacteriocins from LAB have received increasing attention in recent years because of their 
potential application as natural preservatives in the food industry to inhibit the growth of 
food spoilage and pathogenic bacteria (Cleveland et al. 2001; Cotter, Hill & Ross 2005; De 
Vuyst & Leroy 2007; O’sullivan, Ross & Hill 2002; Settanni & Corsetti 2008). In addition to 
the antimicrobial activity against undesirable bacteria, bacteriocins have widespread 
application to be used as starter cultures in food applications (Vogel et al. 1993). 
Lactobacillus plantarum has received increasing attention because of its use as a probiotic 
starter culture for fermented vegetable and sausage products (Bacus & Brown 1985; 
Daeschel & Fleming 1984; Hugas et al. 1993; Hugas, Marta & Monfort 1997; McKay & 
Baldwin 1990).  
 
The specific environmental and culture conditions required for the production of 
bacteriocins have been extensively studied (Abo-Amer 2011; Aguilar & Klotz 2010; Cheigh 
et al. 2002; Delgado et al. 2007; Leal-Sanchez et al. 2002; Lim 2010; Motta & Brandelli 
2003; Todorov & Dicks 2004; Vignolo et al. 2008). The precise culture conditions can 
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dramatically affect the level of bacteriocin produced by LAB and are strain-specific. 
Unique environmental parameters are often required for maximum bacteriocin 
production (Todorov 2008).  
 
In this chapter, the acid production and antimicrobial activity of the new LAB isolates 
from nem chua (B14, B15, B20, B31, B33, A17 and A6) (Tran 2010) were examined to 
identify the bacteriocin-like activity of these strains and the proteinaceous nature of the 
antimicrobial activity produced by L. plantarum B21 was also investigated. The effect of 
culture conditions (incubation time and temperature, initial pH, media type, aeration, 
carbon and nitrogen sources) on bacteriocin production by LAB strain B21 was 
systematically evaluated to identity the optimal conditions required for bacteriocin 
production.  
 
3.2 Antimicrobial activity of lactic acid bacteria (LAB) isolated from Nem 
chua  
3.2.1 Production of acid by LAB isolates 
The acid producing properties of LAB strains were evaluated separately by testing the 
final pH of the cell free supernatant (CFS) after growth of LAB strains in MRS broth for  
24 h at 30 °C from a starting pH of 6.0. Figure 3.1 shows that LAB strains A17 and A6 
showed the highest production of acid after growth in MRS broth for 24 h, decreasing the 
final pH of the CFS to 3.7 and 3.8, respectively. This is in agreement with the results of 
Tran (2010), which indicated that A17 was the strongest acid producer of the nem chua 
new LAB isolates. This strain was later shown not to produce any bacteriocin (Figure 3.1). 
The weakest acid producers were strains B14 and B15 whose final culture pH was ~5.0. 
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Later 16S rRNA sequence analysis (Chapter 4, Section 4.2) revealed that these two strains 
cluster phylogenetically to a Lactobacillus brevis species,  
while the remaining LAB strains are closely related to L. plantarum species.  
L. plantarum is classified as facultatively heterofermentative, while L. brevis is an obligate 
heterofermentator (Axelsson 2004). Kostinek et al. (2005) showed that the majority of 
the L. plantarum strains are characterised by a faster and higher acid production, 
resulting in a larger and faster decrease in the pH of the growth medium compared to 
heterofermentative lactobacilli. Strains B21, B31 and B33 showed similar acid producing 
properties to each other, with a final pH of ~3.9, consistent with the stronger acidification 
properties of L. plantarum.  In general, all LAB strains exhibited strong acid producing 
properties with only B14 and B15 exhibiting the weaker acid production, more typical of 
the L. brevis strains studied in this work. A subset of the L. plantarum strains B21, B31 and 
B33 were also later shown to produce antimicrobial peptides (Section 3.2.2).  
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Figure 3.1 Final cell free supernatant (CFS) pH of LAB strains after 24 h of growth in MRS broth at 
30 °C using a 2% (v/v) inoculum from a 24h culture of B21. Growth was without agitation and 
samples were taken after 24 h. The CFS was collected by centrifugation at 5000 x g for 20 min at 4 
°C and examined for final pH. Lactobacillus plantarum ATCC 8014 (regular LAB) was used as 
control for pH measurement and the final pH was about 3.76. ANOVA was used to determine the 
error base for the significance of any differences at a confidence level of p < 0.05, as identified by 
different letters. The letters indicate the clustring of data into different groups, i.e. A or AB 
meaning between A and B.  
 
 
 
 
 
 
 
A A 
B AB AB AB 
E E 
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3.2.2 Evaluation of the antimicrobial activity of LAB strains by the well diffusion agar 
(WDA) assay 
The LAB strains isolated from nem chua (Tran 2010) were examined for evidence of 
antimicrobial activity using the WDA assay. Cell free supernatant (CFS) from a mixture of 
LAB strains and three individual strains B21, B31 and B33 were also examined for 
inhibitory activity (Figure 3.2 and 3.3). Five out of eight strains (B20, B21, B31, B33 and 
A6) appeared to produce an antimicrobial substance(s) and exhibited an inhibitory effect 
against the Gram-positive bacteria shown in Table 3.1. Other indicator bacteria, including 
Staphylococcus aureus ATCC 25923 and Escherichia coli strains appeared to be resistant 
to the antimicrobial substance(s) produced by the LAB strains tested. Similar results were 
reported by Messi, et al. (2001) who showed that plantaricin 35d produced by L. 
plantarum was not able to inhibit any Gram-negative bacteria. LAB bacteriocins are 
typically active against a wide range of Gram-positive bacteria (Rojo-Bezares et al. 2007; 
Van Reenen, Dicks & Chikindas 1998), while Gram-negative bacteria are generally far 
more insensitive to LAB bacteriocins because their outer membrane provides them with 
an additional permeability barrier (Omar et al. 2006). 
 
Table 3.1 shows that B21, B31 and B33 were the most active bacteriocin producers 
amongst the strains tested, with B21 demonstrating the greatest inhibitory activity 
(Figure 3.2 and 3.3). Strain B21 was strongly inhibitory against Lactobacillus arabinosus 
17-5 which has been reported as a food spoilage organism by Jay et al. (2005). An 
inhibitory mixture of all these LAB strains, including B21, B31 and B33 gave similar levels 
of killing to that obtained with B21 alone. Clearly, B21 was responsible for most of the 
activity in a mixed culture.  Antimicrobial substance(s) produced by this strain had 
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previously showed interesting characteristics, such as good pH (3 to 10) and thermo-
stability (up to 90 °C for 20 min) (Tran 2010). Hence strain B21 was selected for further 
study. 
   
  
 
Figure 3.2 The inhibitory activity of LAB strain B21 (a) and B33 (b) antimicrobial 
substance(s) (neutralised CFS) were examined against L. plantarum A6 using the WDA 
assay.  
(a) 
(b) 
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Figure 3.3 The inhibitory activity of LAB strain B31 (1) and strain B20 (2) were examined 
against L. plantarum A6 using WDA assay.  
1 
2 
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Table 3.1 Evaluation of LAB isolates antimicrobial activity scored by WDA assay 
 
LAB 
isolates 
 
Indicator strains 
  
Lactobacillus 
plantarum A6 
 
Lactobacillus 
plantarum ATCC 
8014 
 
Lactobacillus 
arabinosus 17-5 
(food spoilage 
bacteria) (Jay et 
al., 2005) 
 
Lactococcus 
lactis 345-18 
 
Lactobacillus 
brevis 19012 
 
Lactobacillus 
casei ATCC 7469 
 
Staph 
aureus ATCC 
25923 
 
E coli ATCC 
25922 
 
E coli 
ATCC 
35218 
 
E coli 
NCTC 
9001 
B14 
 
- - - - - - - - - - 
B15 - - - - - - - - - - 
B20 - - - - (+) - - - - - 
B21 ++++ +++ ++++ +++ + - - - - - 
B31 ++ + ++ + + - - - - - 
B33 +++ ++ +++ ++ + - - - - - 
A6 - - - - (+) - - - - - 
A17 - - - - - - - - - - 
Mixture of 
B21, B31 
and B33 
++++ +++ ++++ +++ + - - - - - 
Mixture of 
LAB 
isolates
#
 
++++ +++ ++++ +++ + - - - - - 
Positive inhibitory activity [+], No inhibitory activity [-], weak but reproducible inhibitory activity [(+)]  
# 
Strains B14, B15, B20, B21, B31, B33, A6 and A17 obtained directly from nem chua.  
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3.2.3 Comparison of the WDA and Spot-agar antimicrobial assays  
The inhibitory activity of strains B21, B31 and B33 were compared using the WDA and 
Spot-agar assays. L. plantarum A6 was used as the indicator strain in all experiments. The 
zone of inhibition (mm) produced by all three strains using the Spot-agar assay appeared 
greater than when compared in the WDA assay (Table 3.2 and Figure 3.4). This is 
presumably because the inhibitory effect of acid production has been eliminated by 
neutralising the pH of the CFS to 6.0-6.5 (see Materials and Methods Section 2.2.7.2) and 
the enhanced inhibitory activity of LAB strains is due to the production of both acid and 
antimicrobial substance(s). These results show that the new LAB isolates from nem chua 
are potentially able to demonstrate a range of inhibitory activities. The WDA assay was 
used in all further experiments to quantitatively evaluate the antimicrobial activity of LAB 
strains under a variety of growth conditions.  
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Table 3.2 The WDA and Spot-agar assays were compared for the evaluation of 
antimicrobial activity of LAB strains against L. plantarum A6.  
LAB strain Zone of inhibition (mm) 
 Spot-agar assay WDA assay  
   
B21 18 10  
B31 9  7  
B33 17  4  
 
 
 
 
Figure 3.4 The inhibitory activity of LAB strain B21 was compared using the WDA assay 
(left figure) and Spot-agar assay (right figure) using L. plantarum A6 as the indicator 
strain. The larger killing zone in the Spot-agar test due to the additional effect of the pH of 
the CFS can be seen.   
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 3.3 Establishing the proteinaceous nature of the antimicrobial activity 
produced by L. plantarum B21 
To confirm the proteinaceous nature of the LAB B21 antimicrobial activity, the neutralised 
CFS was treated with proteolytic (proteinase K, trypsin and pepsin) and non-proteolytic 
(catalase) enzymes. L. plantarum A6 and ATCC 8014 were used as the indicator strains in 
two separate experiments. The killing activity of the LAB strain B21 CFS showed sensitivity 
to proteinase K, trypsin and pepsin (Figure 3.5 and Table 3.3). The bactericidal activity was 
completely eliminated with proteinase K but only partly eliminated by trypsin and pepsin. 
For many other bacteriocins activity is completely lost with all these proteases (Ammor et 
al. 2006; Todorov et al. 2011; Van Reenen, Dicks & Chikindas 1998). This shows that the 
B21 antimicrobial activity is due to a protein, is not due to hydrogen peroxide, but that it 
may be more resistant to trypsin and pepsin than for other bacteriocins reported (Abo-
Amer 2007; Omar et al. 2006; Van Reenen, Dicks & Chikindas 1998). The bacteriocin from 
L. plantarum B21 appears to show a differential sensitivity to proteinase K, while nisin and 
lactacin 481 from L. lactis have a differential sensitivity toward trypsin (Akçelik et al. 
2006). This may be reflective that these are bacteriocins from different classes.  
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Figure 3.5 Sensitivity of the B21 antimicrobial activity to proteolytic digestion; The WDA 
assay was used to examine the inhibition zone after treatment with both proteolytic 
enzymes. (1) proteinase K; (2) trypsin; (3) pepsin; (4) catalase and (5) untreated CFS.  
L. plantarum A6 was used as indicator strain.   
 
 
Table 3.3 Sensitivity of the B21 antimicrobial activity to proteolytic digestion. The WDA 
assay was used to examine the inhibition zone after treatment with both proteolytic and 
control enzymes as described above (Figure 3.5) 
Indicator 
bacteria 
Zone of inhibition (mm) after treatment with enzymes 
Proteinase 
K 
Trypsin Pepsin Catalase Untreated 
CFS (control) 
      
L. plantarum A6 NI* 5 9 11 11 
L. plantarum  
ATCC 8014 
NI* NI 5 6 6 
*No inhibition (NI) 
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3.4 Effect of culture conditions on B21 bacteriocin production 
3.4.1 Effect of incubation time on B21 growth and bacteriocin production 
To study the effect of incubation time and the growth phase on bacteriocin production, 
LAB strain B21 was grown in MRS broth without initial pH adjustment for a total period of 
36 h at 30 °C with no agitation as decribed in Materials and Methods Section 2.3.4.1. The 
highest activity (800 AU/mL), was obtained with L. plantarum A6 as indicator strain and 
was recorded 16 h after incubation at 30 °C (Figure 3.6), after the culture had reached 
stationary phase. Very similar results were reported by Castro, et al. (2011) and Lim 
(2010). In both cases, no further increase in bacteriocin activity occurred during 
stationary phase. LAB strain B21 maintained a constant level of bacteriocin with no 
further decline, suggesting that it was stable and was not metabolised. In contrast, the 
production of plantaricin TF711 by L. plantarum TF711 is reported to decrease after late 
log phase due to endogenous proteolytic activity (Harris, Fleming & Klaenhammer 1992; 
Hernández, Cardell & Zárate 2005). In the case of B21, this suggests either a possible 
resistance of this bacteriocin to any endogenous proteolytic enzyme  (Kamoun et al. 
2005) or the absence of such an enzyme. 
 
Over the 36 h growth period, the pH decreased from 5.9 to 3.9 and the LAB count (log 
CFU/mL) increased from 7.7 to 10.1 and low levels of bacteriocin activity were detected 
after 8 h of growth. Most authors have reported that good cell growth is associated with 
bacteriocin production by LAB (De Vuyst, Callewaert & Crabbé 1996). A strong correlation 
between biomass and bacteriocin production was previously reported for Lactococcus 
lactis (De Vuyst 1995; Todorov & Dicks 2005). Other works have reported that the 
production of bacteriocin is correlated with growth but is not strictly proportional to 
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growth rate or final cell concentration (Pal, Ramana & Bawa 2010), other factors can also 
clearly influence final bacteriocin levels.  
 
  
 
Figure 3.6 Comparison of growth of LAB strain B21 (-     -), bacteriocin activity (-     -) and 
pH (-   -) measured in MRS broth over 36 h at 30 °C from a 2% (v/v) inoculum from a 24h 
culture of B21 was used. Growth was without agitation and samples were taken at 0, 2, 4, 
8, 12, 16, 24 and 36 h to be tested for pH measurements, LAB count and bacteriocin 
activity.  
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The inhibitory effect of LAB strain B21 against two indicator bacteria (L. plantarum A6 and 
L. plantarum ATCC 8014) was examined in MRS broth, growth was at 30 °C for 36 h 
(Figure 3.7). The results showed that LAB strain B21 had a stronger inhibitory effect 
against L. plantarum A6 (max 800 AU/mL) than against L. plantarum ATCC 8014 (max 400 
AU/mL), therefore L. plantarum A6 was selected as the indicator strain for all further 
studies. 
 
 
 
Figure 3.7 Comparison of the effect of incubation time and indicator strain on the 
bacteriocin activity of L. plantarum B21. The indicator strains were L. plantarum A6 (blue) 
and L. plantarum ATCC 8014 (red) and growth was for 36 h at 30 °C in MRS broth. 
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3.4.2 Effect of incubation temperature on bacteriocin production 
To study the effect of incubation temperature on bacteriocin production and growth, LAB 
strain B21 was grown in MRS broth at 25 °C, 30 °C and 37 °C for 24 h without agitation 
and pH control as decribed in Materials and Methods Section 2.3.4.2 . B21 bacteriocin 
production was higher at 25 °C and 30 °C than at 37 °C; however the cell growth rate was 
higher at 37 °C (Figure 3.8). Interestingly, the optimum temperature for cell growth did 
not correspond to the optimum temperature for bacteriocin production. A lack of strict 
correlation between the optimum temperatures for growth and bacteriocin production 
has been previously reported for LAB strains (Cheigh et al. 2002; Lim 2010). Pal et al. 
(2010) showed that bacteriocin production was detected at 20, 30, 35 and 40 °C, with 
maximum bacteriocin production occurring at 35 °C.  In contrast, Lim (2010) reported that 
no bacteriocin production was detected at 25 °C for L. plantarum KC21.  
 
Despite the apparent similarity in profile between growth and bacteriocin production, the 
maximum bacteriocin levels do not correlate directly with cell mass or growth rate 
(Bogovič-Matijašić & Rogelj 1998; Kim, Hall & Dunn 1997). An enhanced production of 
bacteriocin at non-optimum pH and temperature had led to the suggestion that a low 
growth rate, or unfavourable growth conditions or physiological stress, may stimulate 
bacteriocin production (Aasen et al. 2000). The data in Figure 3.6 infer that a low or 
modest growth rate at high population density (109 CFU/mL) at a pH > 4.75 is required for 
maximum production.  
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Figure 3.8 Effect of incubation temperature on LAB strain B21 growth and bacteriocin 
production from a 2% (v/v) inoculum grown without agitation at 25 °C, 30 °C and 37 °C for 
24 h. ANOVA was used to determine the error base for the significance of any differences 
at a confidence level of p < 0.05, as identified by different letters. The letters indicate the 
clustring of data into different groups, i.e. A or AB meaning between A and B. Uppercase 
letters correspond to cell growth and lowercase letters correspond to bacteriocin activity.  
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3.4.3 Effect of initial pH on LAB strain B21 bacteriocin production 
To study the effect of initial pH on B21 bacteriocin production, cultures were grown in 
MRS broth at different initial pH values at 30 °C for 24 h as decribed in Materials and 
Methods Section 2.3.4.3. Optimal B21 bacteriocin production (800 AU/mL) was measured 
after growth in MRS broth with an initial pH of both 6.0 and 8.0,  without agitation (Figure 
3.9).  Similar results were reported by Todorov & Dicks (2005),  with maximum bacteriocin 
production by L. plantarum strains at an initial pH of 6.0.  In contrast  L. plantarum KC21 
bacteriocin production was reported to decrease significantly at pH 8.0 (Lim 2010). It 
would appear that LAB strain B21 produces maximum bacteriocin levels over a relatively 
wide pH range, even as high as 8.0. Most reports for LAB suggest a maximum production 
between pH 5.5 to 7.5 (Todorov 2008; Todorov & Dicks 2005; Vignolo et al. 2008). 
However, low levels of B21 bacteriocin production were recorded at more extreme values 
pH 5.0 and 9.0, similar results were reported for other LAB bacteriocins (Jiménez-Díaz et 
al. 1993; Todorov 2008; Todorov & Dicks 2005). No bacteriocin activity could be detected 
in MRS broth with an initial pH of 4.0, in agreement with the finidings of Lim (2010) for L. 
plantarum KC21. For LAB B21 the final pH values of all the cultures ranged between 3.6 
and 4.2 (Table 3.4). 
 
The relative stability of LAB B21 bacteriocin both in culture and over a wide range of pH 
values as high as 9, plus its partial resistance to trypsin and pepsin, suggests that this 
bacteriocin may be different from the more classical bacteriocins.  
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Figure 3.9 Effect of initial pH on bacteriocin production by LAB strain  B21 (see Materials 
and Methods Section 2.3.4.3) ANOVA was used to determine the significance of 
differences at a confidence level of p < 0.05 as identified by different letters. The letters 
indicate the clustring of data into different groups, i.e. A or AB meaning between A and B. 
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Table 3.4 Effect of different culture pH values on B21 bacteriocin production during 
growth in MRS broth at 30 °C for 24 h.  
Initial pH 4.0 5.0 6.0 8.0 9.0 
Final pH 3.62 ± 0.03 3.82 ± 0.02 3.90 ± 0.03 4.03 ± 0.03 4.15 ± 0.01 
Bacteriocin activity 
(AU/mL) 
0 de  400 ± 0 cb 800 ± 0 a 800 ± 0 a 400 ± 0 cb 
Data represent the means ± SD of triplicate analyses from each trial. The different letters 
in each column show a significant difference (P < 0.05).  
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3.4.4 Effect of media type and aeration on LAB strain B21 bacteriocin production  
Growth and bacteriocin production of strain B21 was examined using different media 
(MRS broth, M17 broth supplemented with lactose and minced pork) under both aerobic 
and anaerobic conditions but without initial pH adjustment. Maximum growth and 
bacteriocin production (400 AU/mL) were recorded in MRS broth under both aerobic and 
anaerobic conditions (Figure 3.10). A number of papers have reported that MRS medium 
is a better medium for LAB cell growth and bacteriocin production than other media 
(Daba et al. 1993; McGroarty & Reid 1988; ten Brink et al. 1994). In contrast, Cheigh, et al. 
(2002) demonstrated that M17 broth supplemented with 0.5% lactose was the best 
medium for bacteriocin production . LAB B21 cell growth and acid production were higher 
in MRS broth under aerobic condition than under anaerobic conditions, while the same 
bacteriocin activity (400 AU/mL) was recorded for both conditions. Low growth and 
bacteriocin production was recorded in a minced pork media incubated either under 
aerobic or anaerobic conditions. No bacteriocin production, very low acid production and 
limited cell growth occurred in M17 broth (supplemented with lactose) (Table 3.5). These 
results show that specific nutrients or stimuli and reasonable growth to good population 
densities are required for significant bacteriocin production by LAB strain B21. This is in 
accordance with reports of bacteriocin production in L. plantarum AMA-K according to 
Todorov (2008), where bacteriocin production was again greatly influenced by the type of 
media. The effect of specific media components (carbon and nitrogen sources) on B21 
bacteriocin production in a defined media is discussed in detail in Section 3.4.5.   
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Figure 3.10 Effect of media and oxygen on LAB strain B21 growth and bacteriocin 
production (See Materials and Methods Section 2.3.4.4). ANOVA was used to determine 
the error base for the significance of any differences at a confidence level of p < 0.05, as 
identified by different letters. The letters indicate the clustring of data into different 
groups, i.e. A or AB meaning between A and B. Uppercase letters correspond to cell 
growth and the lowercase letters correspond to bacteriocin activity.  
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Table 3.5 Effect of media type and oxygen on LAB B21 growth, bacteriocin production and 
final culture pH.   
Aerobic/Anaerobic Media Bacteriocin 
activity 
(AU/mL) 
Final culture 
pH 
LAB count  
(log CFU/mL) 
     
Aerobic MRS 400 ± 0 d 3.86 ± 0.02 10.68 ± 0.03 DE 
M17 0 a  6.42 ± 0.02 8.23 ± 0.00 AB 
Minced pork 200 ± 0 ab 5.77 ± 0.02 8.21 ± 0.05 BC 
Anaerobic MRS 400 ± 0 d 3.93 ± 0.01 10.11 ± 0.01 CD 
M17 0 a 6.53 ± 0.03 8.13 ± 0.00 BC 
Minced pork 100 ± 0 bc 5.72 ± 0.02 8.26 ± 0.00 BC 
 
Data represent the means ± SD of triplicate analyses from each trial. The different letters in each 
column show a significant difference (P < 0.05). Uppercase letters correspond to cell growth and 
the lowercase letters correspond to bacteriocin activity against L. plantarum A6. The letters 
indicate the clustring of data into different groups, i.e. A or AB meaning between A and B. 
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3.4.5 Effect of media components on LAB strain B21 bacteriocin production 
3.4.5.1 Effect of carbon source on B21 bacteriocin production 
To investigate the effect of carbon source on the cell growth and maximum bacteriocin 
production LAB strain B21 was cultured in MRS broth basal medium (with no carbon 
source) supplimented with 2% (w/v) of an alternative carbon source (Materials and 
Methods Section 2.3.4.5). Fructose, sucrose and lactose were compared and MRS broth 
containing glucose (2%) was used as a positive control while MRS broth with no added 
carbon source served as a negative control. All cultures were incubated at 30 °C for  
24 h. Maximum B21 cell growth was obtained in medium containing sucrose, closely 
followed by glucose and lactose (Figure 3.11); however, B21 grown in media containing 
glucose or lactose demonstrated the highest bacteriocin production. This observation 
agreed with the earlier reports by Lim (2010) who also reported maximum bacteriocin 
production by L. plantarum KC21 with either glucose or lactose. Other reports have also 
shown that glucose is the most favourable carbohydrate for bacteriocin production by 
LAB (Pal, Ramana & Bawa 2010; Todorov et al. 2011), while Cheigh et al. (2002), reported 
sucrose and lactose to be the most suitable carbon source for cell growth, while 
bacteriocin production was shown to be eight times higher using lactose. Fructose 
produced the lowest levels of bacteriocin by LAB B21 in comparison to media containing 
any of the other carbon sources. This is in agreement with Cheigh et al. (2002) who also 
reported minimal bacteriocin production with fructose as the solo carbon source.   As 
expected the negative control a, containing no added carbon source showed very low 
levels of cell growth and no bacteriocin production. This confirms that the carbon source 
is important for bacteriocin production by LAB B21, with lactose and glucose appearing to 
be the best.    
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Figure 3.11 Effect of carbon source on growth and bacteriocin production by LAB strain  
B21 using a 2% (v/v) inoculum and incubated at 30 °C for 24 h (see Materials and Methods 
Section 2.3.4.5). The letters indicate the clustring of data into different groups, i.e. A or AB 
meaning between A and B. Uppercase letters correspond to cell growth and the lowercase 
letters correspond to bacteriocin activity. Error bars are shown for a confidence level of  
p < 0.05.  
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3.4.5.2 Effect of nitrogen source on LAB strain B21 bacteriocin production 
To study the effect of a complex nitrogen source on B21 cell growth and bacteriocin 
production, MRS basal medium (without a nitrogen source) was supplemented with 
either 2% (w/v) yeast extract, meat extract or tryptone. MRS broth contaning a mixture of 
different nitrogen sources (yeast extract, meat extract , peptone and triammonium 
citrate) was used as positive control, and MRS broth with no nitrogen source, as negative 
control. The cultures were incubated at 30 °C for 24 h before being tested for LAB growth 
and bacteriocin activity. Figure 3.12 shows the effect of nitrogen source on the B21 cell 
growth and bacteriocin production. Comparing the three single nitrogen sources, yeast 
extract was found to be the best complex nitrogen source for growth of LAB strain B21, 
followed by meat extract and tryptone. Yeast extract probably contains more vitamins 
and has a larger proportion of free amino acids and short peptides (Aasen et al. 2000; De 
Vuyst 1995). Media containing tryptone as a single nitrogen sources was found to exhibit 
the best bacteriocin production. These results are in agreement with other reports 
showing that tryptone is the best nitrogen source for maximum bacteriocin production by 
LAB (Pal, Ramana & Bawa 2010; Todorov et al. 2011). Todorov et al. (2011) reported 
tryptone to be required for optimal bacteriocin production in L. plantarum ST16Pa, while 
yeast extract and meat extract as single nitrogen sources showed a 50% reduction in 
bacteriocin production. This is in contrast to the report of Cheigh et al. (2002) and Lim 
(2010), who state that yeast extract is the best nitrogen source for bacteriocin production 
in other LAB strains. A positive control, MRS broth containing a mixture of nitrogen 
sources, resulted in a higher bacteriocin production by strain B21 compared to media 
contaning a single nitrogen source, while MRS broth with no added nitrogen source 
(negative control) showed no bacteriocin production despite some limited cell growth. 
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This suggests that a mixture of nitrogen sources is required for optimal bacteriocin 
production in B21 with tryptone and standard MRS broth being the best.  
 
Although the effect of growth phase on production of classical bacteriocins (Class I and II) 
have been widely studied (Abo-Amer 2011; Aguilar & Klotz 2010; Castro et al. 2011; 
Cheigh et al. 2002; Delgado et al. 2007; Leal-Sanchez et al. 2002; Lim 2010; Papamanoli et 
al. 2003; Todorov 2008; Todorov & Dicks 2005; Todorov et al. 2011), very little is known 
for the other classes of bacteriocins. This again underlines that the relationship between 
growth and production of a particular class of bacteriocin is complex.  
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Figure 3.12 Effect of nitrogen source on growth and bacteriocin production by LAB strain  
B21 using a 2% inoculum and incubated at 30 °C for 24 h (see Materials and Methods 
Section 2.3.4.5). ANOVA was used to determine the error base for the significance of any 
differences at a confidence level of p < 0.05, as identified by different letters. The letters 
indicate the clustring of data into different groups, i.e. A or AB meaning between A and B. 
Uppercase letters correspond to cell growth and the lowercase letters correspond to 
bacteriocin activity.  
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3.5 Conclusion 
The acid producing properties of the LAB isolates from nem chua were investigated in 
MRS broth by measurement of their culture pH.  LAB strains A17 and A6 showed the 
highest production of acid in MRS broth after 24 h, while the weakest production of acid 
was shown by strains B14 and B15. In the Chapter 4, it is shown that these two strains are 
Lactobacillus brevis, while the remaining LAB strains are all closely related to  
L. plantarum. Strains B21, B31 and B33 showed similar acid producing properties to each 
other, but less that A17 and A6 and higher than B14 and B15. These strains (B21, B31 and 
B33) were shown to produce a bacteriocin-like protein. 
 
The antimicrobial activity of eight LAB isolates from nem chua was evaluated against 
several indicators strains. LAB strains B20, B21, B31, B33 and A6 demonstrated 
antimicrobial activity against at least one indicator. B21, B31 and B33 produced a strong 
antimicrobial effect, with B21 demonstrating the greatest inhibitory activity. LAB strain 
B21 was selected for further study due to its stronger inhibitory effect compared to other 
LAB isolates, good stability in culture, partial stability to certain proteases and the novel 
source of the organism.  
 
Two antimicrobial activity assays, the WDA and Spot-agar assays, were compared for the 
evaluation of antimicrobial activity. The antimicrobial activity of LAB strains using the 
Spot-test assay appeared higher possibly due to the production of both acid and 
bacteriocin in the culture supernatant. The effect of acid was eliminated in WDA assay 
and the inhibitory activity was probably due to the production of antimicrobial proteins 
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alone. This assay was selected for quantitative evaluation of the antimicrobial activity of 
the LAB strains examined in this work.   
 
The B21 antimicrobial activity was completely eliminated after treatment with  
proteinase K, but was partially resistant to trypsin and pepsin, confirming that the B21 
antimicrobial activity was due to a secreted protein.  At present the bacteriocin appears 
active only against the LAB strains tested. 
 
The effect of culture conditions (incubation time and temperature, initial pH, media type, 
aeration, carbon and nitrogen sources) on bacteriocin production by LAB strain B21 was 
studied. The optimum conditions identified for bacteriocin production were for growth of 
B21 in MRS broth containing glucose as carbon source and a complex nitrogen source 
with an initial pH of 6.0, at 30 °C for 24 h without agitation. These conditions were used to 
produce larger amounts of bacteriocin for later purification and characterisation. While 
growth and bacteriocin production are related, it is not a proportional correlation. A low 
or modest growth rate at high population density (109 CFU/mL), at a pH > 4.5 is required 
for good bacteriocin production by B21.   
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Chapter 4 
Mapping the bacteriocin related (pln) genes of LAB isolates from 
nem chua 
4.1 Introduction 
In Chapter 3, three strains (B21, B31 and B33) had shown strong evidence of bacteriocin 
secretion. L. plantarum mainly produces classical type II bacteriocin (Cho et al. 2010; 
Gong, Meng & Wang 2010; Hata, Tanaka & Ohmomo 2010; Man et al. 2014; Navarro et 
al. 2008; Rojo-Bezares et al. 2008). In this chapter a molecular approach is taken to 
classify the LAB nem chua isolates phylogenetically and to elucidate their classical pln 
locus with respect to recently established genetic maps. The genetic arrangement of the 
pln locus, the nature and function of the genes are reviewed in the Introduction Chapter, 
Section 1.2. The presence or absence of specific pln structural genes was established and 
their 16S rRNA sequences were analysed to provide a phylogenetic comparison.  
 
4.2 LAB isolates strain identification (ID) 
4.2.1 Phylogenetic analysis of LAB isolates   
In order to evaluate the suitability of 16S rRNA sequences for comparison of lactobacillus 
species and strain identification, a number of 16S rRNA sequences from different 
lactobacillus species available from the NCBI database were aligned, using the  
L. plantarum WCFS1 16S rRNA sequence (accession number NR_075041) as reference.  
L. plantarum strains KW30, AF1 and LP3 (accession numbers GU552552, FJ386491 and 
AY675256, respectively) had 16S rRNA sequences with 99-100% identity to the reference 
sequence, while Lactobacillus brevis strains Ni730, NRIC 1684 and JCM 7775 (accession 
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numbers AB601180, AB024299 and AB911501 respectively), showed only 93-94% 
identity.  Similarly Lactobacillus casei strain Shirota 16S rRNA sequence (accession 
number AB531131) had 92% identity to WCFS1. These results show that comparison of 
16S rRNA sequences will allow both a species and strain identification.   
 
4.2.2 Optimising primer design for 16S rRNA amplification   
Four primer sets (P1 – P4) (Table 4.1) were designed and used to amplify the 16S rRNA 
regions from nem chua isolates B21, B33 and a positive control L. plantarum ATCC 8014 in 
order to identify the best primer set for the amplification of the 16S rRNA region (Table 
4.1). Primer set P1 and P2 were designed using the NCBI Primer-BLAST design tool 
(http://www.ncbi.nlm.nih.gov/tools/primer-blast/) (Ye et al. 2012) and synthesized with 
reference to the conserved 16S rRNA sequence from L. plantarum WCFS1 (accession 
number NR_075041). The first set of primers pairs WCF16-F and WCF16-R corresponded 
to positions 1 to 24 and 1553 to 1571, respectively, of the 16S rRNA region from  
L. plantarum WCFS1 and amplified a 1571 bp product (Table 4.1). The second pair 
WCF16plus-F and WCF16plus-R were designed to amplify a larger 16S rRNA sequence 
region corresponding to positions 502813 to 502834 and 504464 to 504483, respectively, 
of the genome from L. plantarum WCFS1 (accession number AL935263) and produced a 
16S rRNA fragment of 1671 bp (Table 4.1). Two other primers pairs (P3 and P4) were 
selected from previous studies (Brosius et al. 1978; Osborn, Moore & Timmis 2000; Tiwari 
& Srivastava 2008). L. plantarum ATCC 8014 was used as a positive control in all 16S rRNA 
PCR amplification experiments.  
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All primer sets gave amplification products of the expected sizes in PCR reactions. The P2 
primer set produced a larger product than with the P1, P3 and P4 primer sets (Figure 4.1); 
however it did not generate a strong band with LAB test strain ATCC 8014 and was not 
considered reliable. Primer set P1 (designed based on WCFS1 data) produced a strong 
band and was therefore selected as the primer set of choice for reproducible 
amplification of the 16S rRNA region for all new LAB isolates.   
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Table 4.1 PCR primers and conditions used to amplify the gene of 16S rRNA from LAB isolates. 
Primer 
Set 
Reference Strain Primer Name Primer sequence  
(5’- 3’) 
Annealing 
temperature  
(°C) 
Amplicon size  
(bp) 
Reference 
       
P1 L. plantarum WCFS1 
(Accession number AL935263) 
WCF16-F ATTAATTTGAGAGTTTGATCCTGG 61 1571 This work 
 WCF16-R AGAAAGGAGGTGATCCAGC 
P2 L. plantarum WCFS1 
(Accession number AL935263) 
WCF16plus-F CTAGCAAATAAATTTTAGTACA 52 1671 This work 
 WCF16plus-F CAAAACTAAACAAAGTTTC 
P3 L. brevis RO66 
(Accession number AF515220) 
Lactb-F TGCCTAATACATGCAAGT 58 1600 Tiwari and Srivastava 
(2008)  Lactb-R CTTGTTACGACTTCACCC 
P4 Universal primers 
E. coli 
63F CAGGCCTAACACATGCAAGTC 67 1541 Brosius et al. (1978); 
Osborn et al., (2000) 
 
 1389R ACGGGCGGTGTGTACAAG 
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Figure 4.1 PCR amplification of the 16S rRNA region from LAB strains generated by 
primers set P1 (lanes 1, 5 and 9), P2 (lanes 2, 6 and 10), P3 (lanes 3, 7 and 11) and P4 
(lanes 4, 8 and 12) using total DNA from strain B21 (lanes 1-4),  
L. plantarum ATCC 8014 (lanes 5-8) and strain B33 (lanes 9-12). Lane M is 50 bp ladder 
(HyperLadder™ 50 bp, Bioline, USA) used as molecular weight marker. The annealing 
temperatures are shown in Table 4.1. 
 
 
 
 
 
 
 
 
 
 
1000bp 
1600bp 
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4.2.3 16S rRNA PCR sequencing and phylogenetic analysis 
Primer set P1 (Table 4.1) was used to amplify the 16S rRNA region of all LAB strains 
(Figure 4.2). The PCR products (~1.6kb) were purified using the ISOLATE II PCR and Gel kit 
and sent to AGRF for sequencing on both strands (see Materials and Methods Section 
2.2.7.3). The sequences obtained were analysed by BLAST search and compared to the 
sequences available in GenBank (http://www.ncbi.nlm.nih.gov) (Altschul et al. 1990). The 
strains from the GenBank database that showed the closest NCBI BLAST hit for 16S rRNA 
sequences of the LAB isolates are presented in Table 4.2. Strains B14 and B15 16S rRNA 
sequences showed 100% identity to the 16S rRNA region of L. brevis strains; while the 
remaining LAB isolates (B20, B21, B31, B33, A6 and A17) demonstrated high similarity (99-
100%) to L. plantarum strains, as shown in Table 4.2. 
 
The 16S rRNA sequences obtained were also used to construct a phylogenetic tree using 
the phylogeny.fr online tool as shown in Figure 4.3 (Dereeper et al. 2008). Based on 
phylogenetic analysis of 16S rRNA, six out of eight isolates B20, B21, B31, B33, A6 and 
A17, were identified as Lactobacillus plantarum strains while the two remaining isolates, 
B14 and B15, are more closely related to Lactobacillus brevis species, confirming the 
BLAST results shown in Table 4.2.  
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Figure 4.2 PCR amplification products generated by P1 primer set. M 50 bp DNA ladder 
(HyperLadder™ 50 bp, Bioline, USA); lanes 1-8, B14, B15, B20, B21, B31, B33, A6 and A17, 
respectively. The PCR annealing temperature was 61 °C. 
1000bp 
1600bp 
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Table 4.2 Strain ID of LAB isolates from nem chua. The 16S rRNA sequences were analysed by BLAST using the online NCBI database tool. The 
results with the highest score alignments are shown in this table.  
16S rRNA sequence 
from strain 
Closest BLAST hit Related accession numbers 
   
B14 Lactobacillus brevis (100%)* AP012167.1; JX545342.1; AB680189.1; GU125558.1 
B15 Lactobacillus brevis (100%) AP012167.1; JX545342.1; AB680189.1; GU125558.1 
B20 Lactobacillus plantarum (100%)  KF186666.1; KF472174.1; CP005942.1; AB713898.1 
B21 Lactobacillus plantarum (100%) AB713901.1; JX183220.1; JX193626.1; AL935263.2 
B31 Lactobacillus plantarum (100%) KF472174.1; CP006033.1; CP005942.1; AB713901.1 
B33 Lactobacillus plantarum (100%) KJ095651.1; KJ160195.1; KJ026699.1; AB911471.1 
A6 Lactobacillus plantarum (99%) JX183220.1; JX193626.1; AB601179.1; AL935263.2 
A17 Lactobacillus plantarum (100%) KJ095651.1; KJ160195.1; FJ386491.2; HF677504.1 
*Percentage identity as shown by BLAST search
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Figure 4.3 Phylogenetic analysis of 16S rRNA sequencing results for LAB strains from nem chua (strains B14, B15, B20, B21, B31, B33, A6 and 
A17). The remaining lactobacillus 16S rRNA sequences were obtained from NCBI database and sequences were analysed using Phylogeny.fr 
online tool (Dereeper et al. 2008).  
  
L. brevis 877G 
L. brevis NBRC_3960 
L. brevis IMAU80136 
LAB strain B14 
LAB strain B15 
L. plantarum G8 
L. plantarum TO_1003 
LAB strain B21 
LAB strain A6 
L. plantarum AP1 
L. plantarum WCFS1 
L. plantarum SD1S6L2 
L. plantarum AF1 
LAB strain A17 
LAB strain B20 
LAB strain B31 
LAB strain B33 
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4.3 Identification of bacteriocin-encoding genes 
4.3.1 Primers and PCR conditions for the amplification of bacteriocin related genes 
Total DNA from LAB isolates were obtained from 24 h cultures grown in MRS broth as 
described in Materials and Methods Section 2.2.7.3.1. Specific primers previously 
described for L. plantarum strains (Sáenz et al. 2009), were used (Table 4.3) to identify 
the 15 bacteriocin related genes in the pln locus of the eight nem chua isolates (B14, B15, 
B20, B21, B31, B33, A6 and A17). The primers were previously designed using pln genes 
sequences from L. plantarum C11, NC8, WCFS1, J23 and J51 sequences (Sáenz et al. 2009) 
published in GenBank (accession numbers X94434, AF522077, AL935263, DQ323671 and 
DQ340868, respectively). In the first experiment with B21, a negative PCR control used 
Staph aureus ATCC 25923 total DNA. In later experiments, primers amplifying plnK and 
plNC8βα genes, using B21 total DNA, were used as positive and negative controls, 
respectively.  
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Table 4.3 PCR primers used for mapping genes of the pln locus from LAB strains. Standard 
PCR conditions are described in Materials and Methods Section 2.2.7.3.2 and the 
annealing temperature was 47 °C.  
Gene Primer name Primer sequence (5’- 3’) Expected size (bp) Reference 
     
     
plnK plnK-F CTGTAAGCATTGCTAACCAATC 246 Remiger et al., (1996) 
 plnK-R ACTGCTGACGCTGAAAAG   
plnA plnA-F GTACAGTACTAATGGGAG 450 Remiger et al., (1996) 
 plnA-R CTTACGCCAATCTATACG   
plnB plnB-F GCTTCTTATTTAAGTAGAGGATTTCTG 927 Sáenz et al., (2009) 
 plnB-R GCCACGATTACTACCCTTAG   
plnC plnC-F AGCAGATGAAATTCGGCAG 108 Remiger et al., (1996) 
 plnC-R ATAATCCAACGGTGCAATCC   
plnNC8βα plNC8-F GGTCTGCGTATAAGCATCGC 207 Maldonado et al., 
(2003) 
 plNC8-R AAATTGAACATATGGGTGCTTTAAATTCC   
plNC8HK plNC8HK-F TCGGTACCATCGTTTGGATT 758 Sáenz et al., (2009) 
 plNC8HK-R CCTTTAGTTTGGGCATCGAA   
plnG plnG-F TGCGGTTATCAGTATGTCAAAG 453 Remiger et al., (1996) 
 plnG-R CCTCGAAACAATTTCCCCC   
plnV plnV-F CAGTTTATTGGCAGCAATCG 727 Sáenz et al., (2009) 
 plnV-R ATCCACTCCATCCAAACAATC   
plnW plnW-F GATCAGCCACGATACCAAC 752 Sáenz et al., (2009) 
 plnW-R CTAAAGAAAAAGCCCCTGAAAC   
plnL plnL-F ACGGCGTCTGAGATCCAATG 413 Sáenz et al., (2009) 
 plnL-R GTTCTGGAAGTCACTGCGATTG   
plnR plnR-F CCCAGCAGTCCCATCACTAA 236 Sáenz et al., (2009) 
 plnR-R TTACGGAGCGGCATCTATGTC   
plnEF plnEF-F GGCATAGTTAAAATTCCCCCC 428 Remiger et al., (1996) 
 plnEF-R CAGGTTGCCGCAAAAAAAG   
plnJ plnJ-F TAACGACGGATTGCTCTG 475 Sáenz et al., (2009) 
 plnJ-R AATCAAGGAATTATCACATTAGTC   
plnN plnN-F ATTGCCGGGTTAGGTATCG 146 Remiger et al., (1996) 
 plnN-R CCTAAACCATGCCATGCAC   
plnS plnS-F ACTAAATATCACTGTGGTAAAGTAAAG 466 Sáenz et al., (2009) 
 plnS-R GACCGAAACAATCATGGGAAG   
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4.3.2 Mapping of the pln genes and classification of LAB strains based on their pln locus 
characteristics  
Primers and PCR conditions described in the previous section were used to identify the 
pln genes in eight LAB isolates (Figure 4.4). PCR reactions to identify pln locus genes were 
repeated at least three times for each LAB strain and only strong reproducible results are 
reported (Figures 4.5 – 4.9 and Table 4.4). The genes previously reported for the pln loci 
of L. plantarum C11, WCFS1 and J23 strains (Diep, Håvarstein & Nes 1996; Kleerebezem et 
al. 2003; Rojo-Bezares et al. 2008) are also shown in Table 4.4.  
L. plantarum strains were classified into different genetic groups, based on their pln locus 
genes, as previously described by Sáenz et al., (2009). Fourteen pln genes were detected 
from the collection of six L. plantarum strains.  The remaining two LAB strains, L. brevis 
B14 and B15, appeared to lack bacteriocin related genes (Table 4.4). Strains B20, B21, B31 
and B33 proposed thirteen out of fifteen of the pln genes tested. All these strains except 
strain B20 have demonstrated antimicrobial activity against the indicators strains as 
reported in Section 3.2.2. The identified pln genes were used to draft a genetic map of the 
LAB strains pln locus in comparison to available reference strains (Figure 4.4).  The four 
strains, B20, B21, B31 and B33 were classified in the same group as reference strains C11 
and WCFS1, having the common features of the plnABCD regulatory system; however, 
strain A6 was shown to have a pln locus much more similar to the reference strain J23, 
differing from the previous group in that it contains the plnNC8HK-D regulatory system 
but lacks the plnABC regulatory system and the plnK structural gene.  LAB strain A17 was 
shown to contain only the plnL and plnR-like genes; this will be discussed in Section 4.4.3. 
PlnL has been suggested to be involved in immunity to the two-peptide KJ bacteriocin 
(Diep, Håvarstein & Nes 1996; Diep et al. 2009). Strain A17 did not exhibit any 
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antimicrobial activity in the WDA assay against the tested strains as reported in the 
previous chapter. This suggests that A17 retains a copy of the plnL gene in order to give 
immunity to the bacteriocins produced by other strains in a naturally mixed microbial 
community.   
 
Genes that encode integral membrane proteins, plnS, plnV and plnW, and plnG that 
encode the ABC transporter protein (Anderssen et al. 1998) (located in the plnGHSTUVW 
operon), were present in all strains having a pln locus (B20, B21, B31, B33 and A6). This is 
in agreement with the structure of the pln locus genes reported in other L. plantarum 
strains (Sáenz et al. 2009). Similarly, plnEF genes that encode a two-peptide bacteriocin 
(Diep, Håvarstein & Nes 1996) were also present in the above five strains. Sáenz et al., 
(2009) suggests that this phenomena demonstrates the importance of these genes for 
bacterial survival and adaption. The plnK gene encoding plantaricin K (one part of the 
two-peptide bacteriocin KJ), was only present in four of the strains that have a pln locus 
(B20, B21, B31 and B33). The LAB strain A6, like L. plantarum J23, does not contain the 
plnK gene. Selected PCR products (B21, plnA, -C, -N, -K, -J, -E, -F, -W, -S, A6, plnC8HK and a 
few unexpected products with fragment sizes from B14, B15 and A17) were sequenced, 
and are analysed in Section 4.4.  
 
In order to study the complete pln locus from strain B21 a whole genome sequencing 
approach was taken, and this is reported in the proceeding chapter.  
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Table 4.4 pln locus genes amplified by PCR using total DNA of LAB strains. Primers and PCR conditions are described in Section 4.3.1.  
L. plantarum C11, WCFS1 and J23 sequences were used as reference for comparison to classify the pln locus types from LAB strains. 
LAB Strains pln locus genes amplified by PCR*  
Pln
A 
plnB plnC plnK plnN plnR plnL plnW plnEF plnV plnJ plnS PlnC8
HK 
PlnC8β
α 
PlnG 
B14 - - d - - d d d d d d - - - - 
B15 - - d - - d d d d d d - - - - 
B20 + + + + + + + + + + + + - - + 
B21 + + + + + + + + + + + + - - + 
B31 + + + + + + + + + + + + - - + 
B33 + + + + + + + + + + + + - - + 
A6 - - - - + + + + + + + + + - + 
A17 
 
- - - - - d + - - d - - - - - 
Reference 
strains:  
WCFS1 and 
C11# 
+ + + + + + + + + + + + - - + 
Reference 
strain: J23# 
- - - - + + + + + + + + + - + 
 
* Results of PCR analysis: positive (+); negative (−); the size of the analysed amplicon was different from the expected size (d). Only strong reproducible 
results are summarized.   
# L. plantarum C11, WSFS1 and J23 sequences have been obtained from GenBank database (accession numbers X94434, AL935263 and DQ323671, 
respectively). The presence or absence of genes was extracted from the published data (Diep, Håvarstein & Nes 1996; Kleerebezem et al. 2003; Rojo-Bezares 
et al. 2008; Sáenz et al. 2009; Siezen et al. 2012).  
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Figure 4.4 Genetic maps for the pln loci (partial) from new L. plantarum strains (B20, B21, B31, B33 and A6) in 
comparison to the L. plantarum reference strains C11, WCFS1, J23, J51 and NC8 (Diep, Håvarstein & Nes 1996; 
Kleerebezem et al. 2003; Maldonado, Ruiz-Barba & Jiménez-Díaz 2003; Navarro et al. 2008; Rojo-Bezares et al. 2008). 
The pln genes represented by arrows in different colours corresponding to each operon. The incomplete arrows 
represent incomplete gene sequences based on available data on GenBank (accession numbers X94434, AF522077, 
AL935263, DQ323671 and DQ340868). Small black arrows represent the promoter sequences. Colours code for pln 
operons functions: yellow/black for the genes from regulatory operon; red/green for two-peptide bacteriocins operon 
(plnEFI and plnJKLR); blue colour for plnMNOP operon; pink for plNC8βαc operon and purple for ABC transporter system 
genes. Strain specific genes are presented as ‘orf’ and in different colours (Sáenz et al. 2009). The genes plnM, -O, -P, -Q, 
-I, -H, -T, -U, -X, -Y, -NC8IF, orfz1, orfz2 and orfz3 may also be present in some of the new LAB strains as PCR  
identification was not carried out for these genes in this chapter.      
Strain WCFS1 
                                                                                                                                                                                                      
 
Strain C11 
                                                                                                                                                                                           
 
 Strains B21, B31, B33 and B20 
                                                                                                                                                                                                     
 
Strain J23 
                                                                                                                                                                                                      
 
Strain A6 
                                                                                                                                                                                                     
 
Strain J51 
                                                                                                                                                                                                      
 
Strain NC8 
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Figure 4.5 PCR identification of bacteriocin related genes from the pln locus from LAB 
strains B14 (a) and B15 (b). Lane M, 50 bp DNA ladder (HyperLadder™ 50 bp, Bioline, 
USA); lanes 1 - 17, plnA, plnB, plnC, plnK, plnN, plnR, plnL, plnW, plnEF, plnV, plnJ, plnS, 
plnC8HK, plnNC8βα, plnG, respectively; Lane 16 positive control (Lactobacillus plantarum 
B21 plnK); lane 17 negative control (Lactobacillus plantarum B21 plnNC8βα). PCR primers 
and conditions were described in Table 4.3. 
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Figure 4.6 PCR identification of bacteriocin related genes from the pln locus in LAB strain B20. Lane 
M, 50 bp DNA ladder (HyperLadder™ 50 bp, Bioline, USA); lanes 1 - 17, plnA, plnB, plnC, plnK, plnN, 
plnR, plnL, plnW, plnEF, plnV, plnJ, plnS, plnC8HK, plnNC8βα, plnG, respectively; lane 16 positive 
control (Lactobacillus plantarum B21 plnK); lane 17 negative control (Lactobacillus plantarum B21 
plnNC8βα). PCR primers and conditions were described in Table 4.3. 
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Figure 4.7 PCR identification of bacteriocin related genes from the pln locus in LAB strain B21. Lane 
M, 100bp DNA ladder (Promega, USA); lanes 1 - 16, plnA, plnB, plnC, plnK, plnG, plnV, plnL, plnR, 
plnEF, plnW, plnS, plnJ, plnN, plnNC8βα, plnC8HK, respectively; lane 16 negative control (S. aureus 
ATCC 25923 plnS). PCR primers and conditions were described in Table 4.3. 
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Figure 4.8 PCR identification of bacteriocin related genes from the pln locus in LAB strains 
B31 (a) and B33 (b). Lane M, 50 bp DNA ladder (HyperLadder™ 50 bp, Bioline, USA);  
lanes 1 - 17, plnA, plnB, plnC, plnK, plnN, plnR, plnL, plnW, plnEF, plnV, plnJ, plnS, plnC8HK, 
plnNC8βα, plnG, respectively; Lane 16 positive control (Lactobacillus plantarum B21 plnK); 
lane 17 negative control (Lactobacillus plantarum B21 plnNC8βα). PCR primers and 
conditions were described in Table 4.3. 
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Figure 4.9 PCR identification of bacteriocin related genes from the pln locus in LAB strains 
A6 (a) and A17 (b). Lane M, 50 bp DNA ladder (HyperLadder™ 50 bp, Bioline, USA);  
lanes 1 - 17, plnA, plnB, plnC, plnK, plnN, plnR, plnL, plnW, plnEF, plnV, plnJ, plnS, plnC8HK, 
plnNC8βα, plnG, respectively; Lane 16 positive control (Lactobacillus plantarum B21 plnK); 
lane 17 negative control (Lactobacillus plantarum B21 plnNC8βα). PCR primers and 
conditions were described in Table 4.3. 
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4.4 Sequencing and bioinformatics analysis of bacteriocin related genes 
from the pln locus of LAB strains  
4.4.1 Sequencing and bioinformatics analysis of pln locus genes from strain B21 
 Two genes from the regulatory operon plnABCD, plnC and plnA, and seven bacteriocin 
structural genes, pln N, plnK, plnJ, plnE, plnF, plnW and plnS (Ben Omar et al. 2008; 
Moghadam et al. 2010; Sáenz et al. 2009), were selected for further analysis. The PCR 
amplicons consisting of parts of these genes (Figure 4.7) were purified using ISOLATE II 
PCR and Gel kit and sequenced from both strands (AGRF). The DNA sequences and 
translated amino acid sequences were analysed and compared to the reference strain 
WCFS1 (accession number AL935263). A summary of the analysis is presented in Table 
4.5. Each of the pln genes examined from B21 showed 100% identity to that of its target 
pln gene from the WCFS1 reference strain. On the basis of these studies, B21 would 
appear to have the potential to produce classical type II bacteriocins. In order to identify 
and study any other possible differences in the pln locus from strain B21, the genome 
sequence of this strain was determined and analysed (Chapter 5).  
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Table 4.5 Strain B21 pln genes bioinformatics analysis and comparison with reference strain WCFS1 at DNA and amino acid levels. Strain B21 
pln genes’ sequences were translated using online translation tool (http://web.expasy.org/translate/) (Artimo et al. 2012) to obtain the putative 
amino acid sequences. Bioinformatics analysis was carried out using Clone Manager software and NCBI database.  
pln gene Function(s) Homology (100%), corresponding to 
WCFS1 DNA level position 
Homology (100%), corresponding to 
WCFS1 amino acid level position 
NCBI reference 
plnC Two-component response regulator 
a
 244 - 286 81 - 95 YP_004888438.1 
plnA Plantaricin A structural gene and bacteriocin 
production induction factor 
a
 
1 - 147 1 - 48 YP_004888436.1 
plnN Plantaricin N structural gene 
a
 63 - 115 22 - 38 YP_004888431.1 
plnJ Two-peptide bacteriocin structural genes 
a
 38 - 168 1 - 44 YP_004888429 
plnK Two-peptide bacteriocin structural genes 
a
 1 - 99 26 - 57 YP_004888428 
plnE Two-peptide bacteriocin structural genes 
a 1 - 97 26 - 56 YP_004888442.1 
plnF Two-peptide bacteriocin structural genes 
a 1 - 159 1 - 52 YP_004888441.1 
plnS Plantaricin S structural gene 
b
 1 - 300 1 - 99 YP_004888445 
plnW Plantaricin W structural gene and 
membrane protein 
b
 
1 - 420 1 - 142 YP_004888449.1 
a 
(Diep et al. 2009) 
b
 (Ben Omar et al. 2008) 
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4.4.2 Sequencing and bioinformatics analysis of the plnC8HK gene from L. plantarum A6 
The mapping of the pln genes from strain A6 revealed that this strain lacked the 
regulatory genes plnABC and was the only strain amongst the nem chua LAB isolates that 
contained the regulatory operon plnC8HK-D as described in Section 4.3.2. Strain A6 was 
classified in the same bacteriocin group as L. plantarum J23 (Figure 4.4). The A6 pln locus 
also lacked the structural genes for plnK and plNC8βα which distinguish this variant of the 
pln locus for this strain from the two other L. plantarum reference strains J51 and NC8 
(Figure 4.4). Man et al., (2014) reported the PlNC8HK protein to be a histidine protein 
kinase and cytoplasmic membrane protein with six transmembrane helices. This regulates 
the production of bacteriocin in L. plantarum KLDS1.0391 in concert with the response 
regulator protein PlnD. The plnC8HK PCR amplicon from strain A6 with the size of 758 bp 
(Figure 4.9a) was purified and sequenced from both strands (AGRF). The DNA sequence 
obtained was searched against the NCBI database using BLAST (Altschul et al. 1990), the 
top three hits are presented in Table 4.6. The bioinformatics analysis of the plnC8HK gene 
sequences showed 99% identity to a part of plnC8HK gene corresponding to L. plantarum 
J23 pln locus 9441 to 10124 at DNA level, to the L. plantarum NC8 bacteriocin locus 8490 
to 9173 and to the L. plantarum subsp. plantarum strain YM-5-2 pln locus 8376 to 9059 
confirming that these are highly conserved.  
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Table 4.6 Top three NCBI BLAST hits for the plnC8HK gene sequence from L. plantarum A6. 
Description Query 
cover 
E value Identity Accession 
Number 
     
L. plantarum strain J23 pln locus 100% 0 99% DQ323671.2 
L. plantarum NC8 bacteriocin 
production locus 
100% 0 99% AF522077.2 
L. plantarum subsp. plantarum strain 
YM-5-2 pln gene locus 
100% 0 99% JQ900767.1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 4 
 
158 
 
4.4.3 Sequencing and bioinformatics analysis of the bacteriocin plnR and plnL genes, 
from L. plantarum A17  
As described in Section 4.3.1 the plnR specific primer set, plnR-F, 
CCCAGCAGTCCCATCACTAA and plnR-R, TTACGGAGCGGCATCTATGTC, was designed to 
amplify a product of 236 bp from the plnR gene in several L. plantarum strains. LAB strain 
A17 DNA gave rise to a larger product (~300 bp) than expected (Table 4.4, Figure 4.9b).  
The 300 bp bacteriocin query product referred to as plnR-like, was excised from the gel, 
purified and sequenced from both strands (AGRF). The resulting DNA sequence was 
searched against the NCBI database using BLAST (Altschul et al. 1990). Two BLAST hits 
were obtained which are presented in Table 4.7. Bioinformatics analysis of the plnR-like 
sequence from strain A17 revealed that it had high similarity (98-99% identity) to a gene 
from L. pentosus responsible for the production of a bacteriocin immunity protein, 
corresponding to the L. pentosus MP-10 genome positions 25725 to 25882 and to the  
L. pentosus IG1 genome positions 1472581 to 1472738. In was shown previously (Table 
4.4) that strain A17 also contained the plnL immunity protein gene. This suggests that 
both bacteriocin immunity genes (plnL and plnR-like) are likely to be important for the 
survival of this strain in a mixed microbial community and are required to provide 
protection against other strains, producing classical type II bacteriocins.    
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Table 4.7 Top two NCBI BLAST hits for plnR-like sequence from L. plantarum A17. 
Description Query 
cover 
E value Identity Accession 
Number 
     
Lactobacillus pentosus MP-10 draft 
genome, annotated contig 00016 
98% 1e-72 99% FR871812.1 
Lactobacillus pentosus IG1, annotated 
genomic scaffold 00001 
100% 4e-71 98% FR874854.1 
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4.4.4 Sequencing and bioinformatics analysis of genes from L. brevis B14 
As described in Section 4.3.1 the plnC specific primer set, plnC-F 
AGCAGATGAAATTCGGCAG and plnC-R ATAATCCAACGGTGCAATCC, was designed to 
amplify a product of 108 bp from the regulatory gene plnC of the L. plantarum strains. In 
strain B14, the same primer set resulted in a larger than expected fragment (~600 bp). 
This product (Figure 4.5a) was referred to as plnC-like and was purified and sequenced 
from both strands (AGRF). The DNA sequence obtained was searched against the NCBI 
database using BLAST (Altschul et al. 1990). Two BLAST hits were obtained from L. brevis 
strains and presented in Table 4.8. The bioinformatics analysis of the plnC-like sequence 
from strain B14 revealed that it has 99% identity to a part of the “glycerophosphoryl 
diester phosphodiesterase” gene, corresponding to L. brevis KB290 genome 825796 to 
825999 and to the L. brevis ATCC 367 genome 1242802 to 1243005. These results are in 
strong agreement with 16S rRNA data (Section 4.2.3) confirming that LAB strain B14 is an 
L. brevis strain.  
 
The amplification of the plnJ gene from LAB strain B14 again produced a larger product 
than expected (~800bp). This product (Figure 4.5a) referred as plnJ-like was purified and 
sequenced from both strands (AGRF). The DNA sequence obtained was searched against 
the NCBI database using BLAST (Altschul et al. 1990). Only one BLAST hit was obtained 
from L. brevis strain KB290. The bioinformatics analysis of plnJ-like sequence from B14 
revealed that it had 99% identity to one part of the enzyme “4-deoxy-L-threo-5-
hexosulose-uronate ketol-isomerase” gene, corresponding to L. brevis KB290 genome 
345359 to 345955. The plnC-like and plnJ-like genes from strain B14 were not obviously 
related to bacteriocin production.  
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Table 4.8 Top two NCBI BLAST hits for the plnC-like sequence from LAB strain B14.  
Description Query 
cover 
E value Identity Accession 
Number 
     
Lactobacillus brevis KB290 DNA, 
complete genome 
100% 7e-100 99% AP012167.1 
Lactobacillus brevis ATCC 367, 
complete genome 
100% 7e-100 99% CP000416.1 
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4.4.5 Sequencing and bioinformatics analysis of the plnC-like gene from L. brevis B15 
Similar to LAB strain B14, the use of the specific primer set for plnC in LAB B15 resulted in 
a larger than expected fragment (~600 bp). This product (Figure 4.5b) referred to as  
plnC-like was purified and sequenced from both strands (AGRF). The DNA sequence was 
searched against the NCBI database using BLAST. Two BLAST hits were obtained from 
L. brevis strains, these were the same as those previously found for the plnC-like hits from 
B14 (Table 4.8). The bioinformatics analysis of plnC-like sequence from B15 revealed that 
it had 99% identity to one part of the membrane “glycerophosphoryl diester 
phosphodiesterase” gene, corresponding to L. brevis KB290 genome 825792 to 826273 
(accession number AP012167.1) and to L. brevis ATCC 367 genome 1242528 to 1243009 
(accession number CP000416.1). The plnC-like gene from B15 was not obviously related to 
bacteriocin production and the sequences of 16S rRNA (Section 4.2.3) showed that strain 
B15 was also a L. brevis strain. 
 
4.5 Long range PCR amplification of the L. plantarum pln locus from 
bacteriocin producing strains  
The specific primer set from previous study on L. plantarum strains (Ben Omar et al. 2008) 
was used to amplify the large DNA fragment (~16 kb), from bacteriocin producing strains 
B21, B31 and B33, that includes the bacteriocin operons reported in strains C11 and 
WCFS1 (accession numbers AL935263 and X94434, respectively) (plnJKLR, plnMNOP, 
plnABCD, plnEFI and plnGHSTUV). Two primers were designed upstream of the plnJKLR, 
plnR-F (5′-CCCAGCAGCCCCATCACTAAG-3′) and downstream of the plnGHSTUV, plnV-R (5′-
ATCGCCACCGTTATCCAGTT-3′) operons, a distance of ~16 kb. GoTaq® Long PCR Master 
Mix containing a mixture Taq DNA polymerase and proofreading DNA polymerase 
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enzymes was used in PCR reactions to ensure a long range amplification. The large DNA 
fragment from pln locus was detected in all three strains examined (Figure 4.10) and LAB 
strain B15 was used as a negative control. This result is in complete agreement with the 
early data obtained for the pln genes in Table 4.4 and these strains are likely to have a full 
pln locus.  
 
                                                                 M      1               2      3      4 
 
 
Figure 4.10 PCR amplification products with primers plnR-F and plnV-R used to amplify the 
bacteriocin operons described in L. plantarum WCFS1. The plantaricin amplicon is 
indicated by arrow. M, 1kb DNA ladder (Bio-Rad, USA); Lane 1, B15, negative control; Lane 
2, B21; Lane 3, B31 and Lane 4, B33. The PCR materials and methods are described in 
Section 2.4.3. The annealing temperature was 50 °C.  
 
 
 
 
15kb 
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4.6 Conclusion 
The 16S rRNA sequencing was used to classify the new nem chua LAB isolates by means of 
a phylogenetic tree analysis. Six out of eight isolates were classified as L. plantarum 
strains and the remaining two isolates as L. brevis strains.  
 
Identification of the bacteriocin related genes were carried out using specific PCR primers 
for the amplification of known pln genes. These were used to map the pln locus in order 
to classify the strains into pln locus groups. Four out of eight LAB strains (B20, B21, B31 
and B33) contained thirteen pln genes and were classified with the reference strains 
WCFS1 and C11. A6 was shown to contain a different type of pln locus structure and was 
classified in the same group as the J23 reference strain. The remaining strains, B14, B15 
and A17, all lacked a full pln locus and are summarised in Figure 4.4.  
 
Several bacteriocin structural and regulatory genes plnC, plnA, pln N, plnK, plnJ, plnE, plnF, 
plnW and plnS, from strain B21 were sequenced and analysed. All pln genes sequenced 
showed high similarity to pln reference genes from strain WCFS1. The bacteriocin 
regulatory gene plNC8HK from strain A6 was sequenced and analysed and showed high 
similarity to plnC8K from the reference strains J23 and NC8.  
 
Several larger than expected PCR products were obtained for plnR-like, plnJ-like and plnC-
like from strains A17, B14 and B15, respectively, these were sequenced and analysed to 
investigate their involvement. The plnR-like sequence from strain A17 showed high 
similarity to bacteriocin immunity protein genes from L. pentosus strains. The plnJ-like 
and plnC-like genes from strains B14 and B15 showed high similarity to gene sequences 
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from L. brevis strains and appeared not to be directly related to bacteriocin production 
but to other biochemical function.  
 
Whole genome next Generation Sequencing (NGS) using the Illumina and Ion Proton 
platforms were carried out in order to reveal the similarities and possible differences 
between the pln loci for strains B20, B21 and A6 and their reference strains. Partial 
sequence for two non-bacteriocin producing strains, B15 and A17, were obtained on the 
in-house Ion proton sequencing platform for comparison with the genome data for the 
bacteriocin producing strains. A detailed comparison of the whole genome sequencing 
results is presented in Chapter 5. 
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Chapter 5 
Genomic sequencing, and analysis of the pln locus from nem chua 
LAB isolates  
5.1 Introduction 
In Chapter 4, 16S rRNA sequencing was carried out to identity the LAB isolates. The 
bacteriocin related genes were then identified, sequenced and analysed to partially map 
the pln locus for the new LAB strains (B20, B21, B31, B33 and A6). To map and analyse the 
full pln locus in more detail, the B21 genome was sequenced on the Illumina platform 
(BGI). Subsequently, to facilitate comparison with other strains (B15, B20, A6 and A17) 
genome sequencing was carried out using the RMIT University NGS Ion Proton facility. 
B21 was re-included in the Ion Proton sequencing run as a control and to enable 
comparison of the two platforms and further validation of the B21 sequencing data.  The 
genome sequencing data were used to confirm and extend the mapping of pln genes in 
the LAB strains B21, A6 and B20. Bioinformatics analysis was undertaken to compare the 
B21 pln locus with the reference strain L. plantarum WCFS1 in detail to identify any 
single-nucleotide polymorphism (SNPs) and insertion or deletion of nucleotide(s) (Indels) 
in the pln genes, and any resultant changes at the amino acid level.   
 
5.2 L. plantarum B21 genome sequencing using the Illumina platform 
5.2.1 L. plantarum B21 DNA extraction for genome sequencing  
In order to obtain large amounts of exceptionally clean genomic DNA from L. plantarum 
B21 free of any possible contaminating plasmid, a CsCl gradient preparation method was 
used as described in Materials and Methods Section 2.5.1.1. The quality of the extracted 
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genomic DNA was confirmed by visualising the sample using agarose gel electrophoresis 
and digestion with restriction enzymes, EcoRI and BamHI, as shown in Figure 5.1. The 
DNA sample loaded on the agarose gel produced a single thick band without any evidence 
of degradation, samples digested with EcoRI and BamHI produced a smear as expected. In 
addition, the presence of three pln genes (plnC, plnEF and plnJ) was confirmed by PCR 
using the CsCl purified DNA sample. The UV 260/280 ratio was 1.8 suggesting little or no 
protein and RNA contamination.  
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Figure 5.1 Evaluation of L. plantarum B21 genomic DNA quality and confirmation of the 
presence of the pln genes (plnC, plnEF and plnJ). Lane M, 1 kb DNA ladder (HyperLadder™ 
1 kb Plus, Bioline, USA); Lane 1 B21 CsCl gradient extracted DNA; Lanes 2 and 3, B21 DNA 
digested with EcoRI and BamHI respectively; Lanes 4, 5 and 6, B21 PCR of pln genes (plnC, 
plnEF and plnJ respectively) using CsCl gradient extracted DNA,; Lane 7 B21 plnC PCR using 
DNA extracted with CTAB method (positive control).   
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5.2.2 Genome sequencing analysis of L. plantarum B21  
Whole genome sequencing of L. plantarum strain B21 was performed using the Illumina 
HiSeq 2000 sequencing platform (BGI-Shenzhen, Shenzhen, China). A total of 527 Mb of 
data was produced with next-generation Illumina paired-end sequencing technology. A 
genome library containing different fragment length insertions (500 bp and 6 kb) was 
constructed, and 6,354,788 of paired end 90-bp reads, were generated with 164 fold 
coverage of the genome. The sequencing statistics of LAB B21 are shown in Table 5.1.  
 
The de novo assembly was performed using SOAPdenovo (Li et al. 2008; Li et al. 2010) and 
in its final form consisted of 29 contigs and 20 scaffolds. The statistics of the contigs and 
scaffolds are presented in Table 5.2. Based on the assembly results, the assembly genome 
size of L. plantarum B21 was 3,467,660 bp with a GC content of 44.29%. The genome 
contained 3,328 genes with a total length of 2,905,650 bp, which made up 83.8% of the 
genome. The average gene length was 873 bp and the GC content in gene region was 
45.4%. The B21 genome contained 562,010 bp of intragenic region which made up 16.2% 
of the genome with a GC content of 38.6%. The number of tandem repeat sequences was 
96 consisting of tandem sizes of between 6 to 624 bp. The total length of the tandem 
repeat sequences was 16,891 bp which made up only ~ 0.5% of genome. The number of 
minisatellite and microsatellite DNAs was 57 and 5 respectively.  The number of rRNA, 
tRNA and sRNA genes was 17, 65 and 2 respectively. The genome contained nine genomic 
islands.   
 
The BLAST analysis  comparing the LAB strain B21 genome with L. plantarum WCFS1 (with 
an identity cut off of 40%), revealed that 2668 out of 3328 genes (80.17%) of strain B21 
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aligned well with those of WCFS1 with a mean identity of 99%. There were 660 genes in 
the new B21 genome that did not align to the nearest neighbour, WCFS1 genome. The 
sequence of the B21 genome was ordered according to that of the reference strain 
WCFS1, using the MUMmer software version 3.22 (Kurtz et al. 2004). Then upper and 
following axes of a linear synteny graph were constructed after applying the same 
proportion of size reduction in the length of both sequences. The synteny graph is 
presented in Figure 5.2. The B21 Illumina genome data was used in Section 5.5 and 
Section 6.5 (Chapter 6) to identify, map and analyse the bacteriocin related genes of 
interest in detail.  
 
In order to identify the similarities and differences between the pln loci for the remaining 
strains, B20, B21 and A6 and the new reference genome for B21, in-house whole genome 
sequencing using the Ion Proton platform was carried out. 
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Table 5.1 Sequencing statistics of LAB strain B21 sample, Illumina HiSeq 2000 sequencing platform.  
Sample 
Name 
Insert sizea 
(bp) 
Reads length 
(bp) 
Raw data 
(Mb) 
Adapterb (%) Duplicationc 
(%) 
Total reads Filtered 
reads (%) 
Low quality 
filtered reads 
(%) 
Clean data 
(Mb) 
B21 418 (90:90) 371 1.17 0.19 4,123,436 5.42 2.17 351 
B21 6,074 (90:90) 201 1.29 0.32 2,231,352 12.36 5.90 176 
a Insert size, the length of insert fragment; b Adapter, the ratio of adapter contaminated reads; c Duplication, the ratio of duplication reads. 
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Table 5.2 De novo assembly statistics of Illumina genome data for LAB strain B21 using 
SOAPdenovo software. 
 Scaffold Contig 
   
Total number 20 29 
Total length (bp) 3,467,660 3,464,495 
N50 (bp) 3,243,769 932,965 
N90 (bp) 3,243,796 660,338 
Maximum length (bp) 3,243,796 1,650,473 
Minimum length (bp) 531 286 
GC Content (%) 44.29 44.29 
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Figure 5.2 The syntenic analysis of L. plantarum B21 genome in comparison with L. plantarum WCFS1 (accession number AL935263) using MUMmer software version 3.22. 
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5.3 Whole genome sequencing of new LAB strains by Ion Proton NGS 
5.3.1 DNA extraction of LAB strains for genome sequencing  
For LAB strains (B15, B20, A6 and A17) high quality genomic DNA was extracted using the 
phenol chloroform method as described in Materials and Methods Section 2.5.2.1, since 
no evidence of plasmids had been found. The quality of the extracted genomic DNA was 
confirmed by visualising the sample as shown in Figure 5.3. LAB strain B21 genomic DNA 
was used from the CsCl gradient preparation (Section 2.5.1.1). The UV 260/280 ratio for 
B15, B20, A6 and A17 was 1.80, 1.82, 1.84 and 1.80, respectively.  
 
 
                         M          1      2     3     4          
 
Figure 5.3 Genomic DNA for LAB strains extracted by phenol chloroform method for 
sequencing on the Ion Proton platform. Lane M, 1 kb DNA ladder (HyperLadder™ 1 kb, 
Bioline, USA); Lane 1 to 4, DNA of B15, B20, A6 and A17, respectively.  
 
 
10kb 
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5.3.2 LAB strains genomic DNA fragment library preparation 
The library preparation for LAB strains (B15, B20, B21, A6 and A17) from genomic DNA 
was carried out using the Ion Xpress™ Plus gDNA Fragment Library Preparation kit v2, as 
described in Materials and Methods Secion 2.5.2.2.1. The fragmentation of the genomic 
DNA and ligation of the barcoded adapters was followed by size selection of the DNA 
fragments to optimise the read length of the sequencing, the size selection targeted 
fragments with sizes of 220-250 bp (150 bp library excluding barcodes and adapters). The 
E-gel image of the library size selections are presented in Figure 5.4.  
 
 
Figure 5.4 The E-gel image of LAB library size selection. Lane M, DNA molecular marker 50 bp; 
Lanes 2, 3, 6 and 7 DNA libraries of A6, A17, B21 and B20, respectively. The DNA library samples 
were loaded in the top wells and the selected size fragments were collected from the bottom wells 
at the appropriate time according to the DNA marker location. The image was taken when 250 bp 
marker was in the bottom well and the 300 bp marker was just entering the well.  
Top wells 
Bottom wells 
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The prepared LAB libraries were analysed on an Agilent 2100 Bioanalyzer to determine 
the molar concentration of the DNA samples and to assess the size distribution of the 
libraries. The DNA molar concentrations (Table 5.3) were used to calculate the library 
dilution required for each DNA sample to be used in the template preparation. The 
Bioanalyzer electropherograms are presented in the Figures 5.5 and 5.6. The peak at 35 
bp (Figures 5.5 and 5.6) is the lower marker and the 10,380 bp peak represents the upper 
marker. The major peaks for fragments with a size range of approximately 200 to 300 bp 
were well represented in the new LAB strain libraries. The small peaks at  
47-49 bp were a result of primer-dimer contamination with adapters and barcodes that 
had not been removed during the library preparation and cleaning steps. In order to 
remove this contamination, individual libraries were pooled together at the same 
concentration level and a final clean up step was carried out using Agencourt® AMPure® 
beads according to manufacturer’s instructions. The Bioanalyzer electropherogram of the 
final LAB library is presented in Figure 5.6c and demonstrated the successful removal of 
primer-dimer contaminations.    
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Table 5.3 Quantification of prepared libraries of LAB strains by High Sensitivity DNA Assay 
using Agilent 2100 Bioanalyzer; Software: 2100 Expert version B.02.08.SI648. The 
concentrations presented in this table are for the DNA size range of 200 to 300 bp.  
LAB DNA library Concentration (pg/µL) Molarity (pmol/L) 
A6 120 696 
A17 102 607 
B20 106 635 
B21 1270 8618 
B15 417 2552 
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Figure 5.5 Bioanalyzer Electropherogram of High Sensitivity DNA analysis of library 
preparations; (a) B21; (b) A6 (c) A17. The X-axis represents the product size in bp and the 
Y-axis is the arbitrary fluorescence intensity.  
 
 
(a) 
(b) 
(c) 
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Figure 5.6 Bioanalyzer Electropherogram of High Sensitivity DNA analysis of library 
preparations; (a) B20; (b) B15; (c) Final sample of pooled cleaned libraries. The X-axis 
represents the product size in bp and the Y-axis is the arbitrary fluorescence intensity.  
 
 
 
(a) 
(b) 
(c) 
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5.3.3 Template preparation and sequencing of new LAB strains genomes using Ion 
Proton platform 
The pooled LAB libraries (8 - 10 µL) at a concentration of 100 pM was used for template 
preparation in the Ion OneTouch™ 2 Instrument and Ion OneTouch™ ES using Ion PI™ 
Template OT2 200 Kit v3 as described in Materials and Methods Section 2.5.2.3.  The 
enriched Ion Sphere™ Particles (ISPs) obtained from the template preparation steps were 
used in the sequencing run. The sequencing run was carried out on Ion PI™ Chip v2 using 
the Ion PI™ Sequencing 200 Kit v3, as described in Materials and Methods Section 2.5.2.4. 
The primary analysis was performed on Torrent Suite™ Software 4.0.2 (See Chapter 2, 
Section 2.5.2.5 for the technical definitions). The total filtered and trimmed base pairs 
obtained from the run was 13.5 Gb. The percentage of chip wells that contained a live ISP 
(ISP loading) on the Ion PI™ Chip was 85% (15% empty wells). The ISP density image is 
shown in Figure 5.7. The percentage of live ISPs with a key signal that is identical to the 
library key signal referred to as ‘Key Signal’ was 97. The total number of filtered and 
trimmed reads independent of length was 88,543,666 with the mean length of 153 bp. 
The usable reads defined as percentage of library ISPs that pass the polyclonal, low 
quality, and primer dimer filters was 72%. The percentages of clonal and polyclonal ISPs 
were 78% and 22%, respectively. A summary of the sequencing data obtained for each 
strain is presented in Table 5.4.  
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Figure 5.7 ISP density image of LAB sequencing run. This is a pseudo-color image of the 
Ion Chip™ Plate showing the percentage of ISP loading across the physical surface 
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Table 5.4 Summary of the sequencing data of new LAB strains reported from the Ion Proton sequencing platform.   
Barcode name Sample Bases ≥ Q20* Reads Mean read length# 
      
IonXpress 005   A6 2,594,358,824 2,258,618,871 16,367,342 158 bp 
IonXpress 006  A17 2,561,138,638 2,261,878,034 16,706,676 153 bp 
IonXpress 008  B20 2,526,151,744 2,212,714,848 16,430,682 153 bp 
IonXpress 012  B21 837,808,840 736,459,690 5,481,415 152 bp 
IonXpress 080  B15 1,164,217,967 1,046,206,500 9,145,477 127 bp 
 
*The percentage of reads that have a predicted quality score of Q20 or higher. A Q20 score is the predicted quality of a Phred-like score of 20 
or better, or one error in 100 bp 
#The average read length, in bp, of all filtered and trimmed library reads. 
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5.3.4 Coverage analysis of new LAB strains by Torrent Suite™ Software 
The coverage analysis (CA) plugin in Torrent Suite™ Software provided statistics and 
reports that allowed an analysis of the sequence coverage produced for each LAB 
genome. Several CA runs were performed for each LAB strain (A6, A17, B20, B21 and B15) 
using three reference strains available on NCBI database (L. plantarum WCFS1,  
L. plantarum ZJ316 and L. brevis KB290). For strain B21 an additional coverage analysis 
was run using the Illumina sequencing data (Section 5.2) as a reference. The summary of 
the coverage analysis for each LAB strain (using the reference strain to demonstrate the 
highest percentage of alignment) is presented in Tables 5.5 to 5.9.  
 
The coverage analysis of LAB strain A6 was performed using L. plantarum ZJ316 
(accession number CP004082.1) as a reference (Table 5.5). The total number of reads 
mapped to the reference was 14,145,400. The average base coverage depth was 616.1 
and the uniformity of base coverage was 89.5%. The coverage overview is presented in 
Figure 5.8.  
 
Strain A17 genome sequence did not show very high similarity (<70%) to any of the three 
reference strains used. The summary of the A17 coverage analysis using L .plantarum 
ZJ316 is presented in Table 5.6. The total number of reads mapped to the reference was 
11,070,864 with the average base coverage depth of 301.4. The uniformity of base 
coverage was 64%. The coverage overview is presented in Figure 5.9.    
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Table 5.5 L. plantarum A6 genome base coverage analysis by Torrent Suite™ Software.  
L. plantarum ZJ316 (accession number CP004082.1) was used as the reference strain.    
Genome Base Coverage# 
Bases in reference genome 3,203,964 
Average base coverage depth  616.1 
Uniformity of base coverage  89.5% 
Genome base coverage at 1X  96.1% 
Genome base coverage at 20X  91.3% 
Genome base coverage at 100X  89.6% 
Genome base coverage at 500X  80.4% 
Genome bases with no strand bias  97.5% 
# 
See Chapter 2, Section 2.5.2.5.1 for the technical definitions 
 
 
 
 
 
 
Figure 5.8 The overview of coverage analysis for the LAB A6 genome sequence using 
Torrent Suite™ Software. L. plantarum ZJ316 (accession number CP004082.1) was used as 
the reference strain.    
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Table 5.6 L. plantarum A17 genome base coverage analysis by Torrent Suite™ Software. L. 
plantarum ZJ316 (accession number CP004082.1) was used as the reference strain.    
Genome Base Coverage# 
Bases in reference genome 3,203,964 
Average base coverage depth  301.4 
Uniformity of base coverage  64.0% 
Genome base coverage at 1X 97.6% 
Genome base coverage at 20X 77.7% 
Genome base coverage at 100X  59.1% 
Genome base coverage at 500X  26.5% 
Genome bases with no strand bias  78.9% 
# 
See Chapter 2, Section 2.5.2.5.1 for the technical definitions 
 
 
 
 
 
Figure 5.9 The overview of coverage analysis of LAB strain A17 genome sequence using 
Torrent Suite™ Software. L. plantarum ZJ316 (accession number CP004082.1) was used as 
the reference strain.    
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The coverage analysis of LAB strain B20 was also performed using L. plantarum ZJ316 
(accession number CP004082.1) as the reference (Table 5.7). The total number of reads 
mapped to the reference was 14,133,584 with uniformity of base coverage of 91.3%. The 
average base coverage depth was 589.6. The coverage overview is presented in Figure 
5.10.  
 
The coverage analysis of LAB strain B15 was also performed using L. brevis KB290 
(accession number NC_020819.1) as the reference (Table 5.8). The total number of reads 
mapped to the reference was 7,716,869. The average base coverage depth was 372.5 and 
the uniformity of base coverage was 94.6%. The coverage overview is presented in Figure 
5.11. 
 
The B21 genome data obtained using the Illumina platform was used as reference for the 
coverage analysis of the B21 Ion Proton sequencing data. The total number of reads 
mapped to the Illumina data was 5,464,355 with an average base coverage depth of 239. 
The uniformity of base coverage was 99.8%. In a separate analysis L. plantarum WCFS1 
(accession number AL935263) was used as a reference for the coverage analysis of strain 
B21. The number of mapped reads, average base coverage depth and the uniformity of 
base coverage were 4,824,283, 200.7 and 91.9%, respectively. The coverage analysis 
summary and the coverage overview are presented in Table 5.9 and Figure 5.12.  
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Table 5.7 L. plantarum B20 genome base coverage analysis by Torrent Suite™ Software. L. 
plantarum ZJ316 (accession number CP004082.1) was used as the reference strain.    
Genome Base Coverage# 
Bases in reference genome 3,203,964 
Average base coverage depth  589.6 
Uniformity of base coverage  91.3% 
Genome base coverage at 1X  96.4% 
Genome base coverage at 20X  92.6% 
Genome base coverage at 100X  91.4% 
Genome base coverage at 500X  67.7% 
Genome bases with no strand bias  97.9% 
# 
See Chapter 2, Section 2.5.2.5.1 for the technical definitions 
 
 
 
 
 
Figure 5.10 The overview of the coverage analysis for the LAB B20 genome sequence using 
Torrent Suite™ Software. L. plantarum ZJ316 (accession number CP004082.1) was used as 
the reference strain.    
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Table 5.8 L. plantarum B15 genome base coverage analysis by Torrent Suite™ Software. L. 
brevis KB290 (accession number NC_020819.1) was used as the reference strain.    
Genome Base Coverage# 
Bases in reference genome 2,395,134 
Average base coverage depth  372.5 
Uniformity of base coverage  94.6% 
Genome base coverage at 1X 96.9% 
Genome base coverage at 20X  95.2% 
Genome base coverage at 100X 94.4% 
Genome base coverage at 500X  7.5% 
Genome bases with no strand bias  98.9% 
# 
See Chapter 2, Section 2.5.2.5.1 for the technical definitions 
 
 
 
 
 
Figure 5.11 The overview of coverage analysis for the LAB B15 genome sequence using 
Torrent Suite™ Software. L. brevis KB290 (accession number NC_020819.1) was used as 
the reference strain. 
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Table 5.9 L. plantarum B21 genome base coverage analysis by Torrent Suite™ Software. L. 
plantarum B21 (Illumina data) and WCFS1 (accession number AL935263) were used as the 
reference strains.    
Genome Base Coverage
#
 B21 (Illumina Data) L. plantarum WCFS1  
   
Bases in reference genome 3,467,660 3,308,273 
Average base coverage depth  239.0 200.7 
Uniformity of base coverage  99.8% 91.9% 
Genome base coverage at 1X 99.8% 95.1% 
Genome base coverage at 20X  99.8% 92.2% 
Genome base coverage at 100X  99.5% 91.3% 
Genome base coverage at 500X  3.3% 0.1% 
Genome bases with no strand bias  99.0% 98.3% 
# 
See Chapter 2, Section 2.5.2.5.1 for the technical definitions 
 
 
 
Figure 5.12 The overview of coverage analysis for the LAB B21 genome sequence using 
Torrent Suite™ Software. (a) L. plantarum B21 (Illumina data), (b) and WCFS1 (accession 
number AL935263), were used as the reference strains.    
 
 
 
 
 
a 
b 
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5.3.5 Variant Caller analysis of new LAB strains by Torrent Suite™ Software 
The Torrent Variant Caller (TVC) plugin incorporated into the Torrent Suite™ Software 
was used to call single-nucleotide polymorphisms (SNPs), multi-nucleotide 
polymorphisms (MNPs), insertions, and deletions (Indels) in the new LAB genome data, 
using the reference genome for comparison (See Materials and Methods Section 
2.5.2.5.2). A summary of the variant caller analysis is presented in Table 5.10. The TVC 
analysis for A6, A17 and B20 was performed using the L. plantarum ZJ316 strain as 
reference. L. brevis KB290 was used as reference strain for the TVC analysis of B15.  
L. plantarum WCFS1 and the new B21 genome (Illumina) were used as the two reference 
strains for B21 TVC analysis.  The TVC parameter setting was set to high stringency for all 
analysis runs except the analysis of the B21 using Illumina data as reference. High 
stringency settings are optimized for low frequency variant detection with minimal false 
positive calls. For the TVC analysis of B21 Ion Proton sequencing data compared to the 
new B21 Illumina genome sequence, the low stringency setting was used to obtain high 
frequency variants and minimal false negative calls. This analysis detected 214 variants 
between the B21 genome data generated using Ion Proton versus the Illumina platforms. 
This included 194 SNPs, two MNPs, eight insertions and ten deletions.  
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Table 5.10 Variant Caller Analysis of whole genome sequences of LAB strains using the 
Torrent Variant Caller plugin. 
Sample Reference strain Variants 
A6 L. plantarum ZJ316 (accession number  CP004082.1) 21,733 
A17 L. plantarum ZJ316 (accession number  CP004082.1) 69,662 
B20 L. plantarum ZJ316 (accession number  CP004082.1) 23,092 
B15 L. brevis KB290 (accession number NC_020819.1) 15,751 
B21 L. plantarum WCFS1 (accession number AL935263) 16,755 
B21 B21 new genome Illumina (this work, Section 5.2) 214 
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5.3.6 Genome assembly for new LAB strains from the Ion Proton data  
The Ion Proton sequencing data (Fastq) for LAB strains (A6, A17, B20, B15 and B21) were 
submitted to AGRF for de novo assembly (see Materials and Methods Section 2.5.2.5.3). 
The Ion proton sequencing data was screened using Fastqc tools and the Ion Torrent 
barcodes and adaptors were removed. The reads were also quality trimmed at the ends 
with Q20 quality cut-off. The summary of the quality control is presented in Table 5.11.  
 
Cleaned data were then used for de novo assembly of LAB genomes by Mira 4 (Chevreux 
et al. 2004). The assembly statistics are presented in Table 5.12.  The genome data for 
new LAB strains was used in Section 5.5 to further study the pln locus and the bacteriocin 
related genes in detail.  
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Table 5.11 The quality control summary of Ion Proton sequencing data for new LAB 
strains. 
Sample Total reads Duplication (%) Filtered reads* 
A6 16,367,342 78.14 4,775,867 
A17 16,706,676 79.59 7,066,858 
B20 16,430,682 80.31 5,072,186 
B15 9,145,477 81.5 3,422,564 
B21 5,481,415 76.74 1,691,072 
*The adapter and quality trimmed reads 
 
 
Table 5.12 The de novo assembly statistics for new LAB genome sequences based on Ion 
Proton data using the Mira 4 assembly software.  
Sample Total length 
(bp) 
Total contigs N50 (bp) GC content (%) 
     
A6 3,390,450 121 78,754 44.29 
A17 3,742,485 151 63,668 46.14 
B20 3,427,326 166 67,367 44.24 
B15 2,519,568 102 87,593 45.65 
B21 3,436,838 132 80,382 44.26 
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5.4 Comparison of B21 genome sequencing data obtained from Illumina 
and Ion Proton platforms 
Two different sequencing technologies, Illumina and Ion Proton platforms were described 
in the Introduction Chapter Section 1.4.1. The L. plantarum B21 whole genome was 
sequenced on both platforms which enabled a comparison of these two platforms for de 
novo genome sequencing to be made. The summary of the sequencing and assembly 
comparisons are presented in Table 5.13.  
 
Performing a fair and complete comparison of NGS technologies is nearly impossible, 
since they have particular strengths and weaknesses for particular applications. However, 
some critical points were considered in this study. LAB strain B21 DNA from the same 
preparation was used for both sequencing methodologies as an internal comparison. The 
identified SNPs and Indels in the Illumina genome data (for B21 pln locus) in comparison 
to the reference strain WCFS1 were validated and confirmed using conventional PCR 
sequencing of both strands (Section 5.5.1.2) and in all cases perfect agreement was 
obtained. This enabled the use of the new Illumina genome data almost as a gold 
standard for the Ion Proton sequencing data and its subsequent ease of assembly.    
 
The genome sequencing on the Illumina platform employs paired-end sequencing, both 
ends of DNA fragments are sequenced and the respective ends are later mapped to 
locations in the genome using mapping algorithms (Mitra et al. 2014) which maintains the 
linkage (even if the sequence between them is unknown); In contrast, the Ion Proton 
platform uses single-end sequencing technology and only one end of the DNA molecule is 
sequenced, because some reads may not be mapped to the genome uniquely this leads 
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to a decrease in sequencing assembly efficiency. The number of genome contigs obtained 
by de novo assembly was 29 for Illumina with a maximum contig length of 1,650,473 and 
132 for Ion Proton data with a maximum contig length of 438,281 (Table 5.13). The 
paired-end sequencing enabled the construction of 20 scaffold using Illumina data with 
maximum scaffold length of 3,243,796 bp (assembly genome size 3,467,660 bp, 94% of 
the genome); however scaffold construction could not be achieved using the single-end 
sequences of the Ion Proton data. The short reads (100-200 bp) without paired-end 
sequencing or a mate-paired type library protocol, are too short to enable accurate de 
novo assembly (Quail et al. 2012). The advantages of Illumina technology, including high 
quality, paired-end sequencing and scaffolds construction make it a far better platform 
for de novo genome sequencing.  
 
The B21 Ion Proton sequencing data contained a very high percentage of duplicate reads 
(76%) compared to Illumina (<0.5%). The Illumina and Ion Proton platforms use different 
duplication removal algorithms (Zhu et al. 2014). Duplicate reads cause variant detection 
errors. These errors, PCR errors, mismatches and gaps accumulate in duplicate reads and 
a false positive variant result is more likely when too many low fidelity reads are mapped 
to the same location of the genome (Zhu et al. 2014); hence the removal of duplicate 
reads is a crucial quality control step. The trimming of the duplicate and low quality reads 
(with a Q20 cut-off) in the Ion Proton data resulted in huge loss of data (69%). The high 
duplication rate in Ion Proton data may arise as a result of PCR-bias during library 
amplification or enzyme fragmentation bias. This is a common disadvantage of PCR-based 
NGS platforms (Shokralla et al. 2012), although the duplication rate was significantly less 
in the Illumina data.  The PCR reactions for preparation of the Ion Proton libraries was 
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conducted as described in the manufacturers manuals. A careful optimisation of the 
library preparation steps is recommended to reduce duplication rate, there is however no 
way of confirming this without completing full data acquisition and analysis, making 
effective optimisation difficult and expensive to achieve.  
 
The contig N50 for B21 Illumina data assembly was 932,965 bp but was 80,382 bp for Ion 
Proton, and the Scaffold N50 for the Illumina assembly was 3,243,769 bp. The shorter 
N50 length of the Ion Proton data did not allow the reconstruction of the full pln locus in 
one intact contig as it had for the Illumina data. This also applied to the Ion Proton data 
for B20 and A6.  
 
The alignment analysis of bacteriocin related genes for the B21 (from pln locus) using Ion 
Proton data in comparison to Illumina data, revealed the presence of homopolymer 
sequencing errors, including overcall and undercall of the number of homopolymer bases 
(Figure 5.13). This error has been previously reported as a major limitation of Ion Torrent 
sequencing technology (Diaz-Sanchez et al. 2013; Jünemann et al. 2013; Liu et al. 2012; 
Mitra et al. 2014; Zhu et al. 2014). In Ion Proton sequencing, when multiple nucleotides 
are called, it results in the release of more hydrogen Ions per cycle. This causes a larger 
change in pH and a proportionally greater electronic signal. The larger number of repeats 
cannot be distinguished from repeats of a similar but different number (Mitra et al. 2014).  
In contrast, during Illumina sequencing the base calls are made from single nucleotide 
incorporation as a single direct signal measurement for each cycle. This method enables 
robust base calling across the genome, including repetitive sequence regions and within 
homopolymers (Diaz-Sanchez et al. 2013). Increasing the stringency level (for example 
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from Q20 to a Q25 cut-offs) for the B21 Ion Proton data did improve the homopolymer 
sequencing errors to some extent but could not overcome the issue completely. Zhu et al. 
(2014) reported that when a candidate SNP site is a gap site, it is difficult for Ion Proton 
technology to distinguish between a SNP and an Indel. Jünemann et al. (2013) 
demonstrated that the rate of Indel per read for Illumina sequencing (MiSeq) was 0.0013 
to 0.0018 (based on read length) but is 0.3878 to 1.8726 for Ion Torrent (PGM, based on 
read length). However, the substitution rate was equal or slightly higher in Illumina data 
(Miseq). It has been reported that Ion Torrent has a good performance for mismatch 
accuracies but exhibits bias in the detection of Indels (Liu et al. 2012). The low cost and 
high speed of Ion Torrent sequencing has advantages for use in the rapid screening of 
amplicons, however, if SNP or mutation analysis is crucial, this may not be the best 
platform (Diaz-Sanchez et al. 2013).  
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Table 5.13 Comparison of L. plantarum B21 whole genome sequencing using Illumina and Ion Proton sequencing platforms; The de novo 
assemblies of the genome were performed using SOAPdenovo for Illumina and Mira 4 for Ion Proton data.   
Sequencing 
platform 
Run type Read 
Length (bp) 
Duplication 
(%) 
Total Reads Low quality 
filter reads 
(%) 
Contig Scaffold N50 (bp) Maximum 
length (bp) 
Illumina Paired end 90 < 0.5 6,354,788 8% 29 20 3,243,769b 
932,965c 
3,243,796 b 
1,650,473 c 
Ion Proton Single end 152a 76.74 5,481,415 69% 132 0 80,382 438,281 
a Read length mean; b From scaffolds; c From contigs;  
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In this work, Ion Proton sequencing provided a quick method to map and establish the 
presence of the genes of interest for comparison between strains, although de novo 
assembly of this data was at the best only partial. The Ion Proton data confirmed the 
presence of the pln genes in strains B20 and A6 and the lack of the pln locus in strains B15 
and A17. The 16S rRNA sequence deduced from the Ion Proton data for new LAB strains 
(B15, B20, B21, A17 and A6) was aligned with the sequences obtained from PCR 
sequencing (Chapter 4, Section 4.2.3) and all demonstrated 99% identity except for B21 
which showed 100% homology. All 16S rRNA sequences from the Ion Proton data for LAB 
strains (B15, B20, A17 and A6) were searched against the NCBI database using BLAST 
online tool (http://www.ncbi.nlm.nih.gov) (Altschul et al. 1990) and the results were in 
perfect agreement with previous phylogenetic analysis (Chapter 4, Section 4.2.3) 
confirming that LAB B20, A6 and A17 are L. plantarum and that B15 is a L. brevis strain.  
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(a) 
 
B21 plnO/Illumina            tcttg-aaaaaaaacattgctttagaacctgataatccac 
B21 plnO/Ion Proton data     .....a.................................. 
 
(b) 
 
B21 transposon/Illumina      ttgctcagaatcccgattga-tttttttaacacttcgatc 
B21 transposon/Ion Proton    ....................t................... 
 
Figure 5.13 Examples of base call errors from Ion Proton data in homopolymer regions. 
(a), insertion of nucleotide A in plnO sequence (between nucleotides 645 and 646); (b) 
insertion of nucleotide T in the B21 transposon (see Section 5.5.1.3) sequence (between 
nucleotides 975 and 646);   
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5.5 Genetic mapping of the complete pln locus of new LAB strains using the 
whole genome sequencing data 
5.5.1 Analysis of the pln locus from LAB strain B21  
5.5.1.1 Genetic mapping of the pln locus of LAB strain B21 using the Illumina genome 
sequencing data 
In the Chapter 4, 13 bacteriocin genes from the pln locus of LAB strain B21 was identified 
using a PCR-based mapping analysis (Section 4.3.2). The whole genome sequencing data 
for strain B21 was used to map the complete pln locus of this strain (Figure 5.14) with 
reference to the previously characterised pln loci of L. plantarum strains C11, WCFS1, J23, 
J51 and NC8 (accession numbers X94434, AF522077, AL935263, DQ323671 and 
DQ340868). The pln locus in L. plantarum strains possess a mosaic-like structure with 
highly conserved regions related to regulation, bacteriocin production, maturation and 
transport (Anderssen et al. 1998; Ben Omar et al. 2008; Diep, Håvarstein & Nes 1996; 
Rojo-Bezares et al. 2008; Rojo-Bezares et al. 2007). Five operons were identified in the pln 
locus of strain B21 (plnABCD, plnJKLR, plnMNOP, plnEFI and plnGHSTUVW) and a novel 
transposon was located between the plnC and plnD genes, as shown in Figure 5.14.  
 
The genetic organization of the pln locus in strain B21 is similar to that of the WCFS1 and 
C11 strains. The LAB strain B21 pln locus contained two operons, plnEFI and plnJKLR, 
which encode two putative double bacteriocin peptides with double-glycine-type leaders 
(EF and JK), and their putative immunity proteins (PlnI and PlnLR) (Diep, Håvarstein & Nes 
1996; Diep & Nes 1995; Siezen et al. 2012). The length of plnK and plnJ genes is 174 and 
168 bp respectively, while the length of plnE and plnF are 171 and 159 bp. The 
bacteriocins genes are translated as pre-peptides with double-glycine leader sequences 
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which are cleaved off during export to produce the active bacteriocin peptides with sizes 
of 33 aa (PlnE), 34 aa (PlnF), 25 aa (PlnJ) and 32 aa (PlnK). It has been shown that 
complementary peptides (plantaricin J and K - plantaricin E and F) are at least 1000-fold 
more active when they are combined than when they are present individually (Anderssen 
et al. 1998). The plnEFI operon is conserved between different strains of L. plantarum 
strains including strain B21, while plnJKLR operon differs between the different sub-
groups classes of pln locus (Figure 5.14). L. plantarum J51 lacks the plnJK genes (Navarro 
et al. 2008), while only the plnK gene has been removed from the strain J23 pln locus 
(Rojo-Bezares et al. 2008). The third operon in B21 strain (plnMNOP) contains a 
bacteriocin-like ORF, plnN that could encode a one-peptide bacteriocin (Diep, Håvarstein 
& Nes 1996) and putative immunity ORF (either plnM or plnP) (Anderssen et al. 1998). 
plnN appears to contain an N-terminal double-glycine leader consensus similar to the 
two-peptide bacteriocin peptides (plnJK and plnEF) however no bacteriocin activity has 
been previously observed for this peptide (Anderssen et al. 1998). The reference strains L. 
plantarum strains WCFS1, C11 and J23 also contain the plnMNOP operon (Diep, 
Håvarstein & Nes 1996; Kleerebezem et al. 2003; Rojo-Bezares et al. 2008; Siezen et al. 
2012), while strain J51 lacks this operon (Navarro et al. 2008). The L. plantarum NC8 pln 
locus only contains the plnP gene from the plnMNOP operon (Maldonado, Jiménez-Díaz & 
Ruiz-Barba 2004; Maldonado, Ruiz-Barba & Jiménez-Díaz 2003). Genome sequence data 
analysis revealed that B21 pln locus contained the plnABCD regulatory operon which 
encodes quorum-sensing factors necessary fully to express all the bacteriocin related 
genes in L. plantarum strains (Navarro et al. 2008). A new transposon (1319 bp), located 
between the plnC and plnD gene, was identified in the B21 genome data. This is likely to 
impair the plnABCD regulatory operon. The new transposon is discussed in detail in 
CHAPTER 5 
 
203 
 
Section 5.5.1.3. The regulatory operon is responsible for encoding an inducing peptide 
(PlnA), a histidine protein kinase (PlnB) and two response regulators (PlnC and PlnD) 
(Sáenz et al. 2009). Plantaricin A is an induction factor for bacteriocin production (Diep, 
Håvarstein & Nes 1996) which acts as an extracellular signal (pheromone) that provokes 
bacteriocin production and possesses a strain-specific inhibitory activity (Anderssen et al. 
1998). The regulatory operon of plnABCD is highly conserved in many L. plantarum strains 
(WCFS1, C11, and J21); however it has been replaced by the plnNC8IF-HK-D regulatory 
operon in other strains notably NC8 and J23 (Figure 5.14).  The last operon identified in 
the LAB B21 pln locus was plnGHSTUV. This operon is very highly conserved between 
plantaricin-type L. plantarum strains (Figure 5.14); however it has been only partially 
sequenced in some strains. The plnGHSTUV operon encodes for an ABC transporter 
system for peptides containing double-glycine N-terminal leaders (Ben Omar et al. 2008). 
plnGH contains two ORFs encoding an ABC-transporter and its accessory protein, 
respectively, possibly involved in maturation and export of the two-peptide bacteriocin 
proteins (Diep, Håvarstein & Nes 1996). The remaining four ORFs (plnS, plnT, plnU, and 
plnV) of this operon encode polypeptides of 99, 140, 222, and 44 aa, respectively, of 
which PlnV probably represents the N-terminus of a much larger polypeptide (Diep, 
Håvarstein & Nes 1996). The 3’ end of plnS overlaps the first 154 codons of plnT, as in the 
reference strain WCFS1. Diep et al. (1996) reported that the predicted proteins from 
these four ORFs are hydrophobic and contain transmembrane helices, suggesting a 
membrane location. These proteins show significant homology to each other as well as to 
proteins belonging to the type II CAAX amino protease family (Pei & Grishin 2001). Pei 
and Grishin (2001) published a motif analysis which suggests that these four putative 
proteases (PlnS, T, U and V) could be involved in maturation and transportation of 
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bacteriocins. The definitive function of these proteins is as yet unknown. plnXY was 
identified in the B21 pln locus and is similar to the reference strains WCFS1 and J23. 
These two genes are absent in strain C11 (Figure 5.14) and their possible role in 
bacteriocin production is as yet unknown.   
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Figure 5.14 Genetic map of the pln loci for new LAB strains, B21, B20 and A6, based on 
NGS data. L. plantarum reference strains C11, WCFS1, J23, J51 and NC8 data obtained 
from previously publish works (Diep, Håvarstein & Nes 1996; Kleerebezem et al. 2003; 
Maldonado, Ruiz-Barba & Jiménez-Díaz 2003; Navarro et al. 2008; Rojo-Bezares et al. 
2008; Sáenz et al. 2009). The pln locus of LAB strains B20 and A6 have been presented in 
two parts showing that the pln genes were located on two separate contigs of the Ion 
L. plantarum  WCFS1 
                                                                                                                                                                                                      
 
 L. plantarum  C11 
                                                                                                                                                                                           
 
New LAB strain B21 
 
 
New LAB Strain B20 
 
 
 L. plantarum  J23 
                                                                                                                                                                                                      
 
New LAB strain A6 
                                                                                                                                                                                                      
 
 L. plantarum  J51 
                                                                                                                                                                                                      
 
 L. plantarum  NC8 
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Proton data. The pln genes represented by arrows in different colours corresponding to 
each operon. The incomplete arrows represent incomplete gene sequences based on 
available data on GenBank (accession numbers X94434, AF522077, AL935263, DQ323671 
and DQ340868). Small black arrows represent promoter sequences. Colours code for pln 
operons: yellow/black for the genes from the regulatory operon; red/green for two-
peptide bacteriocins operon (plnEFI and plnJKLR); blue colour for the plnMNOP operon; 
pink for the plNC8βαc operon and purple for the ABC transporter system genes. Hatched 
orange for transposons from strains A6 and B21; Strain specific genes are presented as 
‘orf’ and in different colours (Sáenz et al. 2009).    
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5.5.1.2 Comparative analysis (alignment) of pln locus genes from strain B21 and WCFS1 
The bacteriocin-related genes sequences (the pln locus) from the LAB B21 genome data 
were searched using BLAST against L. plantarum WCFS1 genome (accession number 
AL935263). The summary of the alignment analysis is presented in Table 5.14. A few of 
the pln genes showed 100% similarity to that of WCFS1 strain (plnR, plnL, plnJ, plnM, 
plnN, plnP, plnQ, plnA, plnB, plnC, plnI, plnE, plnF, plnG, plnS, plnT and plnV). Six genes 
(plnK, plnO, plnD, plnH, plnU and plnW) showed SNPs or Indels in comparison to the 
WCFS1 genome data at the DNA level. The translated putative protein sequences were 
then compared against the corresponding pln protein sequences from WCFS1. A mutation 
from T to C in plnD of B21 genome sequence (location 1774456, scaffold 1) resulted in no 
changes at amino acid level and was a silent mutation. In the other five pln genes (plnK, 
plnO, plnH, plnU and plnW) the mutation(s) resulted in change(s) of amino acid(s) at 
protein level.  
 
The B21 PlnK amino acid sequence showed 100% identity to that of L. plantarum C11, 
NC8 and V90 (accession numbers X94434, AF522077 and FJ809773.1, respectively) and 
98% identity to L. plantarum WCFS1 (Table 5.14). In the B21 pln locus, the mutation of 
nucleotides TT to CC in the plnk gene (Scaffold 1_1765980 and 1765981) caused a change 
from Asn to Gly at position 25 in comparison to L. plantarum WCFS1. The plnK gene 
encodes the precursor of bacteriocin-like peptide in L. plantarum strains (Diep, Håvarstein 
& Nes 1996; Kleerebezem et al. 2003; Navarro et al. 2008; Rojo-Bezares et al. 2008; 
Siezen et al. 2012). The plnK pre-peptide contains 57 amino acids and the cleavage of the 
double glycine leader peptide (25 amino acids) results in a mature bacteriocin with 32 
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amino acids. The minor amino acid change in B21 PlnK protein does not suggest any 
strong impact on the bacteriocin peptide functionality.  
 
The B21 plnO gene showed 99% identity to that of strain WCFS1 (Table 5.14). In the B21 
pln locus, the mutation of G to A (Scaffold 1_1768013) corresponded to an amino acid 
change from Asn to Ser at position 301 of the predicted protein. The plnO gene is from 
plnMNOP operon of the pln locus in L. plantarum strains (Diep, Håvarstein & Nes 1996; 
Kleerebezem et al. 2003; Navarro et al. 2008; Rojo-Bezares et al. 2008; Siezen et al. 2012) 
and encodes a large (399 amino acids) polypeptide with an acidic pI and low 
hydrophobicity with significant homology to a family of 2-glycosyl transferases (Diep, 
Håvarstein & Nes 1996), however the function of this gene in bacteriocin production is as 
yet unknown (Diep et al. 2009).  
 
The B21 plnH showed 99% identity to that of strain WCFS1 (Table 5.14); however the 
deletion of nucleotide A (Scaffold 1_ between 1779520 and 1779521) from B21 plnGH 
operon, resulted in a frame shift of the ORF. Therefore, the first 130 translated amino 
acids are 100% identical to the PlnH protein from strain WCFS1 followed by a stop codon 
in strain B21. The PlnH protein contains 457 amino acids in L. plantarum WCFS1 (Table 
5.14). Diep et al. (1996) demonstrated that PlnG and PlnH are members of the so-called 
ABC transporters family and their accessory proteins, respectively. They are believed to 
constitute the dedicated processing and secretion machinery for the production of 
bacteriocin-like peptides with double-glycine-type leaders. The plnH nucleotide deletion 
and the consequent frame shift in the translated protein results in a major change in the 
length of the protein (from 457 to 130 amino acids) suggesting that the functionality is 
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lost. The loss of functionality for the PlnH protein suggests a major impairment in the 
maturation and secretion of functional B21 bacteriocin peptides.   
 
The plnU gene of strain B21 showed 99% identity to that of strain WCFS1 (Table 5.14). A 
single nucleotide change, A to C (Scaffold 1_1781425) in the plnU gene caused an amino 
acid change from Gln to Pro at the protein level, in the 222 amino acids PlnU protein. The 
B21 plnW gene also showed 99% identity to that of strain WCFS1 (Table 5.14). Four 
mutations were detected, T to C (Scaffold 1_1783443), C to T (Scaffold 1_1783485), G to 
A (Scaffold 1_1783503) and G to A (Scaffold 1_1783526), these resulted in the amino acid 
changes, Leu186Pro, Thr200Ile, Arg206His and Ala214Thr, respectively, for the 228 amino 
acid PlnW protein. The mutation of nucleotide T to C (Scaffold 1_1783522) appeared to 
be a silent mutation. The plnU and plnW genes are from plnSTUVW operon which 
encodes integral membrane proteins that contain the CAAX family domain of membrane-
bound proteases (Pei & Grishin 2001; Rojo-Bezares et al. 2008). The function of these 
proteins is as yet unknown. 
 
Specific primers were designed to and re-sequence specific parts of the pln genes (plnK, 
plnO, plnH, plnU and plnW) for LAB strain B21 to confirm the SNPs and Indel observed in 
the above of B21 genome data. The primer sets used are presented in Table 5.15. The 
PCR products (~500 bp) (Figure 5.15) were purified using the ISOLATE II PCR and Gel kit 
and sent to AGRF for sequencing on both strands. The sequences obtained were analysed 
using Clone Manager and compared to pln genes sequences obtained from the B21 
genome sequence. All five sequences obtained from the PCR-based sequencing for B21 
pln genes (plnK, plnO, plnH, plnU and plnW) 100% matched the genome sequencing data 
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(Section 5.2), confirming the SNPs and Indel commented on above. The new Illumina-
based genome data for B21 was thus validated as a control for the Ion Proton sequencing 
data.   
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Table 5.14 Comparative sequence analysis (alignment) and summary of function for the pln locus genes from L. plantarum B21 with reference to 
the L. plantarum WCFS1. Clone manager software was used for alignment analysis.   
Gene Identity (%)  Length (bp) Location on L. plantarum B21 
genome (scaffold 1) 
Location on L. plantarum 
WCFS1 genome (accession 
number AL935263.2) 
Putative protein remarks 
      
plnR 100 153 1765038 1765190 365826 365978 Plantaricin biosynthesis protein PlnR 
plnL 100 669 1765215   1765883 366003 366671 Immunity protein for plantaricin JK 
plnK 98 174 1765880   1766053 366668 366841 Bacteriocin precursor peptide PlnK (plantaricin K) 
plnJ 100 168 1766084   1766251 366872 367039 Bacteriocin precursor peptide PlnJ (plantaricin J) 
plnM 100 201 1767113   1767313 367901 368101 Bacteriocin immunity protein PlnM 
plnN 100 168 1767441  1767608 368229 368396 Bacteriocin precursor peptide PlnN (plantaricin N) 
plnO 99 1200 1767726   1768925 368514 369713 Plantaricin biosynthesis protein PlnO from glycosyl transferase group 2 family 
plnP 100 747 1768974   1769702 369744 370490 Bacteriocin immunity protein PlnP  
plnQ 100 189 1770056   1770244 370844 371032 Plantaricin biosynthesis protein PlnQ  
plnA 100 147 1770580   1770726 371368 371514 Plantaricin A precursor peptide, induction factor 
plnB 100 1329 1770917             1772245 371705 373033 Histidine protein kinase PlnB; sensor protein 
plnC 100 744 1772246            1772989   373034 373777 Response regulator PlnC; activator 
plnD 99 744 1774430            1775173 373896 374639 Response regulator PlnD; repressor 
plnI 100 774 1775478             1776251 374944 375717 Immunity protein for plantaricin EF from protease CAAX family 
plnF 100 159 1776350             1776508 375816 375974 Bacteriocin precursor peptide PlnF (plantaricin F) 
plnE 100 171 1776533             1776703 375999 376169 Bacteriocin precursor peptide PlnE (plantaricin E) 
plnG 100 2151 1776970              1779120 376436 378586 ATP-binding ABC-transporter protein PlnG 
plnH 99 1376 1779136             1780511 378602 379978 Accessory factor ABC transporter PlnH 
plnS 100 300 1780601              1780900 380068 380367 Plantaricin biosynthesis protein PlnS 
plnT 100 546 1780746              1781291 380213 380758 Hypothetical membrane protein PlnT, membrane-bound protease CAAX family 
plnU 99 669 1781358            1782026 380825 381493 Hypothetical membrane protein PlnU, membrane-bound protease CAAX family 
plnV 100 681 1782113             1782793 381580 382260 Hypothetical membrane protein plnV, membrane-bound protease CAAX family 
plnW 99 687 1782887            1783573   382354 383040 Hypothetical membrane protein PlnW, membrane-bound protease CAAX family 
plnXa 100 228 1783794 1784021 19797b 20024b Unknown function; homologous to plasmid maintenance systems  
plnYa 100 294 1784033 1784326 20036b 20329b Unknown function; homologous to plasmid maintenance systems 
        
a 
The BLAST analysis of plnX and plnY genes has been performed using L. plantarum V90 genome data (accession number FJ809773.1). 
b 
The location of plnX and plnY genes 
on L. plantarum V90 genome. 
c 
The protein function information has been retrieved from L. plantarum WCFS1 genome data (accession number AL935263.2) and the 
previously published works (Diep et al. 2009; Navarro et al. 2008; Rojo-Bezares et al. 2008).   
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Table 5.15 PCR primers used to amplify genes of pln locus from strain B21 in order to 
confirm the SNPs and Indels in comparison to WCFS1 pln locus sequence. Standard PCR 
conditions are described in methods chapter and the annealing temperature was 50 °C.  
Gene Primer name Primer sequence 
(5’- 3’) 
Product size (bp) 
plnK B21plnK-F CCACTTTGGCGAGGGTA 501 
 B21plnK-R TAAGTTGAACGGGGTTGTT  
plnO B21pln O-F AACGATATGCGATGCTCTT 503 
 B21pln O-R TGCTTTTGCCTGATCAAACT  
plnW B21plnW-F GGTATGGCACATCACTGAAT 577 
 B21plnW-R TGCTGGTAAATCTTGTGAGTT  
plnH B21plnH-F CGCGAGATTGTTATTAATGGT 500 
 B21plnH-R CTTGGCACTATTGGCATACT  
plnU B21plnU-F ATACGTTAATGGGGAGCATC 500 
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                                                              M        1       2        3        4       5                            
 
 
Figure 5.15 PCR amplification products generated in order to amplify genes of pln locus 
from strain B21 in order to confirm the SNPs and Indels in comparison to WCFS1 pln locus. 
The primer sets are described in Table 5.15. M 50 bp DNA ladder (HyperLadder™ 50 bp, 
Bioline, USA); lanes 1 – 5, plnK, plnO, plnH, plnU and plnW, respectively.  
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500bp 
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5.5.1.3 Insertion of a novel transposon in the L. plantarum B21 pln locus 
Mapping the complete pln locus from L. plantarum B21 using the Illumina genome data in 
comparison to the nearest reference strain, WCFS1 revealed the presence of an 
intragenic region of 1319 bp located between plnC and plnD (Figure 5.14). The gene 
sequence was searched for possible ORFs using the NCBI open reading frame finder 
(http://www.ncbi.nlm.nih.gov/projects/gorf/orfig.cgi) (Wheeler et al. 2003). Six ORFs 
were identified as presented in Table 5.16. The ORF sequences were compared to each 
other to identify any similarities. The full sequences of ORF-3 (252 bp), ORF-4 (138 bp) 
and ORF-6 (111 bp) showed 100% identity to that of their target in ORF-1 (879 bp); 
however ORF-1 and ORF-2 did not share any homologies in their sequences. ORF-2 (288 
bp) and ORF-5 (126 bp) showed 100% identity over a region of 48 bp.  ORF-1, ORF-2 and 
ORF-5 sequences were searched using nucleotide BLAST (BLASTn) against the NCBI 
database. The BLASTn analysis of ORF-1 (879 bp) showed 99% identity to a target from 
Lactobacillus reuteri I5007 plasmid pLRI01, three Lactobacillus fermentum strains and 
Lactobacillus paracasei N1115 genomes (accession numbers CP006012.1, CP005958.1, 
CP002033.1, AP008937.1 and CP007122.1, respectively). Interestingly, the BLASTn search 
of the ORF-2 (288 bp) and ORF-5 sequences also demonstrated hits from the same 
strains. The ORF-1 gene was translated using the Expasy online tool 
(http://web.expasy.org/translate/) (Artimo et al. 2012) and the amino acid sequence was 
searched using protein BLAST (BLASTp) analysis against the NCBI database. The ORF-1 and 
ORF-2 BLASTp analysis showed hits to conserved transposase domains (accession 
numbers PHA02517, COG2801, pfam01527 and COG2963) (Marchler-Bauer et al. 2009; 
Marchler-Bauer & Bryant 2004; Marchler-Bauer et al. 2011). These results strongly 
suggest that B21 intragenic region is a transposon. A part of the ORF-5 amino acid 
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sequence showed one hit at 93% identity to part of an antimicrobial peptide ABC 
transporter ATPase from Lactobacillus fermentum (accession number WP_014562300.1). 
A search of the new B21 genome data did not identify the rest of the complete ABC 
transporter gene from Lactobacillus fermentum.  This suggested that a part of this gene 
may have been transferred to the B21 genome with the transposable element from  
L. fermentum or a similar strain and this may have been a relatively recent insertion 
event. 
 
Previously, other transposons have been reported in the pln locus of L. plantarum strains 
(Cho et al. 2010; Diep et al. 2009). Diep et al. (2009) reported a 1414 bp transposon 
upstream of the plnQ gene in L. plantarum V90. Similarly, Cho et al. (2010) demonstrated 
the insertion of a transposon disrupting the plNC8HK gene in L. plantarum PCS20 which 
had 92% identity to the transposon reported in V90. Searches in the NCBI database 
revealed that the B21 transposon (1319 bp) is the first of its kind found in L. plantarum. 
The B21 transposon protein sequence showed high similarity (up to 99% identity) to the 
transposons commonly found in Lactobacillus fermentum strains (accession numbers 
WP_024626250.1 and WP_012391422.1). The new B21 genome was searched to identify 
any repeats of the new transposon gene. The full transposon gene sequence (1319 bp) is 
repeated three times in the rest of B21 genome.    
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Table 5.16 ORF search of 1391 bp intragenic region from L. plantarum B21 pln locus using 
NCBI ORF finder online tool 
ORF Frame  Location Length (bp) 
1 -2 50 - 928 879 
2 -3 952 - 1239 288 
3 -3 637 - 888 252 
4 +3 369 - 497 138 
5 +1 1192 - 1317 126 
6 +3 534 - 644 111 
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5.5.2 Genetic mapping of the pln locus of LAB strain B20 using the Ion Proton genome 
sequencing data 
As for LAB B21, 13 bacteriocin genes from the pln locus of LAB strain B20 were identified 
using PCR-based mapping analysis (Section 4.3.2). This strain had shown very weak 
antimicrobial activity against only one L. brevis strain but no inhibitory activity against the 
remaining indicator strains described in Section 3.2.2. The genome of LAB strain B20 was 
sequenced using the Ion Proton NGS platform (Section 5.3). The assembly of the genome 
using the Mira 4 assembler software resulted in 166 contigs. The genome sequence data 
was used to identify the bacteriocin related genes and to map the pln locus for this strain 
(Figure 5.14). The LAB B20 pln locus was assembled on two separate conigs (C16 and C30) 
as presented in Figure 5.14. Similar to the B21 pln locus (Section 5.5.1), five operons were 
identified in B20 (plnABCD, plnJKLR, plnMNOP, plnEFI and plnGHSTUVW), additionally 
contig 16 contained the genes for plnR to plnD and Contig 30 contained plnI to plnW. No 
transposon insertions similar to that seen in B21 were identified. The genetic organization 
of the pln locus in Strain B20 is similar to that of WCFS1 and the C11 strains. In contrast to 
strain B21 and WCFS1, the plnX and plnY genes appeared to be absent in the B20 pln 
locus (Figure 5.14) similar to the strain C11. The possible role of these genes in 
bacteriocin production is as yet unknown.  An alignment of the B20 pln locus genes with 
that of the reference strain L. plantarum WCFS1 was performed using the Clone Manager 
software. All the pln genes showed 98-100 % identity to the reference genome. Some of 
the identified differences between the B20 pln genes and the WCFS1 corresponding 
genes were due to nucleotide insertion in homopolymer regions, a common error in Ion 
Proton sequencing. Further validation is needed to investigate the changes at amino acid 
level.  
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5.5.3 Genetic mapping of the pln locus of LAB strain A6 using the Ion Proton genome 
sequencing data 
LAB strain A6 was used mainly as the indicator strain for WDA assay in this work. Similar 
to strain B20, it has shown very weak antimicrobial activity against only one L. brevis 
strain. In Chapter 4 (Section 4.3.2) PCR-based mapping of pln genes was carried out and 
surprisingly identified 11 pln related genes in this strain. Strain A6 was shown to have a 
pln locus that was very similar to the J23 reference strain, but which differs from WCFS1, 
C11 and B21 in that it has a plnNC8HK-D regulatory system and lacks the plnABC 
regulatory genes and the plnK structural gene. L. plantarum J23 has a different origin and 
is isolated from grape must (Rojo-Bezares et al. 2008).The genome of LAB strain A6 was 
also sequenced using the in-house Ion Proton NGS platform (Section 5.3). The assembly of 
the genome using the Mira 4 assembler software resulted in 121 contigs and the genome 
data was used to identify the bacteriocin related genes and to map the pln locus of the 
strain (Figure 5.14). The A6 pln locus was also assembled on two separate conigs (C17 and 
C3) as presented in Figure 5.14. The presence of 11 pln genes and the absence of plnK, -A, 
-B and plnC genes that were reported in previous PCR-based mapping experiments was 
confirmed. The overall pln locus structure was again similar to the J23reference strain and 
consisted of five operons which included plnNC8IF-plNC8HK-plnD, plnJLR, plnMNOP, 
plnEFI and plnGHSTUVW. Contig 17 contained the genes for orfZ2 to plnE and Contig 3 
contained plnG to plnW, there was no transposon insertion similar to those found in B21 
was identified in A6. In contrast to the J23 pln locus, the plnX and plnY genes have been 
removed from the plnGHSTUVW operon in LAB strain A6. The new region reported in 
strain J23 (Rojo-Bezares et al. 2008), consisting of the orfZ1, orfZ2 and orfZ3 genes, was 
only partially present in strain A6. In contrast to J23, the orfZ1 gene has been deleted 
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from the A6 pln locus. The orfZ2 gene in strain A6 (162 bp) lacks the first 12 nucleotide of 
the complete orfZ2 gene (174 bp). As for LAB J23, the orfZ3 was identified in strain A6 
new genome. A transposon gene of 172 bp was identified upstream of orfZ2, at the start 
of Contig 17 in the A6 genome data. Sequencing data upstream of this gene is not 
available from A6 genome assembly (see Section 5.4 for limitation of the Ion Proton NGS 
data). A BLAST analysis of the transposon gene revealed 100% identity to several 
transposon sequences from LAB strains including L. paracasei N115 (accession number 
CP007122.1) and L. plantarum ZJ316 (accession number CP006248.1).  
 
Similar to reference strains NC8 and J23 (Maldonado, Ruiz-Barba & Jiménez-Díaz 2004; 
Rojo-Bezares et al. 2008) (Figure 5.14) the three-component regulatory system was 
identified in LAB strain A6. This operon encodes the putative auto-induction factor 
(PLNC8IF), a histidine kinase (PLNC8HK) and a response regulator (PlnD). Man et al. (2014) 
also has identified the presence of the plnC8HK-plnD gene in L. plantarum KLDS1.0391. 
Their study showed that the PlNC8HK protein was a cytoplasmic histidine protein kinase 
and membrane protein with six transmembrane helices, while the PlnD protein was a 
response regulator of the LytR/AlgR family. The genetic structure of the pln locus shows 
that the regulatory system for strains NC8, J23 and the new LAB strain A6 plnNC8IF-
plNC8HK-plnD is different from that of strains WCFS1, C11 and B21 (plnABCD). The 
regulatory system of the plnABCD operon is dependent on quorum-sensing mechanism 
(Diep, Håvarstein & Nes 1996; Navarro et al. 2008) while the bacteriocin activity of strains 
containing the plnNC8IF-plNC8HK-plnD regulatory system is more subtle and is not 
induced by high initial inoculum size, but only when co-culturing with very specific LAB 
strains (Maldonado, Jiménez-Díaz & Ruiz-Barba 2004; Maldonado, Ruiz-Barba & Jiménez-
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Díaz 2004; Maldonado, Ruiz-Barba & Jiménez-Díaz 2003; Rojo-Bezares et al. 2008; Rojo-
Bezares et al. 2007). This suggests that LAB strain A6 may produce bacteriocin(s) with 
wider antimicrobial activity if co-cultured with the correct LAB strains.  
 
As for LAB strain J23, plnJLR was also identified in the A6 pln locus and the plnK structural 
gene was absent. As mentioned previously (Section 5.5.1), it has been shown that 
complementary peptides (plantaricin J and K) are much more active when they are 
combined than when they are present individually (Anderssen et al. 1998).  The 
organisation of plnMNOP, plnEFI and plnGHSTUVW in strain A6 is similar to that of J23 
(Figure 5.14). The pln genes of LAB strain A6 showed 97-100% identity when aligned with 
that of J23. The SNPs and Indels in the A6 Ion Proton genome data need to be validated to 
further study the changes at the amino acid sequence level and their effect on the protein 
function.  
 
5.6 Screening of the pln genes in non-bacteriocin producing LAB strains 
5.6.1 Screening for the pln genes in LAB strain A17 using the Ion Proton sequencing data 
L. plantarum A17 was among the two strongest LAB acid producers isolated from nem 
chua (Section 3.2.1). No antimicrobial activity against the indicator strains studied was 
observed for this strain (Section 3.2.2). The PCR amplification of pln genes (Section 4.3.2) 
identified only one bacteriocin related gene (plnL) in strain A17. The A17 genome was 
partially sequenced on the in-house Ion Proton platform to enable comparison with other 
bacteriocin and non-bacteriocin producing strains. The assembly of the genome using the 
Mira 4 assembler software resulted in 151 contigs. The genome data was searched to 
identify pln genes using an online BLAST alignment tool. LAB strain A17 did not show any 
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evidence of a complete pln locus.  Only three pln genes (plnL, plnG and plnC8HK) were 
present in the partial A17 genome, in Contig 7. Identification of the plnL gene in A17 
genome (Contig 7, 14009 - 13356, complementary) was also in agreement with the earlier 
PCR mapping data for the pln genes (Section 4.3.2). BLAST analysis of the A17 plnL gene 
sequence showed 98% identity to plnL from the Lactobacillus pentosus MP-10 draft 
genome (accession number FR871812.1) and 82% identity to plnL from the L. plantarum 
J23 pln locus (accession number DQ323671.2). PlnL has been reported to be involved in 
immunity to the two-peptide bacteriocin KJ (Diep et al., 1996, Diep et al., 2009). This 
suggests that the A17 strain retains the plnL gene in order to be immune to the two-
peptide bacteriocins produced by other strains in the nem chua microbial community.  
 
The second bacteriocin related gene identified in the A17 genome was plNC8HK 
(Location: Contig 7, 17457 - 18366). The nucleotide BLAST analysis of plNC8HK from A17 
revealed only 79% identity to the same gene in L. plantarum J23 and NC8 (accession 
numbers DQ323671.2 and AF522077.2, respectively). As discussed in Section 5.5.1.1,  
L. plantarum B21 and WCFS1 have a different pln structure that does not contain the 
plNC8HK gene.  The plNC8HK gene was not identified in earlier PCR mapping of the pln 
locus in LAB strain A17 (Section 4.3.2). The high rate of nucleotide mutation prevented 
the binding of the plNC8HK specific primers to the DNA molecule at the temperature 
chosen. In bacteriocin producing strains with complete pln locus, the plNC8HK gene is a 
part of plnNC8IF-plNC8HK-plnD regulatory system (Man et al. 2014) and is far more 
conserved ( ≥ 99% identity).  
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The third pln gene identified in LAB strain A17 was plnG (Location: contig 7, 23400 – 
25522). A BLAST analysis of the plnG from A17 revealed only 83% identity to the same 
gene in L. plantarum WCFS1 and J23 (accession numbers AL935263 and DQ323671.2, 
respectively). As mentioned previously, plnG is a part of plnGHSTUV operon which is 
responsible for maturation and export of the two-peptide bacteriocin proteins (Diep, 
Håvarstein & Nes 1996). Again plnG gene was not identified during PCR mapping of the 
pln genes in LAB strain A17 (Section 4.3.2) due to genetic divergence. The full function of 
the plnG and plNC8HK genes in LAB strain A17 remains unknown.  
 
5.6.2 Screening of the pln genes in LAB strain B15 using the Ion Proton sequencing data 
The 16S rRNA analysis revealed that B15 was a L. brevis strain (Section 4.2.3). No 
antimicrobial activity was secreted by B15 against any of the indicator strains used in 
WDA assays (Section 3.2.2). The PCR-based mapping analysis did not identify any pln 
genes of the correct size in this strain (Section 4.3.2). The PCR fragments obtained using 
the pln genes specific primers did not agree with the expected sizes, a plnC-like product 
from B15 (~ 600 bp) was sequenced on both strands and the sequence analysis revealed 
its similarity to a non-bacteriocin related gene of glycerophosphoryl diester 
phosphodiesterase in L. brevis KB290 (accession number AP012167) (Section 4.4.5). The 
B15 genome was sequenced on the in-house Ion Proton platform and the assembly of the 
genome using the Mira 4 assembler software resulted in 102 contigs. The genome data 
was searched to identify any pln genes using the BLAST alignment tool. No bacteriocin 
related genes were identified in the partial B15 genome. This was in agreement with the 
lack of any antimicrobial activity and the PCR-based mapping analysis results. 
Bioinformatic comparison from the NCBI database revealed that two L. brevis strains, 
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KB290 and ATCC 367 (accession numbers AP012167 and CP000416, respectively), also 
lack a complete pln locus. They do however harbour plnI bacteriocin immunity gene (L. 
brevis KB290 genome, 1146949-1147473, L. brevis ATCC 367 genome, 870001-870348).    
 
5.7 Identification of a B21 transposon-like gene in the other LAB strains 
studied   
In order to screen the LAB strains for the presence of a B21 transposon-like gene (Section 
5.5.1.3), specific primers set was designed using the B21 transposon gene  
as template. Primer set P1, (forward, GTCGTTTAGCTTCGGAGTAT and reverse, 
TAAGGACAAGGAGATTGCAC) was designed to target an intragenic region of the B21 
transposon gene with a product length of 874 bp. Primer set P2 (forward, 
AGATTTTCCAGGTAATTTAAATAGT and reverse AGAAAAGGCCATCTTGTTGT) targeted 
larger 1808 bp region that included a part of plnC, the complete transposon gene and a 
part of plnD gene. This primer set was used to identify the transposon-like gene that was 
located between plnC and plnD genes with the same linkage as seen in the B21 pln locus. 
The amplicon size was expected to be 531 bp (instead of 1808 bp) if no transposon-like 
insertion between plnC and plnD.  
 
The LAB DNA samples (B14, B15, B20, B31, B33, A6 and A17) were tested with primer sets 
P1 and P2 (Figure 5.16) for the B21 transposon. L. plantarum B21 DNA was used as a 
positive control in all PCR reactions. Only strong reproducible PCR products, comparable 
with the B21 positive control, were reported as positive for other LAB strains. For LAB 
strains B14 and B15 no PCR product was obtained using either primer set. The B15 Ion 
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Proton partial genome data set was also searched for the transposon-like gene sequence 
and no hits were observed, in agreement with earlier PCR mapping results.  
 
For LAB strain B20, the PCR amplicon obtained using P1 was larger than the expected size 
(~1600 bp) and the product observed using P2 was ~ 531 bp, which implied no insertion 
between plnC and plnD in the pln locus. These results implied the absence of the 
transposon in this location in B20. The lack of a transposon-like gene was confirmed by 
the partial Ion Proton genome data for B20. Like B20, LAB strains B31 and A6 also lacked 
the transposon-like gene identified in B21, and showed a larger sized amplicon with the 
P1 primer set and a smaller sized amplicon (~531 bp for B31 and ~550 for A6) with the P2 
primer set. The PCR product obtained for LAB strain A6 using P2 primer set was ~ 550 bp. 
The P2 forward and reverse primers targeted the plnC and plnD genes, respectively. 
Mapping of the pln genes from A6 revealed that this strain lacked the plnC gene; 
therefore this PCR amplicon was most likely to be from a random product. The analysis of 
the A6 partial Ion Proton genome data confirmed the absence of a transposon-like gene 
and was in agreement with the PCR results.  
 
For LAB strain B33 a strong PCR amplicon (using primer set P1) with the expected size was 
obtained and the presence of transposon-like gene was observed. The PCR product was 
purified and sequenced on both strands. The sequence obtained was aligned against the 
B21 transposon-like gene sequence and showed 100% identity. The PCR product obtained 
by using P2 primer set was ~531 bp and showed that in contrast to B21, the B33 
transposon-like gene was not located between plnC and plnD. LAB strain B33 genome 
sequence was not included in this study. Strain A17 PCR analysis also showed a strong 
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product with the expected size implying that a transposon-like gene is present. No 
product was obtained for this strain with the P2 primer set as it lacked the plnC and plnD 
genes. The PCR product was purified and sequenced on both strands. The sequence 
obtained showed 99% identity to the B21 transposon sequence. The partial A17 Ion 
Proton genome data was also searched and the transposon-like gene was identified in 
Contig 103 of the genome. The sequences obtained from PCR sequencing and the 
genome data showed a 100% match. Among all LAB strains examined for the presence of 
the B21 transposon-like gene, strains B33 and A17 contained it. Clearly, random 
independent integration of the same B21 transposon had occurred independently in each 
of the strains examined. In at least one case B21, this has interrupted or impaired the 
classical bacteriocin pln locus.     
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           M      1      2     3     4      5     6      7     8            9    10   11   12   13   14   15   16       
 
Figure 5.16 PCR amplification of the transposon-like gene from LAB strains generated by 
primer set P1 (lanes 1 - 8) and P2 (lanes 9 - 16) using total DNA of LAB strains: B14 (lanes 1 
and 9), B15 (lanes 2 and 10), B20 (lanes 3 and 11), B21 (lanes 4 and 12, positive control), 
B31 (lanes 5 and 13), B33 (lanes 6 and 14), A6 (lanes 7 and 15) and A17 (lanes 8 and 16). 
Lane M is 1 kb ladder (HyperLadder™ 1 kb, Bioline, USA) used as molecular weight marker.  
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5.8 Conclusion  
Commercial Illumina-based genome sequencing was undertaken for LAB strain B21 to 
provide a new reference genome for the best bacteriocin producer, the full pln locus was 
sequenced, mapped and compared with published data. The locus was shown to be 
impaired by a novel transposon insertion, interrupting the bacteriocin regulatory operon 
plnABCD. A number of other pln genes, most notably plnH, were also subjected to 
mutation which was predicted to impair function. A PCR-based approach was used to 
identify the same transposon gene in two other LAB strains. The transposon appeared to 
be unique, and had not been reported previously in L. plantarum strains. 
 
In order to identify the similarities and differences between pln loci for remaining strains 
B20 and A6 pln with respect to the new reference genome for B21, in-house whole 
genome sequencing using the Ion Proton system was carried out. Two strains lacking the 
pln loci, L. brevis B15 and L. plantarum A17 were also partially sequenced for overall 
comparison. During this process some unexpected limitations of the Ion Proton 
sequencing technology were encountered.  
 
Ion Proton sequencing provided a quick method to map and establish the presence of the 
genes of interest for comparison between strains, although de novo assembly of this data 
was at the best only partial. The strengths and weaknesses of the Illumina versus  
Ion Proton platforms are discussed in Section 5.4. The Ion Proton data confirmed the 
presence of the pln genes in strains B20 and A6 and the lack of the pln locus in strains B15 
and A17. In addition, the 16S rRNA sequence deduced from the Ion Proton data for new 
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LAB strains (B15, B20, B21, A17 and A6) was used to confirm the previous phylogenetic 
analysis of the LAB strains (Chapter 4, Section 4.2).  
 
Since genome data showed that the function of the classical pln locus was impaired at the 
genetic level, the question of identifying the actual bacteriocin produced by B21 that was 
responsible for the killing activity in B21 culture supernatant still needed to be resolved. 
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Chapter 6 
Purification and characterisation of a novel cyclic bacteriocin from 
L. plantarum B21, from protein to genome 
6.1 Introduction 
In the previous chapter, the classical pln locus was mapped and an overview of the whole 
genome sequencing of LAB strains was reported. In this chapter a protein analysis 
approach is taken to identify a bacteriocin activity produced by L. plantarum B21. A novel 
cyclic bacteriocin was identified at both the protein and genome level and was 
characterised using a variety of analytical techniques. The cyclic peptide sequence and 
the bacteriocin locus responsible for the production of this peptide was deduced from a 
partial protein sequence and the new genome data for LAB strain B21.  
 
6.2 Isolation and purification of bacteriocin protein from L. plantarum B21 
The B21 bacteriocin-like activity was used to purify a putative bacteriocin protein from 
the culture supernatant by a four-step protocol consisting of a cell free supernatant (CFS) 
concentration step, extraction into butanol, a desalting/buffer-exchange step using gel 
filtration on a small Sephadex G-25 chromatography and a final cation exchange 
chromatography (FPLC) step.  
 
6.2.1 Concentration of cell free supernatant (CFS) of strain B21  
A 24 h culture of L. plantarum B21 grown from a 2% inoculum was used to prepare a 
neutralised culture supernatant (pH 6 – 6.5) as described in the Materials and Methods 
Section 2.2.7.2.1. In order to concentrate the putative B21 bacteriocin protein, an 
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ultrafiltration cell with either a 10 or 30 kDa molecular weight cut off membrane was 
evaluated in separate experiments. The concentrate and filtrate were collected and 
examined for antimicrobial activity by the WDA assay against L. plantarum A6 as an 
indicator strain. The WDA assay results showed inhibitory activity in both the concentrate 
and the filtrate samples for material concentrated on a 30 kDa cut off membrane, while 
the bacteriocin activity was observed only in the concentrate when using a 10 kDa 
membrane cut off. This showed that the 10 kDa membrane was not permeable to the 
active form of the putative B21 bacteriocin-like protein and was used in subsequent 
experiments to concentrate larger volumes of B21 CFS for purification trials.    
 
A 24 h culture of L. plantarum B21 grown from a 2% inoculum in 1.6 L of MRS broth under 
the optimum conditions described in Chapter 3 (MRS broth, initial pH 6.0, glucose as main 
carbon source, complex nitrogen source, incubation 30 °C, without shaking). The 
neutralised culture supernatant was prepared (Materials and Methods Section 2.2.7.2.1) 
and the bacteriocin activity was calculated as 800 (AU/mL) (see Materials and Methods 
Section 2.2.7.2.2) against L. plantarum A6. The culture supernatant was then 
concentrated using an ultrafiltration cell with a 10 kDa cut off membrane and the overall 
volume reduced to 70 mL. The concentrate was collected and examined for antimicrobial 
activity. The WDA assay results showed that the bacteriocin activity increased from 800 
(AU/mL) to 12,800 (AU/mL) (Figure 6.1), no inhibitory activity was detected in the filtrate 
and a 16-fold concentration was achieved.  
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Figure 6.1 Strain B21 CFS bacteriocin activity using WDA assay against L. plantarum A6 
before (left - 800 AU) and after (right - 12,800 AU) concentration using an ultrafiltration 
cell with 10 kDa membrane cut off.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 6 
 
232 
 
6.2.2 Preparation of bacteriocin-like activity with ammonium sulphate 
Many classical LAB bacteriocin proteins have been purified efficiently using ammonium 
sulphate precipitation (Anderssen et al. 1998; González et al. 1994; Hata et al. 2009; Hata, 
Tanaka & Ohmomo 2010; Holck et al. 1992; Jiménez-Díaz, Rufino et al. 1995; Maldonado, 
Ruiz-Barba & Jiménez-Díaz 2003; Nissen-Meyer et al. 1992; Smaoui et al. 2010). 
Ammonium sulphate fractionation was therefore a logical first choice to trial as an initial 
clean up step. The concentrated supernatant was subject to a variety of ammonium 
sulphate saturation levels (Table 6.1). As obvious visible precipitate was obtained only 
when the saturation level of ammonium sulphate was taken to 80%. After centrifugation 
the resultant protein precipitate and supernatant were examined for antimicrobial 
activity. In all trials the bacteriocin activity was only partly precipitated in the 80% 
ammonium sulphate fraction (~60%), but was also present in the supernatant (~40%) 
(Table 6.1). The overall recovery in the precipitate did not exceed 60%. These results 
appeared to show that the ammonium sulphate precipitation was not an efficient method 
for the recovery of the bacteriocin protein, resulting in little or no purification.  Classical 
bacteriocins are generally hydrophobic in nature (Atrih et al. 2001; Ennahar et al. 2000; 
Holck et al. 1992; Maldonado, Ruiz-Barba & Jiménez-Díaz 2003) and are precipitated 
efficiently at a 40 – 80% ammonium sulphate saturation level (Deraz et al. 2005; Holck et 
al. 1992; Jiménez-Díaz, Rufino et al. 1995; Metivier et al. 1998). This was not achieved for 
the putative bacteriocin in this study. Although this may have been because the 
bacteriocin preparation was not yet sufficiently concentrated.  An alternative strategy 
was therefore investigated.  
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 Table 6.1 Recovery of antimicrobial activity from the concentrated CFS by ammonium 
sulphate precipitation. Solid ammonium sulphate was added to B21 CFS concentrate to 
achieve the ammonium sulphate fractions listed below as described in Materials and 
Methods Section 2.6.1.2.  
Trial Ammonium 
sulphate saturation 
level (%) 
Activity recovery in 
precipitate (%) 
Activity recovery in 
supernatant (%) 
    
1 0 – 20  0 100 
 20 – 55  0 100 
 55 – 80  60 40 
2 0 – 35 0 100 
 35 – 60 0 100 
 60 – 80 57 43 
3 0 – 55 0 100 
 55 – 80 59 41 
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6.2.3 Preferential extraction of bacteriocin-like activity into organic solvent  
Butanol enrichment has previously been used for the extraction of bacteriocin proteins 
from LAB strains (Abo-Amer 2007; Garneau et al. 2003). Abo-Amer (2007) studied the 
extraction of L. plantarum AA135 bacteriocin protein using different organic solvents (di-
ethyl ether, n-hexane, n-butanol, chloroform, i-amylalcohol and n-propanol). Plantaricin 
AA135 was not extracted from the aqueous phase with very non-polar solvents such as 
hexane and di-ethyl ether and the antimicrobial activity of the bacteriocin was almost 
completely destroyed by chloroform. However, butanol extraction exhibited very efficient 
recovery of the bacteriocin activity from the culture supernatant, with only a small 
residual activity observed in the aqueous phase. Garneau et al. (2003) also reported good 
activity recovery of brochocin C after n-butanol extraction. Therefore n-butanol 
extraction of the bacteriocin concentrate was employed (Materials and Methods Section 
2.6.1.3). The organic phase was then dried and resuspended in 20 mM sodium phosphate 
buffer (pH 6.0) and assayed for antimicrobial activity. The WDA assay of the dried butanol 
phase showed strong bacteriocin activity against L. plantarum A6 while no activity was 
observed in the aqueous phase (Figure 6.2). Butanol extraction appeared to exhibit 
complete recovery of the bacteriocin activity. The extraction and extent of recovery 
seemed to be even more efficient than for classical bacteriocins where some residual 
activity is always observed in aqueous phase (Abo-Amer 2007). In order to scale up, the 
equivalent of 70 mL of B21 concentrated culture supernatant (from Section 6.2.1) was 
subjected to butanol extraction. The organic phase was then freeze dried and the 
material was stored at -80 °C for later use in further purification steps.  
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Interestingly, while the bacteriocin-like activity was readily butanol extractable, 
suggesting a moderately hydrophobic protein, the activity was not an easily precipitable 
in good yield with ammonium sulphate, also normally thought to be a hydrophobically 
driven process. This kind of behaviour seems to be atypical and perhaps more 
characteristic of a charged hydrophobic protein or peptide.  
 
 
 
Figure 6.2 The WDA assay examining the antimicrobial activity of organic (left) and 
aqueous phase (right) from the B21 butanol extraction. L. plantarum A6 was used as the 
indicator strain. The inhibitory activity was recorded as negative if no zone of inhibition 
was observed (right figure).  
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6.2.4 Gel filtration/desalting of extracts for purification  
A portion of the B21 dried butanol extraction (equivalent to 165 mL of CFS - see Table 6.2) 
was thawed, and resuspended in 1 mL of 20 mM sodium phosphate buffer (pH 6.0) and 
applied to a NAP10 desalting column pre-packed with Sephadex G-25 resin (Materials and 
Methods Section 2.6.1.4). The protein fraction was eluted with 2.5 mL of 20 mM sodium 
phosphate buffer (pH 6.0). The 0.5 mL fractions were then examined for antimicrobial 
activity by WDA assay as shown in Figure 6.3. The fractions that eluted earlier from the 
NAP10 column (F3, F4 and F5) were referred to as heavy fractions and exhibited stronger 
bacteriocin activity than those that eluted later, fractions F6, F7 and F8, which were 
referred to as light fractions. This step served to help remove excessive 
lipopolysaccharides and any residual salt in preparation for further chromatography. The 
heavy fractions (F3, F4 and F5) or light fractions (F6, F7 and F8) were pooled and used in a 
subsequent FPLC cation exchange chromatography.  
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Figure 6.3 The WDA assay plates examining the bacteriocin activity from the NAP10 
desalting step. The semi-solid MRS agar plates seeded with the L. plantarum A6 was 
incubated at 30 °C for 18-24 h before being examined for the zone of inhibition. The 
inhibitory activity was recorded as negative if no zone of inhibition was observed. 20 mM 
Sodium phosphate buffer (pH 6.0) was tested in well # as a negative control. The zone of 
inhibition for fractions in (mm) was F1, 0, F2, 10, F3, 16, F4, 15, F5, 15, F6, 13, F7, 13, F8, 
12, F9, 7, F10, 0.  
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6.2.5 FPLC cation exchange chromatography of bacteriocin B21 preparation  
The two separate ‘pools’ from the desalting column were chromatographed on a Fast 
Protein Liquid Chromatography (FPLC) cation exchange column in 20 mM sodium 
phosphate buffer (pH 6.0) (Materials and Methods Section 2.6.1.5). These included the so 
called ‘heavy desalting’ fractions (F3 - F5) and the ‘lighter’ or more ‘slowly eluting activity’ 
fractions (F6 - F8). The effect of the desalting on the yield and purification of the 
bacteriocin was studied in order to better optimise the purification. 
 
Approximately 1 mL of extract was adsorbed to a 6 mL column of Uno S-6 (prepacked 
monolith cation exchange column - 12 × 55 mm) (Bio-Rad, USA) equilibrated with buffer A 
(20 mM sodium phosphate buffer, pH 6.0) at a flow rate of 2 mL/min. The column was 
then washed with 20 mL of buffer A and the bacteriocin was eluted from the column with 
a linear NaCl gradient (0 - 1 M) in 66 mL at 2 mL/min (Figure 6.4a). A single peak in 
absorbance at 214 nm and a small peak at 280 nm corresponding to eluted protein were 
observed (Figure 6.4a), the former arising from the peptide bond and the latter from the 
aromatic residues of the bacteriocin peptide. The presence of one major peak is possibly 
because of the selectivity of the butanol extraction and the fact that the protein is 
strongly basic, exhibiting an overall positive charge at pH 6.0 (probably more than +2). 
Thirty three fractions were automatically collected and were examined for antimicrobial 
activity. The fractions taken across the single absorbance peak at 214 nm and 280 nm 
(F14, F15 and E15) showed the strongest bacteriocin activity, while the flow through 
fractions (F3 and F4) also showed some bacteriocin activity. A summary of the WDA assay 
results are presented in Figure 6.4b. Many bacteriocins from LAB are reported to be 
efficiently purified by cation exchange chromatography (Anderssen et al. 1998; González 
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et al. 1994; Hata et al. 2009). The fractions showing the strongest bacteriocin activity (F14 
and F15) were pooled together (6 mL) and were subjected to concentration and buffer 
exchange using an Amicon Ultra Centrifugal Filters (3 kDa) and concentrated to 200 µL. 
This sample was referred to as B21 purified bacteriocin protein and was used for further 
protein analysis. A summary of the bacteriocin purification is presented in Table 6.2.  
 
6.2.6 Overall purification summary 
A representative purification table describing each step is shown in Table 6.2. The overall 
yield, using the G25 ‘heavy fractions’, was 19% and the overall purification factor was 
more than 8000. In practice the yield varied somewhat between 14-31% depending a 
little on whether the desalting step was included or not. Yields were higher when samples 
were desalted first and the ‘heavy’ desalted fraction was used. It is possible that this step 
did remove lipopolysaccharides as intended. Butanol extraction was highly effective and 
appeared very selective, far more selective than for other classical bacteriocins (Abo-
Amer 2007; Garneau et al. 2003), where residual activity was present in the aqueous 
phase.  
 
A simple back calculation would suggest that LAB B21 produces 1 µg/mL bacteriocin in its 
CFS. This is consistent with yields reported in the literature of ~5.5 mg/L (Babasaki et al. 
1985). 
 
During the ion exchange purification step approximately 20-30% of the activity did not 
bind to the column and later mass spectrometry indicated the same bacteriocin 
polypeptide mass in the flow through. Slowing column flow rate and reducing the loading 
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did not change this. One possible explanation could be that a proportion of the 
bacteriocin was bound to another protein or is highly aggregated masking its charge 
properties in some way.  
 
Overall the bacteriocin seems to be slightly atypical behaving as though it is more 
hydrophilic during ammonium sulphate precipitation but nevertheless still extracting 
efficiently into butanol, a more polar organic solvent.  
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Figure 6.4a FPLC of the active fractions from the NAP10 gel filtration column. Pooled fractions from the NAP10 column were applied to a Uno-S6 cation-exchange column 
equilibrated with sodium phosphate buffer pH 6 (buffer A). The column was washed until the A280 returned to zero, and the bacteriocin was eluted with a linear NaCl 
gradient (0 to 1 M) in buffer A (buffer B), green line. Eluted protein was detected at 280 nm (blue line) and 214 nm (red line). The antimicrobial activity of the fractions are 
presented in Figure 6.4b. 
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Figure 6.4b The WDA assay agar plates examining the bacteriocin activity of cation 
exchange chromatography fractions. The semi-solid MRS agar plates seeded with the L. 
plantarum A6 was incubated at 30 °C for 18-24 h before being examined for the zone of 
inhibition. The inhibitory activity was recorded as negative if no zone of inhibition was 
observed. The zone of inhibition for fractions in (mm) was F3 8, F4 7, F5 – F13 0, F14 13, 
F15 15, E15 10, E14 4, E13 2 and E12 0.  
 
F3 
F4 
F5 
F6 
F7 
F8 
F9 
F10 
F12 
F13 F15 
F14 
E15 
E14 
E13 
E12 
CHAPTER 6 
 
243 
 
Table 6.2 Purification of B21 bacteriocin protein as described in Materials and Methods Section 2.6.1. 
Purification steps Volume 
(mL) a 
Activity 
(AU/mL) 
Total activity 
(AU) b 
Protein 
(mg/mL) c 
Total protein 
(mg) d 
Specific activity 
(AU/mg protein) e 
Yield 
(%) f 
Purification 
fold g 
         
CFS 165 800 132,000 10.82 1,785.63 74 100 1 
Butanol extraction 
(concentrated CFS) 
7.2 12,800 92,160 6.53 47.02 1,960 70 27 
Gel filtration (NAP10 
desalting)  
1.5 25,600 38,400 1.91 2.86 13,438 29 182 
FPLC (Concentrated purified 
bacteriocin) 
0.2 128,000 25,600 0.20 0.04 630,542 19 8521 
 
a Only a part of the concentrated CFS (Section 6.2.1) was used in the purification process. The purification table volumes are presented 
accordingly. b Total activity was determined by multiplying the volume and the activity. c Protein concentration was determined by BCA assay 
(described in Materials and Methods Section 2.6.1.7). d Total protein was determined by multiplying volume and the protein. e Specific activity 
is the activity units divided by protein concentration. f The yield is the total activity as the percentage of the initial total activity. g Purification 
fold was calculated based on specific activity.  
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6.3 Protein-based analysis of B21 purified bacteriocin protein 
6.3.1 Stability of B21 purified bacteriocin antimicrobial activity  
The purified B21 bacteriocin (F14 and F15) from the cation exchange column that showed 
the strongest antimicrobial activity were stored at 4 °C and examined for bacteriocin 
activity by WDA assay over an eight weeks period (Materials and Methods Section 
2.6.2.1). The B21 purified bacteriocin remained active against L. plantarum A6 and 
showed no reduction in activity over the period (Figure 6.5). This excellent stability is in 
contrast to that reported for classical bacteriocins. It has been widely reported that 
purified classical bacteriocins from LAB are unstable after being purified. Héchard et al. 
(1992) has reported that bacteriocin activity of purified mesentericin Y105 dropped 80% 
after being stored at 4 °C for 8 h. Hastings et al. (1991)  also showed that leucocin A-UAL 
187 antimicrobial activity was lost rapidly after purification. Similar results are reported 
for carnobacteriocins A (Worobo et al. 1994), while Davey and Richardson (1981) 
demonstrated that Streptococcus cremoris 346 bacteriocin was completely inactive after 
storage at 4 °C for 1 week. Similarly Pasteris et al. (2014) and Banerjee et al. (2013) 
reported a decrease in bacteriocin stability during storage at 4 °C. This and earlier 
purification characteristics seem to suggest that this bacteriocin is not ‘classical’ in nature.   
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Figure 6.5 Evaluation of the stability of the B21 purified bacteriocin inhibitory activity after 
storage at 4 °C for eight weeks by WDA assay. The semi-solid MRS agar plates seeded with 
the L. plantarum A6 were incubated at 30 °C for 18-24 h before being examined for the 
zone of inhibition.  
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6.3.2 Molecular weight determination of B21 purified bacteriocin protein 
A size estimation of B21 FPLC-purified bacteriocin protein was made using a  
Tris-Tricine-SDS-PAGE gel (Materials and Methods Section 2.6.2.2). The gel was cut into 
two halves and the first half was used to estimate the bacteriocin peptide molecular mass 
after staining. The SDS-PAGE result showed a single protein band of approximately 5 kDa. 
No other bands were observed on the gel, providing evidence of the bacteriocin protein 
purity. A large number of LAB bacteriocin proteins have been reported to be low 
molecular weight proteins of less than 10 kDa (González et al. 1994; Kabuki et al. 1997; 
Maldonado, Ruiz-Barba & Jiménez-Díaz 2003; Morgan, Ross & Hill 1995; Smaoui et al. 
2010; Van Reenen, Dicks & Chikindas 1998). The second half of the Tris-Tricine-SDS-PAGE 
gel was used to confirm that 5kDa bacteriocin protein gave an inhibitory zone around the 
protein band, confirming that the single protein band is responsible for bacteriocin 
activity. The SDS-PAGE gel image and the bacteriocin ‘band’ activity assay are presented 
in Figure 6.6. Bacteriocin activity is readily restored after washing the gel, i.e. the 
bacteriocin readily refolds into an active state.  
 
 MALDI-TOF MS is recognized as a valuable tool for accurate molecular mass 
measurements and has been widely used for the analysis of bacteriocin proteins (Hata et 
al. 2009; Hata, Tanaka & Ohmomo 2010; Maldonado, Ruiz-Barba & Jiménez-Díaz 2003; 
Martin-Visscher et al. 2008; Müller et al. 2009; Ross et al. 1999). The average molecular 
mass of all FPLC-purified fractions demonstrating bacteriocin activity (F3, F4, F14, F15 and 
E15) were investigated by MALDI-TOF MS (Materials and Methods Section 2.6.2.3). The 
MALDI-TOF MS analysis of F14 is presented in Figure 6.7. The purity of the active fractions 
eluted from the FPLC column (F14, F15 and E15) was confirmed by observation of one 
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major peak (5668 Da) in the mass spectroscopy analysis (Figure 6.7). The second small 
peak (2830 Da) appeared to be a doubly charged species (Figure 6.7). All fractions were 
confirmed to contain the same bacteriocin peptide with an average molecular mass of 
5668 Da. The MALDI-TOF MS results also showed the presence of the same bacteriocin 
peptide in the flow through fractions (F3 and F4), having the same mass as the purified 
bacteriocin fractions (F14, F15 and E15). These results suggest that a small part of the 
bacteriocin peptide could not bind to the cation exchange column either because the 
protein binding capacity of the column had been exceeded or because it was bound to 
some other proteins, preventing it from binding to the column. The same phenomenon 
occurred when the total protein loading on the column was reduced; strongly suggesting 
either an aggregated state or that it was bound to other proteins. The mass obtained by 
MALDI-TOF MS was in agreement with the results obtained by Tris-Tricine-SDS-PAGE 
analysis (Figure 6.6).  
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Figure 6.6 The B21 purified bacteriocin protein determination by Tris-Tricine-SDS-PAGE 
analysis. Figure A, the SDS-PAGE gel image; lane 1, the low molecular protein marker; lane 
2, B21 purified bacteriocin protein. Figure B, the antimicrobial assay of the SDS-PAGE gel 
protein band incubated with L. plantarum A6. Figure C, demonstrating the alignment of 
the single gel band and with the inhibition zone on the plate. Sample preparation and gel 
specifications are described in Materials and Methods Section 2.6.2.2. 
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Figure 6.7 MALDI-TOF MS spectrum of purified B21 bacteriocin, showing the singly and doubly charged species. The average molecular mass of 
5668 Da is observed for B21 bacteriocin. The preparation of the sample and MALDI-TOF features are presented in Materials and Methods 
Section 2.6.2.3.  
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6.3.3 Criteria for purity of purified bacteriocin, analytical RP-HPLC 
Many classical bacteriocins have been analysed by RP-HPLC and are reported to be eluted 
from a C18 RP-HPLC column using a water-ACN gradient from 0% to 60% (Atrih et al. 2001; 
Hata et al. 2009; Hata, Tanaka & Ohmomo 2010; Müller et al. 2009). A B21 bacteriocin 
protein sample (prepared as described in Materials and Methods Section 2.6.2.4) was 
injected onto a ZORBAX Eclipse analytical C18 column (4.6 × 150 mm). Surprisingly, no 
protein was eluted using an ACN-water gradient up to 60% (ACN), no peak was observed 
at A220 and A280. The ACN concentration gradient was increased to 95% and the 
bacteriocin protein was successfully eluted from the column using a 40-min linear water-
ACN gradient. The only major peak obtained at 37.5 min, corresponded to the B21 
purified bacteriocin protein (Figure 6.8). This experiment was repeated four times and the 
peaks from all runs overlapped. Failure to elute the bacteriocin protein from a C18 column 
by 60% water-ACN strongly suggested that the B21 bacteriocin protein molecule was 
more hydrophobic than the common classical bacteriocins. These results are in 
accordance with the ammonium sulphate precipitation results which suggested a more 
hydrophobic character relative to more classical bacteriocins. The combined 
electrophoresis, RP-HPLC and MLADI-TOF MS analysis confirm a very high level of purity 
and homogeneity of the final B21 purified bacteriocin sample.  
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Figure 6.8 RP-HPLC elution profile of the B21 FPLC purified bacteriocin protein; Top figure A220; Bottom figure A280; An analytical ZORBAX Eclipse 
C18 column fitted to an Agilent 1100 RP-HPLC equipment was used with a flow rate of 1mL/min. The bacteriocin was eluted with approximately 
80% water-ACN. 
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6.3.4 Analysis of the B21 bacteriocin, UV/Vis absorbance spectrum  
The UV/Vis absorbance has been used previously to characterise bacteriocin proteins 
(Gálvez et al. 1989; Netz et al. 2002). The optical absorbance spectrum of purified B21 
bacteriocin protein was scanned using a SHIMADZU 1800 UV/Vis spectrophotometer. 
Figure 6.9 shows UV spectrum of the bacteriocin protein with a broad absorbance peak 
(0.176) at 280 nm and a pronounced shoulder closer to 290 nm. This peak resembled 
tryptophan. The broad absorbance near 280 nm and the shoulder at longer wavelength is 
consistent with a strong tryptophan content (Edelhoch 1967; Schmid 2001; Strickland, 
Horwitz & Billups 1969). A lower wavelength peak at 251 nm (0.132) is more likely to arise 
from phenylalanine residue(s). Based on Schmid (2001), phenylalanine residues 
contribute fine structure to the spectrum between 250 and 260 nm. In the near-UV  
(240-300 nm) the molar absorbance of phenylalanine is much smaller than that of 
tyrosine and tryptophan, and the spectrum of a protein in this wavelength range is 
dominated by the tyrosine and tryptophan contributions. It is important to note that 
since the absorption of tryptophan is about four times that of tyrosine, at their respective 
peaks (~275 nm and 280 nm, respectively), the precision in the determination of 
tryptophan will naturally exceed that of tyrosine (Edelhoch 1967).  The absorbance 
observed at 220 nm is due to the bacteriocin peptides bonds.  
 
The bacteriocin polypeptide sequence (Section 6.4) was used in an online tool to 
determine a theoretical molar extinction coefficient for the protein 
(http://web.expasy.org/protparam/) (Artimo et al. 2012). This taken into account 
coefficients for the known amino acid content. The value calculated for the bacteriocin 
was 11,000 M-1cm-1 which gave a protein concentration for the spectrum in Figure 6.9 of 
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16 µM, corresponding to 0.091 mg/mL. The experimentally determined value using the 
BCA protein assay of 0.072 mg/mL was in good agreement.  
 
    
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.9 UV absorption spectrum of B21 bacteriocin protein, was measured in a 
SHIMADZU 1800 UV-Vis spectrophotometer (blue line) with a 1 nm slit width, at specific 
wavelength range (190nm to 500 nm). Arrow 1, absorbance peak at 280 nm; Arrow 2, 
absorbance peak at 220 nm. The concentrated purified bacteriocin sample was exchanged 
in 20 mM sodium phosphate buffer pH 6.0 (as described in Materials and Methods Section 
2.6.2.5) spectra were record against a buffer base line in optically match quartz cuvettes.  
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6.3.5 CD spectroscopy and secondary structure content 
CD spectroscopy has been widely used to characterise the secondary structure of the 
bacteriocin proteins (Gaussier et al. 2002; Kawai et al. 2004; Martin-Visscher et al. 2008; 
Netz et al. 2002; Papathanasopoulos et al. 1998). The CD spectrum of B21 bacteriocin is 
presented in Figure 6.10. The theoretical protein concentration was used to convert the 
spectral data to standard units of molar ellipticity. A strong θ positive maximum around 
190 nm and negative θ maxima around 208 and 222 nm shows that the bacteriocin 
peptide consisted mainly of α-helical structure (Kawai et al. 2004). The CD data was used 
to predict the overall secondary structure of the bacteriocin by the K2D3 online tool 
(Louis-Jeune, Andrade-Navarro & Perez-Iratxeta 2012). The bacteriocin was 
approximately 69% α-helix structure, no β-sheet and 31% extended confirmation. Again 
features that distinguish B21 bacteriocin from other classical bacteriocins, that tend to be 
more unstructured in aqueous solution. Papathanasopoulos et al. (1998) showed that 
three bacteriocins (leucocin A, B and C) produced by Leuconostoc rnesenteroides TA33a 
seem to have a less ordered structure in water as compare to a membrane-mimicking 
environment. They reported all three bacteriocins to have CD spectra more typical of  
β-sheet than α-helix. In another study Gaussier (2002) demonstrated that classical 
bacteriocin pediocin PA-1 (from class IIa) is mainly composed of flexible and disordered 
polypeptide chains. Similarly, Netz et al. (2002) showed that the aureocin A53 secondary 
structure is mixed consists of α-helix and β-sheet, the latter stabilised by disulphide 
bridges. Like the B21 bacteriocin studied here, gassericin A, reutericin 6 and carnocyclin 
have been shown to adopt a defined α-helix structure (Kawai et al. 2004; Martin-Visscher 
et al. 2008). These bacteriocins are notable in having a cyclic molecular structure (from 
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class IIc or IV) and adopt a very defined rigid structure. The B21 bacteriocin studied here 
appeared to have stronger similarity to the cyclic bacteriocin class.  
 
 
Figure 6.10 CD spectra of purified B21 bacteriocin protein in 20 mM sodium phosphate 
buffer. Spectra were recorded in a Jasco J-815 CD spectrometer in 1 cm cell at 5.3 µM 
protein concentration with a scan speed of 50 nm/min and temperature control at 25 °C. 
Spectra were average from three scans (see Materials and Methods Section 2.6.2.6)  
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6.4 L. plantarum B21 bacteriocin peptide sequencing and analysis 
6.4.1 L. plantarum B21 bacteriocin de novo LC-MS/MS peptide sequencing  
In proteomic analysis, de novo sequencing is used to deduce peptide sequencing from 
tandem mass spectra without the assistance of a sequence database (Ma & Johnson 
2012). This approach has been previously used for the successful identification of 
bacteriocin peptide sequences (Borrero et al. 2011; Martin-Visscher et al. 2008). Initial 
attempts to determine the N-terminal amino acid sequence of the purified B21 
bacteriocin protein by Edman-degradation failed, suggesting that the peptide may be  
N-terminally blocked. A de novo sequencing approach was then taken to identify the 
peptide sequence of the purified bacteriocin peptide using an ESI-LC-MS/MS technique as 
described in Materials and Methods Section 2.6.3. This experiment identified a strong 
precursor ion at m/z 1417.0630 (monoisotopic peak) which corresponded to an intact 
monoisotopic mass of 5664.252 (Figure 6.11a).  This was in good agreement with the 
previous mass measurement obtained by MALDI-TOF MS (Figure 6.7) and the band 
observed by Tris-Tricine-SDS-PAGE analysis (Figure 6.6). Examination of the ion 
fragmentation spectra for this precursor indicated that both CID and HCD methods 
provided some practical fragment information, however ETD failed to provide any useful 
data.  To the improve the MS/MS information a targeted run was setup in which the m/z 
1417 precursor (with an isolation width of 4 Da) was subject to both CID and HCD at three 
different energy levels (CID: 26, 32, 36, and HCD: 24, 26, 30) and activation Q of 0.25 (CID) 
or activation time of 0.1 ms (HCD). The spectrum produced from HCD at 26EV was 
interrogated through the MASCOT package but failed to identify any candidate sequence 
in the existing databases.  Given the spectrum appeared to contain significant sequence 
information, sequence tags were extracted manually (PGWAVAAAGALG, Figure 6.11b) 
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and BLAST was used to search a six frame translation of the new B21 genome (Materials 
and Methods Section 2.6.3). These amino acid peptide sequences showed 100% similarity 
to a part of the translated amino acid sequence of scaffold 5 of the B21 genome data. A 
putative bacteriocin mature protein sequence was obtained from the predicted ORF 
(Figure 6.12). The precursor mass of the peptide was found to be 18 Da less than the 
apparent mass of the predicted mature amino acid sequence, deduced from the DNA 
sequence.  The apparent N-terminal sequence of the peptide, based on mass spectrum 
data started with the sequence PGWAVAAAGALG (Figure 6.11c). From the same fragment 
spectrum the late b ions produced a sequence of AAVILGV (Figure 6.11c) indicating that 
this sequence was close to the C-Terminus of the peptide.  When compared to the 
predicted amino acid from the genome data, this made no sense as the sequence 
AAVILGV occurs just before the PGWAVAAAGALG sequence in the predicted ORF and it is 
not separated by more than 4000 Da of mass (Figure 6.12).  The only logical explanation 
of this data is that the bacteriocin peptide is in fact cyclic.  The formation of a peptide 
bond between the N and C-Terminus and resulting loss of water would also explain the 
mass discrepancy of 18 Da between the gene sequence (5682 Da) and the experimental 
mass of 5664 Da. After the full putative peptide sequence was deduced from the genome 
data, the remainder of the peptide sequence could be traced and confirmed in the 
MS/MS data (Figure 6.11b and 6.11c). The B21 cyclic bacteriocin peptide was named 
plantacyclin B21AG.  
 
The proteomic analysis of plantacyclin B21AG presented in this study were consistent 
with a cyclic bacteriocin. Plantacyclin B21AG had been shown to demonstrate good 
stability both in culture and during storage at 4 °C (up to eight weeks) (Figure 6.5). Cyclic 
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bacteriocins have been reported to be generally more stable than classical bacteriocins 
(Dezwaan et al. 2007; Maqueda et al. 2008). Maqueda et al. (2004) demonstrated that 
cyclic bacteriocin enterocin AS-48 was a very stable peptide. They suggested that 
substantial part of this increased stability was due to the entropic constraints induced by 
the cyclic nature of the polypeptide chain. Plantacyclin B21AG showed some level of 
resistance to proteolytic enzymes (Chapter 3 Section 3.3); cyclic bacteriocins are less 
susceptible to digestion by endoproteinases and this probably increases their spectrum of 
activity. Borrero et al. (2011) suggested that the resistance of garvicin ML to proteolytic 
enzymes was not due to the absence of digestion sites but to the inaccessibility of the 
recognition sites due to a tightly folded three-dimensional structure. In a similar manner, 
cactocyclicin Q was shown to have a high resistance to proteases (Sawa et al. 2009).  The 
plantacyclin B21AG peptide sequence could not be sequenced by N-terminal sequencing 
in agreement with Borrero et al. (2011) who reported that circular bacteriocin garvicin ML 
was resistant to N-terminal Edman degradation sequencing. Similar results have been 
reported for other cyclic bacteriocins, enterocin 62-6 (Dezwaan et al. 2007), lactocyclicin 
Q (Sawa et al. 2009) and butyrivibriocin AR10 (Kalmokoff & Teather 1997). The B21 
bacteriocin peptide was shown to behave more hydrophobically on RP-HPLC column 
requiring a high concentration (~80%) of ACN for elution (Section 6.3.3). This behaviour 
has been observed for other cyclic bacteriocins. Maqueda et al. (2004) reported that high 
concentrations of solvent were necessary to purify enterocin AS-48 on RP-HPLC which 
allowed efficient separation of the circular bacteriocin from hydrophilic compounds. 
Dezwaan et al. (2007) used RP-HPLC on C18 column to purify cyclic bacteriocin enterocin 
62-6 but was unable to recover the bacteriocin from the column due to bacteriocins high 
hydrophobicity. The CD spectroscopy analysis of plantacyclin B21AG revealed that the 
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secondary structure of the bacteriocin appeared to be substantially α-helical (Section 
6.3.5), again consistent with secondary structure measurements reported for other cyclic 
bacteriocins. Maqueda et al. (2004) demonstrated the three-dimensional structure of 
enterocin AS-48 in solution by high resolution nuclear magnetic resonance (NMR), 
consisting of a globular arrangement of five alpha-helices enclosing a compact 
hydrophobic core. Similar results were reported for lactocyclicin Q (Sawa et al. 2009), 
gassericin A, reutericin 6 (Kawai et al. 2004) and carnocyclin A (Martin-Visscher et al. 
2008).  
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Figure 6.11a De novo peptide sequencing of B21 bacteriocin using LC-MS/MS techniques. The HCD fragmentation pattern was used as described 
in Materials and Methods Section 2.6.3 and the combined high resolution HCD spectrum results are presented here.  The +4 species centred at 
1417.81 was manually selected for fragmentation analysis.  
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Figure 6.11b De novo peptide sequencing of plantacyclin B21AG using ESI-LC-MS/MS techniques. This figure shows the identification of the b 
ions and the manual extraction of the peptide sequence from the MS/MS data, peptide sequence obtained was PGWAVAAAGALG.  
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Figure 6.11c De novo peptide sequencing of plantacyclin B21AG using ESI-LC-MS/MS techniques. This figure shows the identification of the late 
b ions and the manual extraction of the peptide sequence from the MS/MS data, peptide sequence obtained was AAVILGV.   
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PGWAVAAAGALG ………… AAVILGV 
 
IVWIARQFGVHLTTKLTQKALDLLSSGASLGTVAAVILGVTLPGWAVAAAGALGGTAA 
 
 
MLSAYRSRLGLNKFEVAILMIISLFILLFATVNIVWIARQFGVHLTTKLTQKALDLLSSGA
SLGTVAAVILGVTLPGWAVAAAGALGGTAA 
 
ttctaaaaaggaggaattactatgctttcagcatatcgtagcaggttaggattgaacaag 
                      M  L  S  A  Y  R  S  R  L  G  L  N  K  
tttgaggttgctattttaatgatcatctctctttttattttattatttgccacagttaat 
 F  E  V  A  I  L  M  I  I  S  L  F  I  L  L  F  A  T  V  N  
attgtatggattgcaagacaatttggtgtgcatttgacaacaaagcttacacaaaaggct 
 I  V  W  I  A  R  Q  F  G  V  H  L  T  T  K  L  T  Q  K  A  
ttagatttattatcttctggagcatctttgggtaccgtagcagctgttatcttaggcgtt 
 L  D  L  L  S  S  G  A  S  L  G  T  V  A  A  V  I  L  G  V  
acattgccaggatgggcagttgcagcagctggggctctcgggggtaccgcagcttaatttg 
 T  L  P  G  W  A  V  A  A  A  G  A  L  G  G  T  A  A  -    
 
 
Figure 6.12 Determination of the amino acid and nucleotide sequence of plantacyclin B21AG. (A) Amino acid sequences 
were obtained by de novo sequencing using LC-MS/MS techniques as described in Materials and Methods Section 2.6.3. 
(B) Plantacyclin B21AG mature peptide sequence corresponding to the linear isotopic mass of 5682 Da, confirming the 
data obtained by MS/MS analysis. (C) The plantacyclin B21AG full putative peptide sequence deduced from translation 
of the predicted ORF in the new B21 genome (scaffold 5). The hypothetical cleavage site of the leader peptide is 
indicated by a blue arrow. (D) The nucleotide sequence obtained from the new B21 genomic data corresponding to the 
plantacyclin B21AG amino acid sequence (location: 2899-2624 of scaffold 5). The symbol (-) demonstrates the 
translation stop codon. (E) Predicted circular structure of plantacyclin B21AG. The red arrow shows the main ion 
fragmentation site identified by the proteomic analysis.   
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6.4.2 Plantacyclin B21AG peptide sequence analysis 
The MS/MS data was used for de novo assembly of two short sequences from Plantacyclin 
B21AG (Figure 6.11a - 6.11c). The sequence of the putative full and mature bacteriocin 
peptide was then deduced from the predicted ORF from the L. plantarum B21 genome 
data (Figure 6.12D). The putative bacteriocin peptide has 91 amino acids (pre-peptide) 
consisting of a 33-amino-acid leader peptide and a 58-amino-acid pro-peptide (Figure 
6.15C). The putative cleavage site for removing the leader peptide is located between 
asparagine and isoleucine, and has homology to the leader peptide cleavage site in 
gassericin A and acidocin B (Kawai et al. 1998; Leer et al. 1995). Cleavage at this site 
(Figure 6.12C) would remove a 33-amino-acid leader sequence and produce a mature 
bacteriocin containing 58 amino acids. The 58-amino-acid peptide is predicted to undergo 
a post-transnational modification that results in the linking of the N-terminal isoleucine to 
the C-terminal alanine, with the elimination of a water molecule, resulting in the active 
and mature B21AG molecule that is actually secreted. The leader peptides in cyclic 
bacteriocins vary in length, from 3 to more than 30 amino acids (Borrero et al. 2011; 
Martin-Visscher et al. 2008; Martínez-Bueno et al. 1994). The amino acid composition of 
the mature cyclic bacteriocin consists of a very high proportion (59%) of hydrophobic 
amino acid residues (Ala, Val, Leu, Ile, Phe, Trp and Pro) and also uncharged hydrophilic 
amino acid residues (32%) (Gly, Ser, Thr and Gln). There is also high ratio of basic (Lys, Arg 
and His) relative to acidic amino acids (Asp) suggesting a strong basic protein character. It 
has been suggested that the basic residues such as Lys present a highly localised positive 
charge on the surface of the cyclic bacteriocins structure which is responsible for 
attracting the peptide to the surface of the negatively charged membrane (Borrero et al. 
2011; Martin-Visscher et al. 2009). Unlike some other cyclic bacteriocins (Babasaki et al. 
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1985; Kawulka et al. 2004; KempermanKuipers, et al. 2003) plantacyclin B21AG does not 
contain any Cys residues, so there are no di-sulphide bridges. The bacteriocin peptide also 
contains three aromatic residues (two Trp and one Phe). The characteristic influence of 
Trp is seen in the UV-Vis observations (Figure 6.9).  
 
6.5 Genetic analysis of plantacyclin B21AG gene cluster   
The b21ag gene (ORF-A) (Figure 6.13) responsible for plantacyclin B21AG production was 
located on the bacterial chromosome (B21 genome data, scaffold 5_2899_2624 reverese 
strand). The b21ag structural gene encodes a 91-amino-acid pre-peptide consisting of a 
33-amino-acid leader peptide and a 58-amino-acid bacteriocin peptide. The DNA 
sequence of plantacyclin B21AG was searched against L. plantarum B21 whole genome 
using BLAST and no other similar genes were observed in the other parts of the genome.  
The DNA sequence of plantacyclin B21AG putative pre-peptide (273 bp) and the mature 
bacteriocin (174 bp) were analysed by nucleotide BLAST (BLASTn) search in the NCBI 
database (Altschul et al. 1990) and no significant similarities were found at the DNA level. 
This result showed that the plantacyclin B21AG gene was unique. The plantacyclin B21AG 
putative protein sequence (ORF-A, 91 amino acids) was analysed by protein BLAST 
(BLASTp) (Altschul et al. 1990) search and compared to all available sequences in the NCBI 
database. The highest hit from the BLASTp search showed only 58% identity (100% query 
cover) to a cyclic bacteriocin produced by Lactobacillus pentosus (accession number 
WP_003637681.1). The second highest similarly showed 53% identity (83% query cover) 
to the gassericin A and acidocin B, cyclic bacteriocins produced by Lactobacillus gasseri 
and Lactobacillus acidophilus respectively (accession numbers WP_012621083.1 and 
CAA84399.1). The BLASTp analysis of the mature bacteriocin peptide (58 amino acids) 
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showed 67% identity (100% query cover) to the cyclic bacteriocin from Lactobacillus 
pentosus (accession number WP_003637681.1) and 65% identity (74% query cover) to 
gassericin A (accession numbers WP_012621083.1). These results demonstrate that 
plantacyclin B21AG is a new member of cyclic bacteriocin class produced by L. plantarum.  
Interestingly, this also shows that the mature sequence is more conserved than the 
leader sequences.  
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Figure 6.13 Genetic map of the putative plantacyclin B21AG operon from L. plantarum 
B21 (this work), pentocin A from L. pentosus KCA1  and gassericin A from L. gasseri LA39  
obtained from previously publish work (Anukam et al. 2013; Ito et al. 2009) for 
comparison. The bacteriocin related genes are represented by arrows in different colours 
corresponding to the genes function. Small black arrows are representing the predicted 
promoter sequences. Colours code for cyclic bacteriocin cluster genes: green for the cyclic 
bacteriocin structural genes; orange and hatched orange arrows for bacteriocin immunity 
genes; blue arrows for ABC-transporter genes; grey for membrane protein genes; black for 
genes that are not specifically related to bacteriocin function.  
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Five additional ORFs (Figure 6.13, ORF-B to ORF-F) were predicted from the new  
L. plantarum B21 new genome data (scaffold 5) to form a potential transcriptional unit 
which contains the plantacyclin B21AG gene (Figure 6.13). The putative proteins encoded 
by each predicted ORF were analysed and annotated using NCBI BLAST tools in order to 
identify the functional gene cluster involved in the production of plantacyclin B21AG.  
 
The BLASTn analysis of ORF-B sequence (location: scaffold5_2532_2059 reverse strand) 
(Figure 6.13) did not show any significant homology to NCBI database sequences at DNA 
level. The BLASTp analysis of the ORF-B putative protein sequence (157 amino acids) 
(Figure 6.13) detected a putative conserved domain from the DUF95 superfamily. The 
members of this family have several predicted transmembrane regions (Marchler-Bauer 
et al. 2009; Marchler-Bauer & Bryant 2004; Marchler-Bauer et al. 2011). The ORF-B 
putative protein sequence has 39% identity (query cover 75%) to the PenD gene from L. 
pentosus (accession number WP_003637682), 33% identity (query cover 94%) to the 
GaaD gene (a membrane protein involved in production of gassericin A, accession 
number WP_012621084.1) (Ito et al. 2009) and 30% identity (query cover 68%) to the 
BviE protein sequence from Butyrivibrio fibrisolvens (accession number AAC69561.2). 
Kalmokoff et al. (2003) suggested that bviE gene is involved in self immunity to the cyclic 
bacteriocin, butyrivibriocin. Based on the report of Nes et al. (1996), the dedicated 
immunity gene is always located next to and downstream from bacteriocin structural 
gene. This analysis strongly suggests that the ORF-B gene could be involved in the 
production of or immunity to the plantacyclin B21AG.  
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The BLASTn analysis of ORF-C sequence (location: scaffold5_2056_1892 reverse strand) 
(Figure 6.13) did not find any significant homology from NCBI database at the DNA level. 
Similarly BLASTp analysis of ORF-C putative protein sequence (54 amino acids) (Figure 
6.13) did not detect any putative conserved domains, however it did show 38% identity 
(query cover 83%) to the GaaI protein from L. gasseri which is again involved in self 
immunity to its cyclic bacteriocin (accession number WP_012621085.1) (Ito et al. 2009). 
These results suggest that the ORF-C gene is involved in immunity of L. plantarum B21 to 
plantacyclin B21AG.  
 
The BLASTn analysis of the ORF-D sequence (location: scaffold5_1851_1189 reverse 
strand) (Figure 6.13) did not find any significant homology from NCBI database at DNA 
level. The ORF-D putative protein sequence (220 amino acids) (Figure 6.13) BLASTp 
analysis showed specific hits to the conserved domain of ABC_DR_subfamily_A (ABC-
transporter ATP-binding proteins).  This family of ATP-binding proteins belongs to a multi-
subunit transporter involved in drug resistance, lipid transport, and bacteriocin immunity 
(such as lantibiotics) (Marchler-Bauer et al. 2009; Marchler-Bauer & Bryant 2004; 
Marchler-Bauer et al. 2011). The BLASTp analysis of this ORF also detected hits to ABC-
ATPase superfamily (Marchler-Bauer et al. 2009; Marchler-Bauer & Bryant 2004; 
Marchler-Bauer et al. 2011) which are a large family of proteins involved in the transport 
of a wide variety of different compounds such as sugars, ions and peptides. It has been 
reported that dedicated transmembrane translocators belonging to the ATP-binding 
cassette (ABC) transporter superfamily are involved in the cleavage of the leader-peptide 
from Class II bacteriocins  and in the transportation of the mature bacteriocin molecule 
across the cytoplasmic membrane (Nes et al. 1996). The ORF-D (Figure 6.13) showed 49% 
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identity (query cover 98%) to the PenT protein from L. pentosus (accession number 
WP_003637684.1) and 46% identity (query cover 96%) to GaaT protein from L. gasseri 
which is involved in the transportation of gassericin A (accession number 
WP_012621086.1) corresponding to amino acid level. These results suggested that ORF-D 
gene should be involved in the cleavage of the leader peptide and transport of 
plantacyclin B21AG bacteriocin protein.  
 
The BLASTn analysis of ORF-E sequence (location: scaffold5_1186_542 reverse strand) 
(Figure 6.13) did not find any significant homology from NCBI database at DNA level. The 
BLASTp analysis of ORF-E putative protein sequence (214 amino acids) (Figure 6.13) 
detected specific hits to the ABC_membrane_5 putative conserved domain from the 
database which related to the ABC_2 membrane transporter family. These domains are 
from superfamily of Acyl_transfer_3 including a range of acyltransferase enzymes 
(Marchler-Bauer et al. 2009; Marchler-Bauer & Bryant 2004; Marchler-Bauer et al. 2011). 
The ORF-E putative protein sequence BLASTp showed only 39% (query cover 96%) to PenE 
protein from L. pentosus (accession number WP_003637685.1) and 37% identity (query 
cover 96%) to membrane protein, GaaE from L. gasseri which is involved in the 
production and transportation of gassericin A (accession number WP_012621087.1). 
These analysis results suggest that ORF-E gene could be involved in transportation of the 
plantacyclin B21AG.  
 
The BLASTn analysis of ORF-F sequence (location: scaffold5_539_18 reverse strand) 
(Figure 6.13) did not find any significant homology from NCBI database at DNA level. The 
BLASTp analysis of this ORF putative protein sequence (173 amino acids) (Figure 6.13) did 
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not detect any putative conserved domains corresponding to the amino acid level. The 
putative protein sequence showed only 31% (query cover 91%) to PenB protein from L. 
pentosus (accession number WP_003637686.1) and 30% identity (93% query cover) to a 
membrane protein with 5 predicted transmembrane segments (TMS) from L. gasseri  
which is involved in production of the cyclic bacteriocin, gassericin A (accession number 
WP_012621081.1). These results suggested that the ORF-F gene could be possibly 
involved in the production of plantacyclin B21AG. 
 
The Orf-a1 and Orf-a2 genes are located next to and upstream of the plantacyclin B21AG 
structural gene (locations: scaffold5_3148_3441 and scaffold5_3512_4471) (Figure 6.13). 
BLASTn and BLASTp analysis of their sequences did not show any significant shared 
homology to any bacteriocin related genes from the NCBI database at the DNA or amino 
acid levels. The BLASTp analysis of the Orf-a2 putative protein sequence (319 amino 
acids) (Figure 6.13) revealed homology to the conserved domain of TpcC superfamily. This 
family of proteins are annotated as conjugative transposons TcpC (Marchler-Bauer et al. 
2009; Marchler-Bauer & Bryant 2004; Marchler-Bauer et al. 2011).  The Orf-a2 BLASTp 
analysis showed high similarity (91%) to a hypothetical transposon protein from 
Lactobacillus mali (accession number WP_003688364.1).  
 
The possibility of further bacteriocin relating genes downstream from ORF-F cannot be 
excluded, data from Pentocin KCA1 (Anukam et al. 2013) suggest the likelihood of an ORF-
G homologous to the Pen R gene from L. pentosus KCA1 (Figure 6.13).  
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6.6 Phylogenetic analysis of plantacyclin B21AG protein  
The phylogenetic analysis of the full protein sequence of plantacyclin B21AG (91 amino 
acids) was performed to investigate the homology of this bacteriocin in comparison to 
other cyclic bacteriocins from Gram-positive bacteria available in the NCBI database. A 
phylogenetic tree was constructed using the Phylogeny.fr online tool (Dereeper et al. 
2008) (Figure 6.14a). Plantacyclin B21AG and pentocin KCA1 (Anukam et al. 2013) cluster 
together as expected from with the BLASTp analysis reported in Section 6.5. The other 
two bacteriocins in the same clade as plantacyclin B21AG were gassericin A (Kawai et al. 
1998) and acidocin B (Leer et al. 1995; ten Brink et al. 1994), both bacteriocins from Class 
IV. The phylogeny shows that plantacyclin B21AG, pentocin KCA1, gassericin A and 
acidocin B are closely related. All four cyclic bacteriocins have 33 amino acids leader 
peptides and 58 amino acids mature bacteriocin peptides of the active protein. The 
conserved regions with a maximum BLOSUM62 score are highlighted in blue (Figure 
6.14b). The butyrivibriocin AR10 (Kalmokoff et al. 2003) and lactocyclicin Q (Sawa et al. 
2009) bacteriocins were also clustered in clade I, but plantacyclin B21AG did not share 
high similarity with these two bacteriocins. The other five cyclic bacteriocins 
(carnocyclicin A, uberolysin, garvicin ML, AS-48 and circularin A) were clustered in a 
separate clade (clade II) and the peptide sequence, number of amino acids and the 
peptide cleavage site is different for this group of cyclic bacteriocins in comparison to 
plantacyclin B21AG.  
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Figure 6.14 Phylogenetic analysis of plantacyclin B21AG full protein sequence (a) and 
protein sequence alignment (gassericin A, acidocin B, pentocin KCA1 and plantacyclin 
B21AG) (b) using Phylogeny.fr online tool (Dereeper et al. 2008). Figure (a): The protein 
sequence of cyclic bacteriocins were obtained from NCBI database, accession numbers AS-
48, CAA72917.1, gassericin A, BAH08712.1, acidocin B, CAA84399.1, butyrivibriocinAR10, 
AAC69560.1, uberolysin, A5H1G9.1, circularin A, AAN86036.1, garvicin ML, ACZ98827.1, 
pentocin KCA1, EIW14922.1, lactocyclicin Q, BAH29711.1, carnocyclin A, ACC93994.1. 
Figure (b) Similar residues are coloured as the most conserved ones according to 
BLOSUM62 alignment score. Average BLOSUM62 score:  Maximum: 3.0 (blue), low: 0.5 
(grey). Gas-A (gassericin A), Aci-B (acidocin B), KCA1 (pentocin KCA1), B21AG (plantacyclin 
B21AG).  
 
 
Gas-A     MVTkYgRNLGLNKVELfAIWAVlVvALLltTANIyWIADQFGIHLATgtARKLLDAmASG 
Aci-B     MVTkYgRNLGLsKVELfAIWAVlVvALLlATANIyWIADQFGIHLATgtARKLLDAVASG 
KCA1      MVlnlkerLqLNrIEavvlvAlfaavLLFATvNIVWlANkFGvHLtnhLtnsILnAVsnG 
B21AG     MlSaYrsrLGLNKfEVailmiIsLfiLLFATvNIVWIArQFGvHLtTkLtqKaLDllsSG 
 
Gas-A      ASLGTAFAAILGVTLPAWALAAAGALGATAA 
Aci-B      ASLGTAFAAILGVTLPAWALAAAGALGATAA 
KCA1       sSLGsAFAvIaGVTLPgWAvAAvGALGATAA 
B21AG      ASLGTvaAvILGVTLPgWAvAAAGALGgTAA 
(a) 
(b) 
Gassericin A 
Acidocin B 
Pentocin KCA1 
Plantacyclicin B21AG 
Butyrivibriocin AR10 
Lactocyclicin Q 
Carnocyclicin A 
Uberolysin 
Garvicin ML 
AS-48 
Circularin A 
I 
II 
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6.7 Conclusion  
The bacteriocin protein from the B21 culture supernatant was successfully purified by a 
four-step process. This consisted of a cell free supernatant (CFS) concentration step, 
extraction into butanol, desalting/buffer-exchange on Sephadex G-25 and a final cation 
exchange chromatography (FPLC) step. The overall bacteriocin yield was approximately 
19% and the overall purification factor was more than 8,000-fold. A simple back 
calculation suggests that LAB B21 produces approximately 1 µg/mL bacteriocin in its CFS.  
The bacteriocin protein showed great stability during eight weeks of storage at 4 °C. Tris-
Tricine-SDS-PAGE suggested a molecular weight of approx. 5.5 kDa and MALDI-TOF MS 
measurements of 5668 Da. The purity of the protein sample was confirmed by a single 
major peak on a RP-HPLC C18 column and single peak on MALDI. The UV-Vis absorbance 
spectrum of the bacteriocin gave evidence of Trp residues. The UV-Vis data and the 
peptide sequence were then used to calculate a molar extinction coefficient at 280 nm 
and this was used to calculate a theoretical protein concentration of 16 µM which agreed 
well with conventional protein assays. CD spectroscopy was used to investigate the 
secondary structure of the protein and showed that the protein structure consisted of 
69% α-helix. Initial attempts to determine the N-terminal amino acid sequence of the B21 
bacteriocin protein by Edman-degradation failed, suggesting that the peptide was 
potentially N-terminally blocked. A de novo sequencing approach was then taken to 
identify the peptide sequence of the purified bacteriocin protein using ESI-LC-MS/MS 
techniques. Two short sequences were manually obtained from the MS/MS data and 
were searched against a six frame translation of the entire B21 genome. A strong hit was 
found which correctly predicted the remaining B ions in the MS/MS data. Furthermore, a 
mass discrepancy between the theoretical and experimental masses of 18 Da, strongly 
CHAPTER 6 
 
275 
 
suggested that the bacteriocin was in fact cyclic. The sequence was a new member of the 
cyclic bacteriocin family with 67% identity over the mature sequence to its nearest known 
homolog.  
 
From the cyclic peptide sequence, the bacteriocin locus responsible for its production was 
fully mapped to the genome data and its gene structure was analysed and compared with 
the literature. The new bacteriocin was named plantacyclin B21AG. The plantacyclin 
B21AG protein sequence was aligned against other cyclic bacteriocins from Gram-positive 
bacteria and a phylogenetic tree and multiple sequence alignment were constructed and 
the conserved regions identified. It is likely to consist of five conserved α-helices and have 
the common saposin fold which imparts stability to this class of cyclic bacteriocins 
(Martin-Visscher et al. 2009).  
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Chapter 7 
Overall conclusion and future direction 
The wide spread use of currently available antibiotics in medicine and agriculture has led 
to an increasing number of antibiotic resistant strains (Smaoui et al. 2010). There is a 
growing need to focus on new antimicrobial agents to overcome this problem. Currently, 
foodborne diseases are costing Australia about $1.2 billion per year and result in a large 
number of hospitalisations and a significant number of deaths (Group 2012; Hall et al. 
2005). The economic and social impact of research to find new antimicrobial agents that 
can contribute to food safety is clear.    
 
Current interests in lactic acid bacteria especially Lactobacillus plantarum have increased 
because of its application as a starter culture in food fermentation (Bacus & Brown 1985; 
Hugas et al. 1993; Hugas, Marta & Monfort 1997). A wide range of bacteriocins from  
L. plantarum have been isolated and studied (Abo-Amer 2007; Fiorentini et al. 2001; Hata, 
Tanaka & Ohmomo 2010; Hurtado et al. 2011; Maldonado, Ruiz-Barba & Jiménez-Díaz 
2004; Müller et al. 2009; Ogunbanwo, Sanni & Onilude 2004; Tiwari & Srivastava 2008; 
Todorov 2008). Currently, there are two bacteriocins, nisin and pediocin PA1/AcH that are 
widely used in the food industry. Despite these apparent advantages, Nisin also has some 
limitations as a natural food preservative (pH range and stability). As demand for new 
antimicrobial compounds for application in both health and food grows, the identification 
and characterisation of new antimicrobial compounds from LAB is a  
timely direction for future research. The last 18 months has seen the addition  
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of 18 new L. plantarum genomes to the database indicating growing interest in this 
organism.  
 
This study focused on characterising the bacteriocin proteins produced by LAB, mainly  
L. plantarum B21, isolated from the Vietnamese fermented sausage nem chua (Tran 
2010). This study also surveyed bacteriocin-related genes in LAB B21 relative to those of 
related organisms and given the absence of a functional classical pln locus, purified and 
characterised an unidentified bacteriocin produced by this strain. The study was then 
extended to other isolates from the same source. 
 
Measurement of the final pH of the bacterial cultures indicated that L. plantarum strains 
A17 and A6 produced largest amount of acid in MRS broth after 24 h, compared to other 
LAB strains. The weakest production of acid was demonstrated by L. brevis strains B14 
and B15. Strains B21, B31 and B33, the antimicrobial substance(s) producing strains, 
showed similar acid producing properties to each other, but less than A17 and A6 and 
more than B14 and B15.  
 
LAB strains B20, B21, B31, B33 and A6 demonstrated antimicrobial activity against at least 
one indicator strain. B21, B31 and B33 produced the most active antimicrobial substances 
amongst the strains examined with B21 demonstrating the greatest inhibitory activity. 
The antimicrobial activity of LAB strains using Spot-test assay appeared higher due to the 
production of both acid and bacteriocin in the culture supernatant.  
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The B21 activity was completely eliminated after treatment with proteinase K but was 
more resistant to trypsin and pepsin. The optimum conditions for bacteriocin production 
consisted of the growth of the B21 culture in MRS broth (containing glucose as carbon 
source and complex nitrogen source) with initial pH of 6.0, at 30 °C for 24 h without 
agitation. A low or modest growth rate at high population density (109 CFU/mL) at a  
pH > 4.5 was required for bacteriocin production.  These conditions were used to produce 
larger amounts of bacteriocin for purification and characterisation purposes. 
 
The phylogenetic analysis based on the 16S rRNA sequencing revealed that six out of 
eight isolates were L. plantarum strains and the remaining two isolates were L. brevis 
strains. PCR-based approaches mapped the bacteriocin-related genes in LAB strains and 
classified the L. plantarum strains into specific pln locus groups, based on their pln locus 
structure (Sáenz et al. 2009). Four out of eight LAB strains (B20, B21, B31 and B33) 
contained thirteen pln genes and were classified with the reference strains WCFS1 and 
C11 (Anderssen et al. 1998; Diep, Håvarstein & Nes 1996; Kleerebezem et al. 2003; Siezen 
et al. 2012). Each of these should in principle have the potential to produce a classical 
type II bacteriocin. LAB strain A6 was shown to contain a different type of pln locus 
structure and was classified in the same locus group as the J23 reference strain (Rojo-
Bezares et al. 2008). The remaining strains, B14, B15 and A17, all lacked a complete pln 
locus. 
 
Sequencing and analysis of several bacteriocin structural and regulatory genes from strain 
B21 demonstrated high similarity of these genes to the pln reference genes from strain 
WCFS1. The bacteriocin regulatory gene plNC8HK from strain A6 also showed high 
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similarity to plnC8K from reference strains J23 and NC8. A bacteriocin related gene 
responsible for the immunity to two-peptide bacteriocins was identified in LAB A17 even 
though it lacked most of the pln locus. Sequencing and analysis of several larger than 
expected PCR products from strains B14 and B15 identified genes that appeared not to be 
directly related to bacteriocin production.  
 
The full genome sequence for B21 has been obtained with good coverage from the 
Illumina platform and partially assembled Ion Proton data was obtained for four other 
LAB strains B15, B20, A6 and A17. A detailed analysis of the classical pln loci has revealed 
the pln locus from LAB B21 was disrupted by a novel transposon insertion which 
interrupted the bacteriocin production regulatory operon plnABCD. A number of other 
pln genes, most notably the plnH, were also subjected to mutation which is predicted to 
impair function. The same transposon gene was identified in two other LAB strains. The 
transposon appeared to be unique, and had not been reported previously in L. plantarum 
strains.  
 
Ion Proton sequencing of LAB strains B15, B20, A6 and A17 provided a quick method to 
map and establish the presence of the genes of interest to facilitate comparison between 
strains, although de novo assembly of this data was at best only partial. The Ion Proton 
data confirmed the presence of the pln genes in strains B20 and A6 and the lack of the pln 
locus in strains B15 and A17. In addition, the 16S rRNA sequence deduced from the Ion 
Proton data for the LAB strains was used to validate and extend the previous phylogenetic 
analysis of the LAB strains. 
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The unidentified (not classical) bacteriocin protein from the B21 culture supernatant was 
successfully purified by a four-step process consisting of a cell free supernatant (CFS) 
concentration step, extraction into butanol, desalting/buffer-exchange on Sephadex G-25 
and a final cation exchange chromatography (FPLC) step.  
 
The purity of the protein sample was confirmed by a single major peak on a RP-HPLC C18 
column and single peak on MALDI with a mass of 5668 Da. CD spectroscopy was used to 
investigate the secondary structure of the protein and showed that the protein was 
predominantly α-helical (69%). The partial sequence of the purified bacteriocin protein 
was revealed using a de novo sequencing approach by means of ESI-LC-MS/MS 
techniques. Two short sequences were obtained manually from the MS/MS data and 
mapped directly to the corresponding genomic sequence.  A consistent difference in the 
theoretical versus experimental mass of 18 Da, strongly suggested that the bacteriocin 
was in fact cyclic. The new bacteriocin was named plantacyclin B21AG.  
 
Unexpectedly, all the bacteriocin activity observed in LAB B21 arises from the new cyclic 
bacteriocin locus. Plantacyclin B21AG has 67% identity to the pentocin KCA1 (Anukam et 
al. 2013) and was shown to be stable and partially resistant to proteolysis but had a 
limited spectrum of bacterial killing. A further bioinformatics analysis of related genomes 
for LAB isolates revealed that most LAB have only one set of functional bacteriocin genes. 
It is hypothecated that the classical locus has been disabled in B21 to allow production of 
the new cyclic bacteriocin, i.e. organisms can tolerate only one functional bacteriocin 
system at a time for reasons of self-toxicity and immunity limitations. We are not aware 
of any LAB strain that simultaneously produces more than one class of bacteriocins. The 
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new cyclic bacteriocin seems to offer properties that would be desirable for food 
preservation in terms of pH and temperature stability, particularly if it had a wider range 
of bacterial killing. The real possibility exists that a ‘wider killing range’ requires the 
production of a mixture of bacteriocins produced by a community of LAB organisms each 
potentially producing a different class of bacteriocin. Augmenting the action of the new 
cyclic bacteriocin by co-production of a more classical bacteriocins may offer real 
potential for the development of enhanced microbial killing systems as anti-infective 
cocktails for the prevention of food spoilage or in health care applications.  
 
Additional studies are required to evaluate the antimicrobial activity of plantacyclin 
B21AG against a wider range of LAB and non-LAB bacterial strains which may assist in 
identification of a commercial application for this bacteriocin in the food industry. A 
possible synergic effect and increase in antimicrobial activity that may result from 
combining plantacyclin B21AG with bacteriocins from other classes or with low levels of 
antibiotics, could be investigated. Completing the B21 genome sequence to obtain a 
gapless chromosome will complete a new reference genome, the only L. plantarum 
genome so far identified that encodes the synthesis of a novel cyclic bacteriocin. 
Plantacyclin B21AG would be a good candidate for determination of a high resolution 
three-dimensional structure by NMR techniques, as for carnocyclin A (Martin-Visscher et 
al. 2009) and AS-48 (Maqueda et al. 2004). Plantacyclin B21AG is currently the only 
known cyclic bacteriocin from L. plantarum, a species with many probiotic strains of 
commercial interest. 
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Future genomics work to complete a gapless genome is required. The literature suggests 
that further plasmid sequences are likely to be present.  
A full genomic analysis of B31 and B33 would be interesting, as these are also bacteriocin 
producing strains with a similar inhibitory activity.    
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Appendix 
Complete genome sequence of Lactobacillus plantarum B21, a bacteriocin-
producing strain isolated from Vietnamese fermented sausage nem chua 
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Lactobacillus plantarum B21 was isolated from Vietnamese sausage (nem chua) and 
demonstrated broad antimicrobial activity due to the production of bacteriocin(s). Here, we report 
the complete genome sequence of this strain (3,284,260 bp).   
 
Current interests in lactic acid bacteria (LAB) especially Lactobacillus plantarum have increased 
because of their application as starter cultures in food fermentation (1, 2). LAB produce a variety 
of compounds with antimicrobial activity including acids, hydrogen peroxide, and bacteriocins (3). 
The antimicrobial activity of bacteriocins provide an advantage for the growth of the producer 
strain, creating a selective microenvironment (4) and probiotic strains with antimicrobial activity 
have unique advantages as starter cultures in food applications. The L. plantarum B21 strain was 
isolated from the Vietnamese fermented sausage nem chua (5) and showed activity against a 
wide range of Gram-positive bacteria due to the production of bacteriocin(s). To date, there are 
only six L. plantarum strains that have been completely sequenced and annotated. Here we 
report the gapless chromosome sequence of L. plantarum strain B21.  
The B21 genome was sequenced using the Illumina HiSeq 2000 sequencing platform (BGI, 
China). A total of 527 Mb of data was produced with next-generation Illumina paired-end 
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sequencing technology. A genome library containing different fragment length insertions (500 bp 
and 6 kb) was constructed, and 6,354,788 of paired end 90-bp reads, were generated with 164 
fold coverage of the genome. The de novo assembly was performed using SOAPdenovo (6, 7) and 
consisted of 29 contigs and 20 scaffolds. Contigs were further assembled using multiple assembly 
software. Finally the SOAPdenovo software was used in combination with a PCR approach to close 
the gaps and correct the mis-assemblies. This resulted in an optimised assembly consisting of one 
final super-scaffold and one contig.  The Glimmer 3.0 programme was used to conduct gene 
prediction and the obtained gene sequences were compared manually with sequences from the 
databases for functional gene annotation. The rRNAmmer, tRNAscan and Rfam software were 
used to predict rRNA, tRNA and sRNA respectively (8-10). 
The complete genome sequence of L. plantarum B21 showed one circular chromosome of 
3,284,260 bp with a GC content of 44.47%. The chromosome contains 3,117 genes with the total 
length of 2,766,912 bp, which made up 84.3% of the genome. The average gene length was 887 
bp and the GC content in the gene region was 45.5%. The number of rRNA, tRNA and sRNA genes 
was 17, 65 and 2 respectively. There is ambiguous evidence for the presence of a number of 
natural plasmids in this strain, which are currently under further investigation.  
Comparison of the B21 genome with the L. plantarum WCFS1 reference strain (Genbank 
accession number AL935263.2) revealed that 2668 out of 3117 genes (80.17%) of B21 aligned well 
with those of WCFS1 with a mean identity of 99%. There were 449 unique genes in the B21 
genome that did not align to WCFS1.  
The presence of classical bacteriocin (pln) structural and immunity genes was confirmed. The 
significant number of transpositions relative to its nearest neighbour WCFS1, confirm the well-
known plasticity of the LAB genome and this Vietnamese isolate. 
Nucleotide sequence accession numbers. The complete genome sequence of L. plantarum 
B21 has been deposited in NCBI GenBank under accession number CP010528.  
APPENDIX 
 
310 
 
ACKNOWLEDGMENTS 
This work was supported by RMIT University. AG thanks Commonwealth Government Australia 
for an RTS award.  
 
REFERENCES 
1. Gao, Y., D. Li, and X. Liu. 2014. Bacteriocin-producing Lactobacillus sakei C2 as starter 
culture in fermented sausages. Food Control 35:1-6. 
2. Hugas, M., and J. M. Monfort. 1997. Bacterial starter cultures for meat fermentation. 
Food Chem 59:547-554. 
3. Cintas, L. M., M. P. Casaus, C. Herranz, I. F. Nes, and P. E. Hernández. 2001. Review: 
Bacteriocins of Lactic Acid Bacteria. Food Sci Tech Int 7:281-305. 
4. Vogel, R. F., B. S. Pohle, P. S. Tichaczek, and W. P. Hammes. 1993. The Competitive 
Advantage of Lactobacillus curvatus LTH 1174 in Sausage Fermentations is Caused by 
Formation of Curvacin A. Systematic and Applied Microbiology 16:457-462. 
5. Tran, K. T. M., B. K. May, P. M. Smooker, T. T. H. Van, and P. J. Coloe. 2011. Distribution 
and genetic diversity of lactic acid bacteria from traditional fermented sausage. Food 
Research International 44:338-344. 
6. Li, R., Y. Li, K. Kristiansen, and J. Wang. 2008. SOAP: short oligonucleotide alignment 
program. Bioinformatics 24:713-714. 
7. Li, R., H. Zhu, J. Ruan, W. Qian, X. Fang, Z. Shi, Y. Li, S. Li, G. Shan, K. Kristiansen, S. Li, H. 
Yang, J. Wang, and J. Wang. 2010. De novo assembly of human genomes with massively 
parallel short read sequencing. Genome Res 20:265-272. 
APPENDIX 
 
311 
 
8. Lagesen, K., P. Hallin, E. A. Rodland, H. Staerfeldt, T. Rognes, and D. W. Ussery. 2007. 
RNAmmer: consistent and rapid annotation of ribosomal RNA genes. Nucleic Acids Res 
35:3100-3108. 
9. Lowe, T. M., and S. R. Eddy. 1997. tRNAscan-SE: a program for improved detection of 
transfer RNA genes in genomic sequence. Nucleic Acids Res 25:955-964. 
10. Gardner, P. P., J. Daub, J. G. Tate, E. P. Nawrocki, D. L. Kolbe, S. Lindgreen, A. C. 
Wilkinson, R. D. Finn, S. Griffiths-Jones, S. R. Eddy, and A. Bateman. 2009 Rfam: updates 
to the RNA families database. Nucleic Acids Res 37:D136-140. 
 
 
 
 
